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Abstract 
Axons are equipped with an exploratory tip, the growth cone, to navigate and sense 
the cues presented by the surrounding environment. Several families of ligands are 
present along the axonal pathways, while their receptors are expressed on the growth 
cone and allow different axons to follow a great variety of trajectories. However, the 
number of molecules involved could be considered relatively small if compared to the 
diversity of trajectories, speed of growth and arborization patterns present in developed 
organisms. The fine tuning and the integration of different guidance cues represent good 
mechanisms to amplify and diversify the outputs of a relatively small number of 
ligand/receptor systems. The molecular players taking part in the modulation and 
integration of different signaling are not yet fully elucidated. In this study I focused on 
three intrinsic mechanisms to modulate receptor tyrosine kinase signaling: 
dephosphorylation by receptor protein tyrosine phosphatases (RPTPs), receptor cleavage 
and receptor cross-talk.  
First, I analyzed TrkB, Ret and Eph receptor interaction with RPTP type O (PTPRO) 
in trigeminal and motor neurons. PTPRO is expressed mainly in TrkB+ and Ret+ 
mechanoreceptors within the TG during embryogenesis. In PTPRO mutant mice, the 
maxillary and ophthalmic branches of the trigeminal ganglion grow more complex arbors 
than in littermate controls. Cultured PTPRO-/- TG neurons display enhanced axonal 
outgrowth and branching in response to BDNF and GDNF compared to control neurons, 
indicating that PTPRO negatively controls the activity of BDNF/TrkB and GDNF/Ret 
signaling. Mouse PTPRO fails to regulate Eph signaling in retinocollicular development, 
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in hindlimb motor axon guidance, and in transfected heterologous cells, suggesting that 
chick and mouse PTPRO have different substrate specificities. 
On a second approach to identify intrinsic mechanisms to regulate receptor signaling, 
I analyzed how receptor cleavage regulates EphA4 signaling during development. Upon 
characterizing EphA4 cleavage in vitro, I generated a knock-in mouse carrying a 
mutation that made the EphA4 receptor cleavage resistant (EphA4CR). Abolishing EphA4 
cleavage led to an increased expression of the full-length protein in hindlimb 
mesenchyme and in dorsal spinal cord, but not on motor neuron soma or axons. 
Moreover, in EphA4CR embryos, LMCL neurons were aberrantly rerouted to the ventral 
mesenchyme, similarly to the guidance defects observed in EphA4-/- embryos. 
Interestingly, two other phenotypes present in EphA4-/- mice, the shallowing of the dorsal 
funiculus and the loss of the anterior commissure, were not present in EphA4CR mice, 
suggesting that cleavage is only required for certain EphA4 functions. 
Finally, I studied, in collaboration with Dr. Irina Dudanova, the molecular 
mechanisms underlying EphA4 and Ret cooperation in motor axon guidance at the sciatic 
plexus. We demonstrated that the two signaling systems act in parallel and independently 
to guide LMCL axons in the dorsal mesenchyme of the hindlimb. When presented as 
opposing gradients, GDNF and ephrinAs cooperated and triggered a stronger turning 
response, suggesting that Ret and EphA4 exert different effects on the same growth cone. 
The in vitro results were consistent with the in vivo expression of the two proteins, where 
GDNF expressed dorsally to the choice point attracts LMCL axons, and ephrinAs 
expressed ventrally repel them. This represents the first example of two opposing cues 
Abstract 
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acting in an additive manner to promote the same guidance choice at an intermediate 
target. 
Taken together these data provide new insights in understanding the regulation of 
receptor signaling by modulatory proteins or by other receptors.  
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1. Introduction 
During embryonic development neurons need to find their appropriate synaptic 
targets among many possible. Each axon terminates with an exploratory tip, the growth 
cone, which is equipped with several receptors to sense different cues in the surrounding 
environment. These cues can be either membrane-bound or soluble, and can provide 
trophic or tropic support. Several families of receptors/ligands are expressed on growth 
cones and in their target tissues and allow different axons to follow a great variety of 
trajectories. Neurons receive support for their outgrowth, branching and survival from 
neurotrophic factors and guidance direction from several families of axon guidance 
molecules [1]. 
In the last decades, four conserved families of axon guidance molecules have been 
identified: ephrins, netrins, semaphorins and Slits. In addition to these well characterized 
families, further guidance factors have more recently been described, e.g. morphogens 
such as Wnts and sonic hedgehog (SHH), growth factors such as hepatocyte growth 
factor (HGF), glial cell line-derived neurotrophic factor (GDNF), immunoglobulin family 
cell adhesion molecules (Ig-CAMs), and protocadherin family (reviewed in [2]). 
However, the numbers of ligand/receptor systems can be considered relatively small if 
compared to the complexity of the nervous system. Nonetheless, regulation and 
integration of guidance cues may represent mechanisms by which only a few molecules 
are sufficient to ensure the correct formation of a great variety of structures in the 
nervous system (as well as in other tissues). Work over the past years has identified 
several means of yielding diverse outcomes from the same ligand/receptor system: firstly, 
the controlled regulation of the molecule’s expression (by alternative splicing, 
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microRNAs, etc.); secondly, the intrinsic (neuron type-specific) or extrinsic regulation of 
the signal transduction pathways; lastly, the interaction with other receptors [3].  
1.1. Receptor Tyrosine Kinases: an overview  
Cells express on their surface a plethora of receptors to transduce a great variety of 
extracellular stimuli. There are three main classes of receptors: G-protein coupled 
receptors (GPCRs), ion channels and enzyme-coupled receptors. The latter can either act 
as an enzyme upon ligand binding or be associated with an enzyme. Among the enzyme-
coupled receptors having their own catalytic activity, the most prominent family is the 
receptor tyrosine kinase family (RTKs) [4]. 
In humans there are 20 subfamilies of RTKs, which share similar structures. The 
mechanism of activation and the downstream pathways are conserved from nematode to 
humans. Mutations that affect RTK activity, abundance, cellular localization or tissue 
expression are associated with numerous diseases, including inflammation, cancer, 
diabetes, and arteriosclerosis [5]. 
Generally, RTKs are activated by dimerization and act on common downstream 
pathways: mitogen activated protein kinase (MAPK), Akt, phospholipase C gamma 
(PLCγ) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). The 
first substrates of the kinase activity are the tyrosine residues present on the receptor, 
which then act as docking sites for adaptor proteins containing Src Homology 2 (SH2) 
and Phospho Tyrosine Binding (PTB) domains. In the absence of a ligand, kinase activity 
is often blocked by an auto-inhibitory mechanism, which can vary among different 
RTKs. For example, in the insulin receptor the auto-inhibitory tyrosine is in the kinase 
loop, whereas in the MuSK receptor the auto-inhibitory tyrosines are located in the 
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juxtamembrane region. Moreover, when not bound to their ligands, receptors can be kept 
in a dephosphorylated state by interaction with protein tyrosine phosphatases (PTPs). 
Pharmacological blockade of PTPs results in a general increase of RTK activation [5]. 
Once the receptor has been activated, it can receive positive and negative feedbacks, 
which can modulate the strength and the duration of the signaling output [5]. Amongst 
others, two families of transmembrane proteins have been characterized as RTK 
regulators: the receptor protein tyrosine phosphatase (RPTP) family and the LIG family 
of leucine-rich repeat (LRR) and immunoglobulin proteins. 
In the following paragraphs I will focus on three RTK subfamilies that play a well-
established role in neuron growth and guidance: Trk, Ret and Eph receptors.  
1.1.1. Neurotrophin/Trk receptor signaling 
The neurotrophin family, in mammals, has four members: nerve growth factor (NGF), 
brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 
(NT-4/5). Neurotrophins act as dimers and are secreted as precursors (pro-neurotrophins). 
Pro-neurotrophins can be cleaved intracellularly (in the trans-Golgi network) by furin and 
other pro-hormone convertases, or extracellularly by plasmin. Neurotrophins bind to two 
classes of receptors: the tropomyosin-related kinase (Trk) receptor family and 
neurotrophin receptor p75 (p75NTR), a member of the tumor necrosis receptor 
superfamily. p75NTR is a common receptor for all neurotrophins, and although it lacks a 
catalytic domain, it regulates neuronal survival and differentiation through interaction 
with other receptors. p75NTR can also act as a co-receptor for the Trk receptors, 
increasing their affinity for the ligand [6, 7].  
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In mammals, the Trk receptor family has only three members: TrkA, TrkB and TrkC. 
Each receptor is characterized by the presence of two cysteine-rich clusters, three 
leucine-rich repeats and two immunoglobulin-like domains in the extracellular region, a 
transmembrane domain and an intracellular kinase domain (Figure 1-1). The membrane-
proximal immunoglobulin domain has been described as important for the binding of 
neurotrophins [8]. Trk receptors undergo alternative splicing generating several isoforms, 
which can either differ by a few amino acids within or around the immunoglobulin 
domain, or be truncated versions of the receptors, lacking portions of the intracellular 
domain. Differences in the immunoglobulin domain modify the affinity of Trk receptors 
to specific neurotrophins, generally to the non-preferred ligands [9, 10]. The truncated 
receptors have different functions than their full-length counterparts: they can either 
initiate their own signaling cascade or act as dominant negative regulators of Trk 
signaling [11, 12]. 
 
Figure  1-1. Structure of Trk receptors and p75 
Schematic drawing of Trk receptors. The Trk extracellular region contains two cysteine-rich clusters (C1-
2), three leucine-rich repeats (LRR1-3) and two immunoglobulin-like domains (Ig1-2). The intracellular 
region has a tyrosine kinase domain. p75 has four cysteine-rich clusters (CR1-4) and an intracellular 
domain lacking kinase activity. NGF is TrkA ligand, BDNF and NT-4/5 are TrkB ligands, and NT-3 is the 
ligand for TrkC (black arrows). p75 binds all neurotrophins with low affinity (grey arrows). 
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TrkA, TrkB and TrkC bind with high affinity to NGF, BDNF and NT-3, respectively. 
TrkB can also bind NT-4/5 (Figure 1-1). Upon ligand binding these receptors dimerize, 
trans-phosphorylate the tyrosine residues in their intracellular domains, and activate 
several signaling pathways. In vertebrates, Trk receptors have 10 conserved tyrosine 
residues that can be phosphorylated upon ligand binding. Three of these tyrosines are 
present in the autoregulatory loop of the kinase domain, thereby controlling receptor 
activation [13].  
 
Figure 1-2. BDNF/TrkB signaling cascade 
Schematic drawing of TrkB signaling. Upon BDNF binding TrkB forms dimers and several of its 
intracellular tyrosines become autophosphorylated. The phospho-residues act as docking sites for few 
adaptor proteins, which activate several downstream pathways, like MAPK/ERK, PI3K, PLCγ. 
In TrkA the two main phospho-tyrosines are tyrosine 490 (tyrosine 484 in TrkB) and 
tyrosine 785 [14]. Tyrosine 490 acts as a docking site for Src homologous and collagen-
like (Shc) and fibroblast growth factor receptor substrate 2 (FRS2), and tyrosine 785 for 
PLCγ. Shc triggers the transient activation of Ras, which then starts the phosphoinositide-
3-kinase (PI3K) and MAPK/ERK signaling pathways; FRS2 recruits Crk, which binds 
the guanine nucleotide exchange factor, C3G [15-17]. Recruitment and phosphorylation 
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of PLCγ leads to formation of phosphatidylinositol-(1,4,5) triphosphate (IP3), which 
stimulates the release of calcium from intracellular storage compartments, and diacyl 
glycerol (DAG), which activates protein kinase C (PKC) [8]. Although tyrosines 490 and 
785 are the main phosphorylation sites, knock-in mice in which these tyrosines have been 
converted to phenylalanine do not show major abnormalities, suggesting that there is a 
redundancy of phospho-tyrosines that can start the downstream signaling pathways [18-
20]. Finally, the tyrosines in the autoregulatory loop can recruit growth factor receptor-
bound protein 2 (Grb2) [21, 22], and c-Abl can also bind to non-phosphotyrosine residues 
[23, 24] (Figure 1-2).  
1.1.1.1. Neurotrophin/Trk signaling for neuron survival 
According to the neurotrophic factor hypothesis, between embryonic day 13 (E13) 
and 18 (E18) neurons generated in excess during development undergo programmed cell 
death, because they compete for limited amount of neurotrophic factors present in the 
target tissues [25, 26]. Genetic ablation of neurotrophin and Trk genes in most of the 
cases, with the exception of NT-4/5, affects mouse viability and the survival of several 
populations of peripheral neurons [13]. Although in vitro neurotrophins promote survival 
of several populations of neurons, in vivo their role seems to be restricted to specific 
populations [8]. 
NGF and TrkA knockout mice display loss of neurons in superior cervical ganglia 
(SCG), dorsal root ganglia (DRG) and trigeminal ganglia (TG). In the DRG there is a loss 
of calcitonin gene related peptide positive (CGRP+), IB4 positive (IB4+) and substance P 
positive (SP+) neurons, and in the spinal cord, projections to lamina I and II (nociceptive 
fibers) are lost. As a consequence of this loss of nociceptive neurons, knockout mice are 
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less sensitive to pain. Moreover, these mutant mice have a reduced number of low-
threshold mechanoreceptor [27-30]. In the central nervous system (CNS), TrkA and NGF 
knockouts show loss of cholinergic projections, although the number of neurons is not 
affected [30]. 
TrkB and BDNF knockout mice display loss of SCG, TG, vestibular, nodose, 
trigeminal mesencephalic nucleus and DRG neurons. The DRG neurons lost in these 
knockouts are a subset of the cutaneous mechanoreceptors. NT-4/5 knockout mice have a 
reduced number of nodose and geniculate neurons, and this phenotype is enhanced in NT-
4/5-/-;BDNF-/- mice  [31-35].  
Based on their expression patterns, TrkC and NT-3 have been associated with 
neurons responsible for proprioception. Consistent with this observation, mutant mice for 
either the ligand or the receptor are impaired in movements and have abnormal postures. 
NT-3 and TrkC mice display loss of neurons in the SCG, in the TG, in the nodose 
ganglion, in the cochlear ganglion and in DRGs. Sensory projections connecting to motor 
pools in the spinal cord (Ia projections, proprioceptive axons) are missing. Moreover, in 
these mice Golgi tendon organs, muscle spindles and sensory peripheral innervation are 
absent. NT-3 mutant mice show a more severe phenotype than the TrkC knockouts, 
suggesting that NT-3 may have additional receptors [36-41].  
Interestingly, a recent paper showed that TrkA and TrkC, but not TrkB are able to 
signal independently of neurotrophin binding. Over-expression of these receptors is 
sufficient to trigger cell death in absence of the ligand, and if NGF or NT-3 are added to 
the neurons, cell death is rescued [42]. This data further prove the hypothesis that TrkA 
and TrkC act as dependence receptors. Dependence receptors are receptors able to initiate 
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two signaling cascades: one in the presence of ligand, leading to survival, differentiation 
or migration; and another one in the absence of the ligand, which triggers or amplifies 
signaling, leading to programmed cell death [43].  
1.1.1.2. Other neurotrophin/Trk functions in the central and peripheral nervous 
system 
In addition to their well-established roles in neuron survival, neurotrophins and Trk 
receptors have been implicated in differentiation, modulation of axonal and dendrite 
outgrowth and guidance, and in the regulation of synaptic plasticity [13].  
In vivo, it has been possible to uncover additional functions of neurotrophin signaling 
only upon crossing neurotrophin and neurotrophin receptor mutants with Bcl-2 associated 
X protein (Bax) knockouts. Removing Bax prevents apoptosis, and allows the uncoupling 
of neurotrophin effects on survival from those on specification. TrkA/Bax and NGF/Bax 
double knockouts show a milder loss of neurons compared to TrkA or NGF single 
knockouts. In NGF-/-, TrkA+ neurons are unable to differentiate into CGRP+, Ret+ and 
SP+ neurons [44]. This in vivo data are supported by the ability of NGF to induce 
neuropeptide expression in cultured embryonic DRG neurons [44]. 
A role for neurotrophins as guidance molecules has been speculated since the 
discovery of NGF-induced neurite outgrowth in cultures [45]. All neurotrophins trigger 
neurite outgrowth in embryonic sensory neuron cultures [46, 47]. The in vivo relevance 
of TrkA signaling in supporting neurite outgrowth was assessed, as described before for 
TrkA role in differentiation, in TrkA/Bax knockouts. In these mice spinal cord innervation 
is unaffected, but cutaneous innervation is disrupted, suggesting that NGF/TrkA signaling 
is required for peripheral innervation, and the absence of projections in the spinal cord of 
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NGF or TrkA knockouts is secondary to cell death [44]. Mice over-expressing NGF or 
BDNF in the dermis provide further evidence for a role of neurotrophins in regulating 
peripheral innervation. since these transgenic mice display hyper-innervation of the 
whisker pad and the dermis [48]. In addition to their trophic functions, neurotrophins can 
act as attractive guidance cues for mouse DRG neurons and Xenopus spinal neurons 
when presented in a gradient [47, 49]. Surprisingly, neurotrophins can also act as 
chemorepellents when cyclic adenosine monophosphate (cAMP) and cyclic guanosine 
monophosphate (cGMP) are inhibited [49]. Although in vitro neurotrophins are able to 
steer the growth cones of several types of neurons, in vivo data support a role for 
neurotrophins in regulating outgrowth, branching and target innervation of several 
neuronal populations, but not axon pathfinding [50]. 
A role for neurotrophins in regulating synaptic plasticity is shown by several lines of 
evidence, including the regulation of their secretion by neuronal activity and their ability 
to potentiate synaptic transmission [51]. Neurotrophins are also able to induce structural 
changes, i.e. regulate the size of dendritic arbors of pyramidal neurons, and to enhance 
short- and long-term synaptic transmission. BDNF and TrkB mutants show severe 
impairment of LTP, although basal synaptic transmission is not affected [52, 53]. 
Consistently with impairment in LTP, neurotrophin mutant mice have several behavioral 
abnormalities when performing tasks to assess their ability to learn or memorize. The 
conditional knockout approach allowed the investigation of behavioral defects in mice 
where TrkB was specifically removed from the hippocampus: this resulted in abnormal 
memory acquisition and consolidation in hippocampus-dependent learning tasks [53]. 
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Similarly to BDNF-/- mice, reduction of NGF levels (NGF heterozygous mice) caused 
impairment in the formation and retention of memory [54].  
1.1.2. Ret/GDNF signaling  
GDNF-family ligands (GFLs) belong to the transforming growth factor-β (TGF-β) 
super-family. They are characterized by the presence of six cysteine residues regularly 
spaced to form 3 disulfide bonds (cysteine knot). They are secreted as precursors 
(preproGFLs), and after being activated by proteolytic cleavage, function as homodimers 
[55]. The four GFLs - GDNF, neurturin (NRTN), artemin (ARTN) and persephin (PSPN) 
-  signal via Ret, a transmembrane receptor tyrosine kinase, and one of the four GPI-
anchored GDNF family receptors alpha proteins (GFRα1-4) [56] (Figure1-3).  
 
Figure  1-3. Structure of Ret, GFRαs and GFLs 
Schematic drawing of Ret receptors, GFRα co-receptors and GFLs. The extracellular region of Ret contains 
four cadherin-like domains (Cad1-4) and one cysteine-rich domain (C1). The intracellular region has a 
large intercalated tyrosine kinase domain.  GFRα1, GFRα2 and GFRα3 have three cysteine-rich clusters 
(CR1-3), whereas GFRα4 has only two. GFLs act as dimers. All GFLs bind to Ret, but using different co-
receptors. GDNF binds with high affinity (black arrow) to GFRα1, and low affinity (grey arrows) to 
GFRα2 and GFRα4. Neurturin (NRTN) binds with high affinity to GFRα2, and low affinity to GFRα1 and 
GFRα4. Artemin (ARTN) binds mainly to GFRα3, and with low affinity to GFRα2 and GFRα4. Persephin 
(PSPN) specifically binds GFRα4. 
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Human Ret exists in three isoforms: Ret9, Ret43 and Ret51, which are generated by 
alternative splicing of the 3’ terminus and which differ in the length of their C-terminal 
domains [57]. The Ret43 isoform is the less characterized and the less evolutionarily 
conserved. Genetic studies have shown that Ret9 has a major role in vivo, indeed 
removing only this isoform is enough to reproduce most of the Ret full knockout 
phenotypes [58]. Ret has four cadherin-like domains and a cysteine-rich region in its 
extracellular part, a single transmembrane domain and a large intercalated intracellular 
kinase domain [59] (Figure 1-3).  
 
Figure 1-4. GDNF/GFRα1/Ret signaling complex 
Schematic drawing of Ret downstream signaling upon GDNF activation. GDNF, as a homodimer, binds to 
two molecules of GFRα1 and two molecules of Ret. This ternary complex starts a signaling cascade, upon 
phosphorylation of several tyrosine residues in the Ret intracellular domain. Ret51 isoform has an 
additional tyrosine (Y1096). Via the recruitment of several adaptor proteins, Ret activates different 
signaling pathways: Ras, PI3K, JNK, p38MAPK, Erk5, STAT3, PLCγ. 
Upon ligand binding a ternary complex (GDNF-Ret-GFRα1) is formed and several 
tyrosines in the intracellular domain of Ret are phosphorylated [60, 61]. GDNF induces 
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phosphorylation of several tyrosines [in human Ret residues 752, 905, 928, 981, 1015, 
1062 and 1096 (the last one is only present in the Ret51 isoform)], but tyrosine 1062 has 
a pivotal role in Ret signaling, representing the main docking site for several downstream 
effectors [62, 63]. Growth factor bound proteins 7 and 10 (Grb7 and Grb10) are recruited 
to tyrosine 905, Src to tyrosine 981, signal transducer and activator of transcription 3 
(STAT3) to tyrosine 752 and 928, and PLCγ to tyrosine 1015. Tyrosine 1062 activates 
the Ras-Erk pathway by recruiting FRS2 or docking protein (Dok) 4/5, the JNK pathway 
via Dok1, the PI3K pathway via the Shc/Grb2/Grb-associated-binding protein 1 (Gab1) 
complex, or via insulin receptor substrate (IRS) binding. Moreover, tyrosine 1062 can 
initiate the ERK5 and p38 MAPK pathway although the downstream adaptor is not 
known yet. The two Ret isoforms, although sharing most downstream effectors, have 
some specific interactors: Shank3 binds to the PDZ domain of Ret9, and Grb2 is recruited 
to the tyrosine 1096, which is only present in Ret51 [64] (Figure 1-4). 
1.1.2.1. GDNF, Ret and GFRα1: mouse models 
GDNF, Ret and GFRα1 knockout mice die after birth due to hypodysplasia or aplasia 
of the kidneys and to severe loss of enteric innervation [65-70]. Kidneys, in mammals, 
develop due to a reciprocal interaction of the ureteric bud and the metanephric 
mesenchyme. The ureteric bud, expressing Ret and GFRα1, is activated by GDNF 
secreted by the metanephric mesenchyme. In the absence of GDNF/Ret signaling 
components, the ureteric bud fails to grow and branch, leading to renal agenesis [71-73]. 
Enteric neural crest (ENC) cells give rise to the majority of enteric neurons and glia. ENC 
precursor cells migrate rostro-caudally to reach the enteric wall. The intestinal 
aganglionosis in GDNF, Ret and GFRα1 knockouts is a consequence of aberrant 
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migration and differentiation of the ENC cells [66, 74]. In humans, Ret mutations are 
associated with Hirschsprung’s disease, characterized by the absence of enteric ganglia in 
the colon [75]. 
In contrast to loss of function approaches, knock-in mice carrying mutations that 
constitutively activate Ret, display several neural crest-derived and endocrine tumors. In 
humans, Ret gain-of-function mutations are associated with multiple endocrine neoplasia 
type 2A or 2B (MEN2A or MEN2B) and familial medullary thyroid carcinoma (FMTC). 
In MEN2A, a mutation in one of the extracellular cysteines causes the formation of inter-
molecular disulfide bonds instead of intra-molecular ones, leading to the constitutive 
dimerization (and therefore activation) of Ret. In MEN2B, mutations are localized in the 
intracellular domain of Ret and cause changes in the kinase activity and the specificity of 
substrates [76].  
1.1.2.2. GDNF, Ret and GFRα1 functions in the central and peripheral nervous 
systems 
GDNF was originally identified as a dopaminergic neuron survival factor in vitro 
[77], however GDNF/Ret signaling in vivo is dispensable for their embryonic 
development. In certain animal models of Parkinson disease GDNF/Ret signaling 
prevents dopaminergic neuron loss and promotes functional recovery [78, 79].   
Work over recent decades has identified GDNF as a neurotrophic factor for several 
other types of neurons, including petrosal and motor neurons [80-84]. In addition to its 
survival effects on motor neurons in vivo and in vitro, GDNF/Ret signaling is important 
for motor neuron specification. At E12.5, motor neurons of the cutaneous maximus (CM) 
and latissimus dorsi (LD) pools are misplaced in the spinal cord of GDNF knockout 
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mice, although their survival is not affected. This misplacement is phenocopied in PEA3 
knockouts. PEA3 is a transcriptional factor of the ETS family required for cell body 
positioning, muscle innervation dendrite morphology and afferent synapse formation of 
the CM and LD motor pools. Work by Haase et al. showed that GDNF/Ret signaling is 
required to induce PEA3 expression in the CM and LD motor pools [85]. The role of 
GDNF/Ret signaling in motor neuron axon guidance will be further discussed later in this 
thesis. 
Another role of GDNF is the regulation of cell migration and peripheral innervation 
[55]. GDNF, Ret and GFRα1 knockout mice show, already in embryonic stages, loss of 
the otic and sphenopalatine ganglia, two parasympathetic ganglia. GDNF is expressed 
within or around the parasympathetic precursor cells, which express Ret and GFRα1, and 
is required for their migration and proliferation [86]. Although GDNF/Ret signaling is 
dispensable for DRG and TG neurons during embryonic development, it may be required 
postnatally for survival and target innervation. For example, in postnatal stages, there is a 
loss of myelinated mechanoreceptors in GDNF heterozygous mice and local hyper-
innervation in mice over-expressing GDNF [87, 88].   
Ret expression labels two classes of sensory neurons. Most Ret-expressing neurons in 
the DRGs are small to medium diameter non-peptidergic nociceptors and express TrkA in 
the early stages of development and Ret only after E15. GDNF/Ret signaling has a 
central role in their maturation and cutaneous innervation [89]. The second class of 
neurons consists of large-soma neurons, which express Ret prior to E11.5 and do not 
express TrkA. GDNF/Ret signaling is required here for the formation of neural circuits 
underlying touch perception [90].  
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1.1.2.3. GDNF and Ret can signal independently of each other 
In the nervous system, GFRα family members are more widely expressed than Ret, 
suggesting that they can have diverse roles, probably interacting with other 
transmembrane receptors or in a homophilic manner. Indeed, Ret-independent GDNF 
signaling has been implicated in cell migration and synapse formation through interaction 
with the p140 neural cell adhesion molecule (p140NCAM) and GFRα1 [91, 92]. In vitro, 
the formation of a ternary complex GDNF/GFRα1/NCAM reduces homophilic 
interaction between NCAM molecules. Ex vivo, GDNF/NCAM signaling induces 
Schwann cell migration and cortical and hippocampal neuron outgrowth. NCAM 
knockout mice have a reduced olfactory bulb, due to the aberrant migration of neuron 
precursor cells in the rostral migratory system [92].  
Another role for NCAM-dependent GDNF signaling is the guidance of commissural 
neurons across the spinal cord midline. GDNF signaling promotes the expression of 
PlexinA1 on commissural axons that reached the midline, by inhibiting the calpain-
dependent proteolytic processing of the receptor. The increased expression of the 
PlexinA1 makes commissural axons more sensitive to Sema3B expressed at the floor 
plate. Sema3B repulsion enables these axons to grow away from the spinal cord midline 
in order to reach their final synaptic targets [93]. 
Interestingly, GDNF-mediated GFRα1 homophilic binding has been implicated in 
synapse formation, and was the first example described of ligand-induced cell adhesion 
molecule interaction. GDNF promotes the homophilic interaction of two GFRα1 
molecules expressed in trans on the presynaptic and post-synaptic termini of 
hippocampal neurons. GDNF/GFRα1 signaling is sufficient to promote pre-synaptic 
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differentiation in vitro, and consistently GDNF mutant mice have decreased presynaptic 
puncta and decreased synaptic localization of pre-synaptic molecules in vivo [91].  
Not only GDNF can signal independently of Ret, but also Ret can signal 
independently of GDNF. In sympathetic neurons in vivo and in vitro, Ret can be 
phosphorylated by TrkA in post-natal stages, independently of both GFLs and GFRαs. 
TrkA-induced Ret phosphorylation results in increased growth, metabolism and gene 
expression [94]. Ret over-expression in some cell lines induces apoptosis, through a 
fragment of the receptor intracellular domain, produced after caspase cleavage. 
Interestingly, application of GDNF stops Ret pro-apoptotic activity, suggesting that Ret 
could act, similarly to TrkA and TrkC, as a dependence receptor [95]. 
1.1.3. Eph/ephrin signaling  
Eph receptors are the largest family of RTKs and are divided into A-type (EphA) and 
B-type receptors (EphB), based on their preference for ephrinA or ephrinB ligands. 
However, EphA4 and EphB2 can bind both ephrinAs and ephrinBs. In mammals, there 
are fourteen Eph receptors (nine EphAs and five EphBs) and eight ligands (five ephrinAs 
and three ephrinBs). Eph receptors have a cysteine-rich domain (CRD) and two 
fibronectin-like domains (FN) in their extracellular region; a kinase domain, a sterile-α-
motif (SAM) and a PDZ binding motif (PBM) in their intracellular region. EphrinAs are 
GPI-anchored proteins, characterized by the presence of a globular receptor binding 
domain (RBD). EphrinBs are transmembrane proteins, characterized by the presence of 
an extracellular RBD and intracellular PBM and five conserved tyrosine residues [96] 
(Figure 1-5). 
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Figure 1-5. Structure of Eph receptor and ephrins  
Schematic drawing of Eph/ephrin structures. The extracellular region of Eph receptors contains a ligand 
binding domain (LBD), a cysteine-rich domain (C1) and two fibronectin-like domains (FN1-2). The 
intracellular region has a tyrosine kinase domain, a SAM domain and a PDZ binding motif (PBM). 
EphrinAs are GPI-anchored proteins, with a Receptor Binding Domain (RBD), and ephrinBs are 
transmembrane proteins with a RBD and an intracellular PBM. 
Similarly to other RTKs, upon binding to their ligand, Eph receptors undergo auto-
phosphorylation in their juxtamembrane tyrosines, which leads to the phosphorylation of 
additional tyrosine residues and the complete activation of the kinase domain. Once the 
receptors are activated, adaptor proteins bind to them and activate downstream effectors, 
enhancing cytoskeletal rearrangements [96]. The major downstream effectors of Eph 
signaling are members of the Rho family of GTPases, namely RhoA, Cdc42 and Rac. 
Rho GTPases can shuttle between two conformational states: active (GTP-bound) and 
inactive (GDP-bound) [97]. The shuttling between the two states can be regulated by 
other families of proteins: guanine exchange factors (GEFs), which promote the binding 
to GTP and the release of GDP, whereas GTPase-activating proteins (GAPs) promote the 
release of GTP. 
Eph
ephrinAs
ephrinBs
LBD
CR1
FN1
FN2
SAM
RBD
RBD
PBM
PBM
Tyrosine
Kinase
Introduction 
 
18 
 
 
Figure 1-6. Eph/ephrin forward signaling 
Schematic drawing of Eph signaling. Upon ligand binding, Eph receptors form dimers, and then oligomers. 
Several tyrosines in Eph receptor intracellular domain become phosphorylated and act as docking sites for 
different adaptor proteins, which lead to the activation of GEF proteins (pink ellipses). The main outcome 
of Eph activation is the remodeling of the actin cytoskeleton, through the differential activation of Rac, 
RhoA and Cdc42. The tyrosine residue numbers are referred to EphA4 sequence, in other Eph receptors the 
same tyrosine may occupy a different position. 
Eph receptors trigger Rho GTPase signaling, mainly through activation of GEFs. Eph 
interacting exchange protein (Ephexin) is constitutively bound to EphAs, and in its 
dephosphorylated state triggers the activation of RhoA, Rac1 and Cdc42. Upon ligand 
binding, EphAs phosphorylate ephexin, probably via Src, and this leads to the 
preferential activation of RhoA, which in neurons promotes growth cone collapse [98, 
99]. Remarkably, α-chimaerin and Nck1/Nck2 knockout mice have similar defects in 
cortical and spinal circuit assembly compared to EphA4 knockouts, demonstrating their 
role as essential downstream effectors [100, 101]. Vav2, a common molecule 
downstream of EphAs and EphBs, activates Rac1-dependent endocytosis of Eph/ephrin 
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complexes, enabling cell-cell repulsion [102]. Other downstream effectors are intersectin-
1, Kalirin-7 and Tiam [103] (Figure 1-6).  
1.1.3.1. Distinctive features of Eph signaling 
Eph/ephrin signaling shows some distinctive features: high-order clustering, bi-
directional signaling and endocytosis, receptor and ligand cleavage, and cis-interactions 
[96]. 
Contrary to other RTKs, Eph receptors form oligomers upon activation. After initial 
receptor/ligand binding, more molecules of Eph and ephrin are recruited, via intracellular 
and extracellular interactions, to generate high-order clusters. The CRD of EphA3 plays 
an important role in the lateral expansion of these clusters, whereas the SAM domain of 
EphA4 and EphB2 may be required for the stabilization of oligomers [104-106]. In the 
absence of ligand, EphA2 ectodomains form array-like networks due to parallel staggered 
(LBD-sushi domain) interactions. Upon ephrinA5 binding, in-register arrays are formed 
due to LBD-LBD and sushi domain-sushi domain interactions [107]. Once the high-order 
clusters are generated additional Eph receptors (hetero-oligomerization) or other 
transmembrane proteins (i.e. metalloproteases or Ryk) can be recruited [108-111]. 
One of the most intriguing aspects of Eph/ephrin interaction between two opposing 
cells is bi-directional signaling: one signaling pathway is triggered in the Eph-expressing 
cell (forward signaling) and one in the ephrin-expressing cell (reverse signaling). 
EphrinAs and ephrinBs use different strategies to transduce reverse signaling. EphrinAs, 
as mentioned previously, lack an intracellular domain, hence they often require a co-
receptor to initiate a signaling cascade. For example, in the retina ephrinA5 interacts with 
p75, phosphorylating Fyn and starting a signaling cascade, which trigger cytoskeletal 
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rearrangement and ultimately causes repulsion [112]. Moreover, ephrinA5 binds TrkB to 
regulate axon branching and synapse formation in retinal ganglion cells (RGCs) and 
hippocampal neurons [113]. Upon Eph-induced ephrinB clustering, Src family kinases 
bind to ephrinB cytoplasmic domain and phosphorylate specific tyrosine residues. These 
phosphorylated residues recruit SH2-containing adaptor proteins, such as Grb4, in order 
to promote actin cytoskeleton rearrangements, changes in focal adhesion, pruning and 
spine maturation in neurons [114-116] (Figure 1-7).  
 
Figure 1-7. Eph/ephrin reverse signaling 
Schematic drawing of ephrin signaling. (A) Eph stimulation triggers the phosphorylation of the five 
conserved intracellular tyrosines of ephrinBs, probably via Src activation. The tyrosine residue numbers are 
referred to ephrinB2 sequence, in other ephrinBs the tyrosines may occupy different positions. 
Phosphotyrosines recruit Grb4 and start the reverse signaling. The PBM recruits PDZ-RGS3, which 
prevents CXCR4 activation. (B) ephrinAs, being GPI-anchored protein, need a co-receptor to transduce the 
signal, i.e. p75 or TrkB. ephrinAs activation recruits Src in the lipid rafts, by an unknown mechanism. 
Interestingly, lymphatic vessel remodeling is more affected in knock-in mice carrying a 
mutation in the ephrinB2 PDZ domain than in mice where the five intracellular tyrosine 
residues of ephrinB2 have been mutated [117]. The PDZ domain can act as a docking site 
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for adaptor proteins, like GRIPs or PDZ-RGS3 [118, 119]. The interaction with the latter 
prevents its binding to CXCR4, a G-coupled receptor, leading to inhibition of CXCR4-
mediated chemoattraction [119]. 
The interaction between Eph receptors and ephrins represents an interesting paradox: 
despite initial high-affinity binding, signaling then leads to cell-cell repulsion. Two 
mechanisms have been shown to promote cell-cell detachment after the initial adhesion: 
bi-directional endocytosis and receptor or ligand cleavage by metalloproteases [96]. Both 
EphB receptors and ephrinB ligands undergo bi-directional endocytosis, in order to 
remove the EphB/ephrinB complexes from cell contact sites. To date, the identity of the 
molecular pathways involved in endocytosis in the Eph expressing cell (forward 
endocytosis) and in the ephrin expressing cell (reverse endocytosis) are still poorly 
characterized [120, 121]. In addition to bi-directional endocytosis, EphBs promote 
repulsion from ephrinB expressing cells, by cleavage of the receptors or the ligand. 
HEK293 cells or hippocampal neurons expressing mutant EphB2, unable to be cleaved, 
are no longer able to detach from ephrinB-expressing cells [122]. The relative importance 
of shedding and endocytosis for repulsion in vivo has not been addressed to date. So far 
the only mechanism proposed for EphA mediated cell-cell repulsion is the cleavage of 
the ephrinA GPI-anchor. EphA3, upon binding to ephrinA5, activates ADAM proteases 
that cleave the ephrinA5 GPI-anchor and allow the two cells to detach [110]. Whether 
ADAM cleaves ephrinAs in cis [123] or in trans [110] and if cleavage plays an essential 
role in in vivo guidance is still debated. In vitro it has been shown that EphA4 activates 
bi-directional endocytosis, but whether this is required for repulsion to occur has not been 
shown [121]. 
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Finally, Ephs and ephrins can be expressed either in a complementary pattern or be 
coexpressed in the same cell, suggesting that the receptor/ligand system can have trans or 
cis interactions. Early evidence for cis interaction came from work done in the 
retinotectal system, where ephrinAs negatively regulate the response of coexpressed 
EphAs. Interactions in cis can be LBD-dependent or -independent, and result in a reduced 
receptor phosphorylation, and therefore reduced sensitivity to trans ephrin stimulation. 
The relative expression levels of the two molecules titrate their cis versus trans 
interactions [124-127]. This last aspect will be further discussed in the motor neuron 
guidance paragraph.  
1.1.3.2. Eph receptor functions during embryonic development and in adulthood 
Eph/ephrin signaling plays a pivotal role in embryonic development and in 
maintaining the homeostasis in adult organisms. It is required in a wide range of 
biological functions, such as axon guidance, cell sorting and positioning, vascular and 
lymphatic development, and synaptic plasticity. Consistent with their versatile functions 
during development, disruption of Eph/ephrin signaling is associated with the onset and 
the progression of several human diseases, e.g. cancer [128].   
Eph receptors play an important role in several guidance systems, where axons are 
presented either with a gradient or a bimodal choice. The best characterized example of 
ephrins expressed in a gradient is the retinotopic map [129-131]. Axons from the retina 
project either to the superior colliculus (SC) (optic tectum in chick) or to the thalamus, 
where they synapse on neurons that project to the visual cortex [132, 133]. 
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Figure 1-8. EphA/ephrinA signaling in the retinotopic mapping 
(A,C) Eph receptors and ephrins, expressed in a gradient on both the RGCs and in the superior colliculus, 
play a pivotal role in the formation of the retinotopic map. In mouse and chick, RGCs overshoot their 
future termination zone (TZ), but branching in the correct topographic location refines the projections and 
the posterior axon is eliminated by pruning. Nasal RGCs, expressing low levels of EphAs, project to the 
posterior region of the superior colliculus, expressing high levels of ephrinAs, whereas temporal RGCs, 
expressing high level of EphAs, terminate in the anterior part, where ephrinA expression is low. (B) 
Interstitial branching is prevented by ephrinA reverse signaling anterior to the TZ, and by EphA forward 
signaling posterior to the TZ. The branching is promoted by BDNF/TrkB signaling. The overlap of these 
three activities defines the TZ. 
In the SC each point is unequivocally defined by the graded expression of guidance 
molecules along its two axes, and retinal ganglion cells (RGCs) are equipped with the 
required set of receptors to find their appropriate termination zone. The RGCs enter the 
anterior part of the SC and overshoot their termination zone (TZ). After entering the SC, 
interstitial branches start forming on the axon shaft, preferentially in the future TZ, and 
they grow along the medio-lateral axis. At this point, the projections are refined by 
pruning of the axon posterior to the TZ and elimination of the ectopic branches and 
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arbors [134]. EphrinAs are expressed in a low to high gradient along the antero-posterior 
axis of the SC and along the temporo-nasal axis in the retina. EphAs are expressed in an 
opposing gradient in both SC and retina [130, 135-139]. Hence, nasal RGCs terminate in 
the posterior region of the SC, whereas temporal RGCs project to the anterior SC (Figure 
1-8). Knockout and knock-in mice have confirmed a role for EphA5, EphA3, ephrinA2, 
ephrinA3 and ephrinA5 in retinotopic mapping [135, 136, 140]. Interestingly, it has been 
shown that it is not the absolute but the relative expression level of Eph receptors in 
RGCs that is critical for the correct formation of the map [135]. The other interesting 
aspect is how the peak of interstitial branching is precisely located at the future TZ. One 
model suggests that branching is prevented by ephrinA reverse signaling anterior to the 
TZ and by EphA forward signaling posterior to the TZ [112, 141-144]. BDNF/TrkB 
signaling promotes RGC branching [145]. The TZ is defined by the area where branch 
promotion by BDNF/TrkB signaling is stronger than the Eph-mediated branch-inhibition 
[134] (Figure 1-8). 
 
Figure 1-9. EphB/ephrinB signaling in retinotopic mapping 
EphB/ephrinB signaling guides RGCs along the dorsal/ventral axis. High levels of ephrinBs repel branches 
of RGCs that are formed medially to the TZ. Low levels of ephrinBs act as attractive cues for branches 
formed by RGCs located laterally to the TZ. 
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EphB/ephrinB signaling controls dorsal/ventral mapping of RGCs, and according to 
their relative expression levels, they can have either attractive or repulsive activities. 
EphrinBs are expressed in a low to high medio-lateral gradient in the SC, and in a high to 
low dorsal/ventral gradient in RGCs. EphB receptors are expressed in an opposing 
fashion. RGCs positioned lateral to their TZ form branches in response to an attractive 
ephrinB signal, whereas branches of RGCs positioned medial to their TZ are repelled by 
high levels of ephrinBs (Figure 1-9) [146, 147]. How these two signaling outputs are 
achieved has not been completely clarified to date. Reverse signaling has been proven to 
be important in Xenopus laevis, but does not seem to be conserved in mice [146, 148].  
Another example of Eph-mediated axon guidance is represented by the spinal cord 
midline. Here alteration of EphA4 signaling leads to misprojections of two populations of 
neurons. The corticospinal tract (CST), the major descending motor pathway controlling 
voluntary movements, originates from neurons in layer V of the cortex and navigates 
through the forebrain, midbrain and hindbrain to reach the spinal cord. In the medulla, 
CST axons decussate (cross the midline), and descend the spinal cord in a structure, 
called the dorsal funiculus (DF). Synaptic targets of CST fibers are usually interneurons 
in the dorsal spinal cord, contralateral to the neurons originating in the cortex and 
ipsilateral to the fibers after the decussation [149]. CST axons express EphA4, whereas 
ephrinB3 is expressed at the spinal cord midline. In wild-type animals, ephrinB3 prevents 
EphA4-expressing axons from aberrantly recrossing to the contralateral side. In EphA4 or 
ephrinB3 knockouts, corticospinal axons aberrantly traverse the midline [150-152]. In 
these mutants not only the axons are misguided but also the anatomical structure 
containing them is altered. In EphA4 or ephrinB3 knockout mice the dorsal funiculus 
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appears shallower, already at P0, when CST axons have not yet invaded the spinal cord 
[150-152]. Thus, the alteration in the morphology of the DF, although dependent on 
EphA4, seems independent of the CST tract misguidance. The molecular mechanisms 
underlying these phenotypes are to date unknown, although it is known that EphA4 
kinase activity is required [152]. In addition to being expressed on CST axons, EphA4 is 
expressed by excitatory commissural interneurons (CINs) in the spinal cord [151, 153]. 
Upon removal of either EphA4 or ephrinB3, similarly to as has been described for CST 
axons, CINs fibers aberrantly cross the midline [151]. This leads to altered innervation of 
the locomotor central pattern generator (CPG). Locomotor CPGs are spinal networks of 
neurons, which generate a rhythmic activity and coordinate left-right and flexor-extensor 
alternations. The behavioral consequence of this aberrant innervation is a hopping gait: 
EphA4 and ephrinB3 knockouts do not show alternate limb movement but move left and 
right limbs synchronously (rabbit-like gait). Both excitatory and inhibitory CINs are 
implicated in left-right alternation [154]. Since in EphA4-/- and ephrinB3-/- excitatory 
axons form ectopic synapses on the contralateral CPGs, they override the commissural 
inhibition and abolish left-right coordination [150-153]. 
An example of Eph receptors required as ligands during development is the formation 
of the anterior commissure (AC), a large forebrain tract. It consists of an anterior (aAC) 
and posterior branch (pAC), which connect the two lobes of the olfactory bulbs and the 
medial temporal cortical areas of the two hemispheres, respectively. EphA4 is required 
for the formation of the aAC and pAC, and EphB2 for the formation of the pAC [150, 
152, 155]. EphA4 is not expressed on the aAC tract but on the surrounding cells [152, 
156]. In EphA4-/- mice the aAC and pAC are not formed, however in EphA4KD (kinase-
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dead knock-in) mice the phenotype is rescued, suggesting that the kinase activity, and 
thus the forward signaling, are not required [150, 152]. 
Eph and ephrin expression is maintained in the adult brain, mainly in areas where 
there is active remodeling of neuronal circuits upon environmental changes. In the 
hippocampus, Eph receptors play an important role in learning and memory, through the 
modulation of LTP and long term depression (LTD). EphA4 and EphB2 knockout mice 
have reduced LTP and LTD, although basal synaptic transmission is not impaired. LTP 
and LTD defects were rescued in knock-in mice expressing EphA4 lacking the 
intracellular domain, suggesting that this function is dependent on reverse signaling [157-
161]. Work from our laboratory showed that EphA4, expressed post-synaptically in 
hippocampal neurons, activates ephrinA3, expressed on perisynaptic astrocytes, and via 
reverse signaling regulates the levels of glial glutamate transporters. EphA4 and 
ephrinA3 knockout mice have more glutamate transporters on the astrocyte and less 
glutamate in the synaptic cleft, causing impairment in LTP [158]. 
1.2.  Neuron development: Axon growth and guidance 
To reach their appropriate synaptic targets neurons navigate the environment 
supported by trophic factors and oriented by guidance molecules. Trk, Ret and Eph 
receptors play key roles in development orchestrating the growth rate and the growth 
direction of several populations of neurons.  
In my thesis I focused on two different populations of neurons - trigeminal and motor 
neurons - and analyzed their development, their growth and branching in response to 
ephrins and neurotrophic factors. 
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1.2.1. Trigeminal neurons 
The trigeminal ganglion (TG) is one of the cranial sensory ganglia. It is composed of 
nociceptive, proprioceptive and mechanoceptive neurons, and provides sensory 
innervation to the face, the oral and the nasal cavities. Trigeminal neurons are 
pseudounipolar.  
 
Figure 1-10. Sensory neuron guidance in the trigeminal ganglion 
Scheme of sensory neuron development in the trigeminal ganglion. (A) At E10.5 pioneering axons emerge 
separated into the three branches of the trigeminal ganglion – ophthalmic (blue), maxillary (fuchsia), 
mandibular (green). Target tissues support their growth by secreting BDNF, NT3 and GDNF. (B) At E11.5, 
NGF expression starts to be up-regulated in the target tissues, and axons start invading the target tissues. 
(C) The three branches grow further in the periphery, and their arbors increase in complexity. (D)  
Trigeminal axons are guided towards their targets by the repulsive signaling of Sema3A/Neuropilin1 and 
Sema3F/Neuropilin2. The arborization of the three branches is regulated by the Slit/Robo signaling. 
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The two axons emerge from the opposite sites of the soma: one grows toward the 
periphery, the other enters the hindbrain. In the periphery the TG has three main 
branches: the maxillary, the mandibular and the ophthalmic. Since they emerge from the 
ganglion, axons are separated into three independent routes, each one corresponding to 
one of the peripheral branches (Figure 1-10). In the periphery axons gradually leave the 
nerve to form branched terminal plexi, whereas as soon as they enter the brainstem, they 
bifurcate to form the ascending and descending projections of the trigeminal tract [162]. 
Pioneering axons leave the ganglion at E9.5 reaching the mandibular epithelium by E10.5 
and the maxillary one by E11. The last axons reach their target tissue by E15. The 
number of neurons in the ganglion peaks at E13, and programmed cell death peaks at E14 
[163]. In vitro and in vivo studies have shown that trigeminal neurons have three phases: 
first they are neurotrophin independent (earlier than E10), then their survival is BDNF 
and NT-3-dependent (E10-E13), later it becomes NGF-dependent [163-165]. 
Lack of TrkA/NGF signaling causes a postnatal loss of trigeminal neurons, whereas 
lack of TrkB/BDNF signaling reduces the number of neurons already at E14, reflecting 
the different timing of their requirement for survival. The switch between BDNF and 
NGF happens around E12, when TrkB signaling is inhibited. This inhibition could be 
partially explained by the reduction of TrkB expression, but to date has not been fully 
elucidated [165]. According to their growth rate, trigeminal neurons can be divided into 
slow and fast growing, although these two populations have not been molecularly 
characterized [166]. Consistent with their role in survival, BDNF and NT-3 mRNA are 
detected in the target tissue before the arrival of pioneering axons, whereas NGF is 
detectable only upon target tissue innervation [164, 167-169]. Neurotrophins are poorly 
Introduction 
 
30 
 
expressed in the brainstem, suggesting that survival of trigeminal neurons is mainly 
dependent on peripheral sources [164]. Neurotrophins are also able to modulate the 
growth and arborization of trigeminal neurons during development. In slice culture, NGF 
stimulation leads to increases in axon elongation of both central and peripheral trigeminal 
axons, whereas NT-3 promotes excessive axon branching of these tracts [170].  
Ret is also expressed in developing trigeminal neurons and GDNF is present in the 
target tissue [171-173]. In vitro GDNF is a trophic factor for a subset of trigeminal 
neurons, however Ret-/- and GDNF-/- mice do not show a loss of trigeminal neurons [55]. 
In GDNF knockout mice there are no GFRα1-positive neurons, and GDNF heterozygous 
mice have less myelinated axons and their associated terminals [87, 173]. To date the in 
vivo extent of GDNF/Ret signaling in supporting trigeminal neuron growth and branching 
has not been fully elucidated.  
Trigeminal neurons express several guidance receptors, including neuropilins, Robos 
and Eph receptors. Neuropilin1/Sema3A and neuropilin2/Sema3F signaling are essential 
for the migration of cranial neural crest cells and the formation of the trigeminal 
ganglion. Semaphorins secreted by the target tissues, i.e. cornea or tongue, prevent the 
premature innervation by trigeminal axons [174]. Neuropilin1 and Sema3A mutants show 
normal TG size and positioning, however axon trajectories are severely disorganized. The 
trigeminal arbors are extremely defasciculated and widely spread, and the ophthalmic 
nerve overshoots its termination area [175, 176]. Robo/Slit signaling is required for 
correct development of the peripheral arbors of the ophthalmic branch [177]. Eph 
receptors and ephrins are expressed both in the target tissue and on the trigeminal neurons 
[178]. So far, the only phenotype reported is impairment of vibrissa innervation in 
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EphA4-/- embryos due to the lack of reverse signaling [179]. In addition to classical 
guidance cues, p75NTR plays a role in determining the arborization of the ophthalmic 
branch. In p75NTR knockouts the ophthalmic branch shows a reduced arbor size, 
partially due to defects in neurite elongation, which is partially due to impaired Schwann 
cell migration [180].  
Although in the mouse some of the receptor tyrosine kinases influencing the growth, 
guidance and survival of trigeminal neurons have been well described, the fine-tuning 
mechanisms that allow axons to extend following a great variety of trajectories and with 
different growth rate have not yet been elucidated. 
1.2.2. Motor neurons of the lateral motor columns  
Motor neurons in the spinal cord are organized in pools according to their position 
and their target muscles. Pools of motor neurons vary at different levels of the spinal 
cord. Lateral motor column (LMC) motor neurons are present at the brachial and lumbar 
levels of the spinal cord, and are further subdivided in medial (LMCM) and lateral 
(LMCL) (Figure 1-11). In vertebrates, LMC axons emerge from the spinal cord at E10.5. 
In the hindlimb, LMC axons from the lumbar segment L3-5 follow a common trajectory 
(sciatic nerve) until E11.5, when they reach the sciatic plexus at the base of the hindlimb. 
At the sciatic plexus, the sciatic nerve divides into a ventral (tibial nerve) and dorsal 
branch (peroneal nerve), formed by LMCM and LMCL axons, respectively [181, 182]. 
LMCM neurons express the transcription factor Islet1, which induces the expression of 
EphBs, whereas LMCL express Lim1, which enhances the expression of EphA4 [183, 
184]. LMCL, expressing high levels of EphA4, are repelled by the ventral mesenchyme, 
enriched in ephrinAs; and LMCM, expressing high levels of EphBs, are repelled by the 
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dorsal mesenchyme, enriched in ephrinBs (Figure 1-11). Lim1-/- mice show 
randomization of this dorsal/ventral choice [185]. In EphA4 knockouts, a subpopulation 
of LMCL axons project ventrally, whereas in the triple EphB knockouts or ephrinB1 
knockouts certain LMCM axons project dorsally [183, 184, 186, 187]. 
 
Figure 1-11. LMC guidance in the limb 
Scheme of a limb horizontal cross-section at E12.5. LMCL neurons express high levels of EphA4, Ret and 
ephrinAs. LMCM neurons express high levels of EphBs and Neuropilin2 (Npn-2). The ventral mesenchyme 
expresses ephrinAs, and the dorsal Sema3F, ephrinBs and EphAs. GDNF is expressed slightly dorsally at 
the sciatic plexus. EphA4/ephrinA repulsive signaling (forward signaling) prevents LMCL axons (blue) 
from entering the ventral mesenchyme, whereas ephrinA/EphA attractive signaling (reverse signaling) pulls 
them in the dorsal region. Ret/GDNF signaling cooperates with Eph receptors in guiding LMCL axons 
(green) in the dorsal mesenchyme. EphB/ephrinB and Sema3F/Neuropilin2 repulsive signaling prevent 
LMCM from entering the dorsal region. 
EphA4/ephrinA signaling has had a controversial role in hindlimb axon guidance 
since both ligands and receptor are expressed on the nerve and in the target tissue [188-
190]. EphA4 can act as a receptor on the nerve, but can also act as a ligand in the 
mesenchyme. Work by Sam Pfaff’s group showed that ephrinAs and EphAs can be 
localized in different membrane patches, from where they can signal independently. 
EphA4 forward signal mediates repulsion, whereas ephrinA reverse signaling mediates 
growth cone spreading, an in vitro correlate of axon attraction [190]. A conditional 
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knockout approach showed that both reverse and forward signaling cooperate to refine 
the axonal trajectories. However, removing EphA4 from only the hindlimb mesenchyme 
is not sufficient to cause LMC misprojections, probably because the loss of EphA4 is 
compensated by the presence of EphA7 and EphA3 [191]. Although the importance of 
Eph-mediated attraction and repulsion are well established, it is still unclear how the 
axons become insensitive to Eph-mediated attraction and grow away from this 
intermediate target (sciatic plexus). Since both EphA7 and EphA4 can be cleaved, two 
scenarios are possible: either they act as soluble ligands or cleavage enables the axons to 
detach from the Eph-expressing cells and to grow further into the limb mesenchyme [192, 
193].    
Another level of complexity is added by the ability of Eph receptor and ephrins to 
interact both in cis and in trans. The availability of Eph receptors to bind ephrins in trans 
is titrated by the levels of co-expressed ephrins. Low expression of ephrins on LMC 
axons, favors Eph/ephrin trans-interactions, and axons are repelled by the ephrin-
expressing mesenchyme. High expression of ephrins favors Eph/ephrin cis-interactions, 
preventing Eph-mediated repulsion. Knock-down or over-expression of ephrinA5 or 
ephrinB2 in chick results in LMCM or LMCL misguidance, due to changes in Eph 
receptor availability for trans interactions [126]. 
The fidelity of this dorsal/ventral choice is also enhanced by the presence of other 
guidance systems [194]. In addition to known guidance molecules, two neurotrophic 
factors, HGF and GDNF, are also involved. In vitro HGF is a very strong chemoattractant 
for motor neurons, although its in vivo role is not yet well characterized [195]. GDNF is 
expressed dorsally to the sciatic plexus, and Ret is highly expressed on LMCL axons. 
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Genetic ablation of Ret or GDNF causes misguidance of a subset of LMCL axons, which 
grow erroneously in the ventral mesenchyme of the hindlimb. Interestingly, Ret and 
GDNF knockouts phenocopy EphA4 mutants. More interestingly, EphA4 and Ret double 
knockouts show a more severe phenotype than the single knockouts, hinting for a genetic 
interaction of the two signaling pathways [196]. Similarly, in chick, over-expression of 
EphA4 or Ret on LMCM neurons is sufficient to re-route a subset of their axons to the 
dorsal mesenchyme [186, 196]. Thus, EphA4 and Ret are likely to cooperate in guiding 
LMCL neurons, although the molecular mechanisms of this cooperation are still unclear. 
Another class of receptors and ligands involved in this dorsal/ventral choice is the 
semaphorin/neuropilin family. At brachial level, the repulsive interaction of Sema3F and 
neuropilin2 contributes to LMCL guidance. Sema3A-neuropilin1 regulates fasciculation, 
outgrowth and bifurcation of both LMC populations [197]. 
 Work over the last years has also started to identify potential downstream effectors 
required for LMC guidance. Src and Fyn are expressed in both populations of LMC 
neurons. Knock-down and over-expression experiments in chick, complemented by 
analysis of knockout mice, have shown a requirement for Src and Fyn in axon guidance 
downstream of Eph receptors. Interestingly, LMCM neurons rely more on Src activity for 
their pathfinding than LMCL [198]. If Src and Fyn act only downstream of Eph receptors 
or if they can be common to signaling cascades initiated by different receptors is still 
unknown.  
1.3.  Intrinsic mechanisms to regulate RTKs signaling 
As mentioned above neurons evolved several mechanisms to regulate axon growth 
and guidance. To ensure the proper connection with the right synaptic target several 
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events must take place: 1) receptors and ligands must be complementarily expressed in 
neurons and target tissues; 2) receptors must have the right cellular localization (axon, 
dendrite, soma or growth cones) and soluble guidance cues must be properly distributed 
in the extracellular environment; 3) signaling from different receptors must be transduced 
and integrated; 4) signaling must be modulated and terminated. Each step introduces a 
different level of regulation, and suggests the presence of several families of intrinsic 
regulators of receptor signaling [199].  
Levels and location of ligands and receptors can be regulated transcriptionally (i.e. 
Lim1-induced EphA4 expression in LMCL neurons) or post-translationally (cleavage of 
pro-neurotrophins by furin and metalloproteases) [183, 200]. Mis-expression of a 
receptor or a ligand can result in guidance, outgrowth or branching defects. For example, 
ectopic expression of Ret in LMCM neurons is sufficient to re-route some of them into the 
dorsal shank of the hindlimb [196]. Over-expression of neurotrophins in the target tissues 
causes hyper-innervation by sensory neurons [48].  
Sub-cellular localization can be regulated either by local translation or by interaction 
with co-receptors or scaffolding proteins. Disrupting ephrinA and EphA4 cellular 
localization in motor neurons, dramatically changes the cis versus trans interaction, 
impairing both reverse and forward signaling [190]. Interestingly, a series of studies 
demonstrated that RTKs can signal either from the plasma membrane or from 
intracellular compartments (i.e. endosomes) [201]. Hence, endocytosis not only regulates 
the abundance of receptor molecules available on the plasma membrane but also 
modulates the signal cascades initiated upon ligand binding.  
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The activation of common downstream effectors is one way to integrate signaling. 
Different receptors can converge on the same pathway, i.e. actin cytoskeletal remodeling, 
and differentially regulate some of the pathway components. In C. elegans for example, 
three different receptor/ligand systems – netrin/DCC, Slit/Robo and ephrin/Eph - regulate 
actin-nucleation via the WAVE/SCAR complex during embryonic morphogenesis. The 
three receptors have distinct effects on F-actin, that once integrated, ensure correct level 
and polarization of the actin cytoskeleton during morphogenesis [202]. 
RTKs can interact with different classes of transmembrane proteins which can 
positively or negatively regulate their signaling. Interaction with RPTPs, provides an 
inhibitory mechanism in the absence of the ligand, but also determines the strength and 
the duration of the signaling cascade after ligand stimulation. Another class of RTK 
regulators is the LIG family of leucine-rich repeat and immunoglobulin proteins. Linx1 
enhances BDNF- and GDNF-mediated growth, guidance and branching [203]. On the 
other hand Lrig1 can negatively regulate GDNF-induced neurite outgrowth, partially by 
preventing GDNF binding to Ret [204].   
In the next paragraphs, I will delve into the role of RPTPs in RTK signaling 
modulation and termination; the role of proteolytic cleavage in regulating receptor 
expression and signaling; and finally, the cooperation of different families of guidance 
cues and receptor cross-talk.  
1.3.1. Keeping the phosphotyrosine balance: RPTPs versus RTKs 
Several signaling cascades, based on tyrosine phosphorylation, regulate different 
aspects of development, including cell proliferation, differentiation and axon guidance. 
Work over the last decades has defined a clear role for kinases in the development of the 
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nervous system, however the role, function and substrate of phosphatases has not been 
fully elucidated. In the human genome there are 107 known phosphatases, and 21 of these 
belong to the RPTP family. RPTPs are a family of transmembrane phosphatases, 
involved in axon guidance, regeneration and synapse formation [205]. In vertebrates 
RPTPs are organized into eight subfamilies, according to their extracellular structure and 
number of phosphatase domains. The extracellular domain contains several motifs, 
common to the CAM family. The intracellular domain contains either one or two 
phosphatase domains. In the molecules with two phosphatase domains, i.e. LAR, the first 
phosphatase domain is responsible for 99% of the catalytic activity [206, 207]. The 
cysteine in the phosphatase domain is the key residue for enzymatic activity [208].  
In Drosophila, all the RPTPs expressed are involved in axon growth and guidance of 
motor neurons, photoreceptors, and neurons in the mushroom body, and in the antennal 
and optic lobes. They have been shown to act both as negative and positive regulators. In 
vertebrates, the regulation of growth and guidance is conserved for class II and III 
RPTPs. Among these two classes the best studied are type II RPTPs, which include LAR, 
PTPσ and PTPδ [205].  
To date, several RTKs have been shown as in vitro substrates of RPTPs. However, in 
most of the cases the in vitro data are not supported by an in vivo interaction. Few RPTPs 
have been proposed as regulators of Trk and Eph receptor signaling, but to date there is 
no RPTP shown to regulate Ret signaling. TrkB is a substrate for LAR and PTPσ, 
although the former acts as a positive and the latter as a negative regulator [209, 210]. 
PTPσ has been previously shown to dephosphorylate TrkA and TrkC specifically when 
coexpressed in HEK293 cells, and later to be able to dephosphorylate TrkB in primary 
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hippocampal cultures upon chondroitin sulfate proteoglycan (CPSG) activation [209, 
211]. PTPσ activation by CPSGs leads to a reduction of BDNF-induced spines [211]. 
LAR enhances TrkB phosphorylation and LAR-/- hippocampal neurons display a 
reduction of TrkB signaling and diminished BDNF-induced survival [210]. However, in 
both LAR-/- and PTPσ-/- mice the observed phenotypes are not compatible with a loss or 
gain of function of TrkB [212, 213]. Finally, RPTPZ can dephosphorylate TrkA and 
reduce NGF-dependent outgrowth in sensory neurons [214].  
EphB2 activity can be regulated by LAR, a type II RPTP. FGFR1 activation can 
increase EphB2 phosphorylation in the absence of ligand, via the inhibition of LAR 
[215]. Interestingly, in C. elegans, ptp3 (LAR ortholog) and VAB-1 (Eph ortholog) have 
synergistic effects in epidermal morphogenesis, suggesting redundant functions for the 
two proteins, rather than LAR acting as a negative regulator of Eph receptor [216]. 
1.3.1.1. PTPRO regulation of Trk and Eph receptors 
PTPRO is a type III RPTP, with eight fibronectin-like domains in the extracellular 
region, a transmembrane domain and one intracellular phosphatase domain. The 
extracellular domain has been shown to act as a repulsive guidance cue for RGCs in 
chick [217]. In mouse, PTPRO has been reported as a regulator of nociceptive (TrkA+) 
and proprioceptive (TrkC+) fiber guidance [218] and, in chick, as a regulator of motor 
and retinal axon guidance [219]. PTPRO knockout mice are less sensitive to thermal 
stimulation, as a consequence of missing CGRP+ DRG neurons and nociceptive fibers in 
the dorsal horn of the spinal cord. Additionally, in these mutants, parvalbumin-positive 
(PV+) neurons terminate before reaching their synaptic target (motor neurons), and cause 
a minor impairment in hindlimb placement and rotarod performance [218]. However, the 
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molecular mechanisms of these guidance defects have not been elucidated. In vitro, 
PTPRO when over-expressed in heterologous cells, is able to dephosphorylate TrkC, but 
this interaction has never been confirmed in vivo [220]. 
In chick, PTPRO knock-down causes the absence of a secondary branch of the 
peroneal nerve in the hindlimb [221]. This phenotype is partially rescued by knocking 
down a type II RPTP, suggesting that these two classes of RPTPs might balance each 
other’s signaling. As for the DRG projections, the potential PTPRO substrates, ligands or 
interactors have not been identified.  
In the chick retina, PTPRO knock-down or over-expression causes aberrant 
projections of RGCs. This phenotype is due to PTPRO-dependent regulation of Eph 
receptor phosphorylation. Over-expression of wild type PTPRO diminishes Eph receptor 
phosphorylation and makes retinal axons less sensitive to ephrin stimulation. Similarly, 
over-expression of a dominant negative form of PTPRO enhances Eph phosphorylation 
and makes axons more sensitive to ephrin stimulation. Since PTPRO dephosphorylates 
Ephs in two conserved juxtamembrane tyrosines, it can act as a phosphatase for both 
EphA and EphB receptors [219]. In mouse, PTPRO’s function as a potential Eph 
regulator and its tissue-specificity have not been addressed. 
1.3.2. Shedding regulates receptor expression and signaling  
Several different post-translational modifications regulate receptor availability at the 
plasma membrane, including regulated endocytosis, receptor trafficking, mRNA transport 
and receptor cleavage. Interestingly, cleavage not only regulates receptor expression, but 
can also modulate its signaling properties. In humans, there are more than 500 proteases, 
constituting 1.5% of the protein-coding genes [222]. Among them, metalloproteases 
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represent a large family of Zinc-dependent proteases, comprising secreted (ADAMTSs, 
MMPs, and Pappalysins), membrane-bound (ACEs, ADAMs, and MT-MMPs), and 
cytosolic proteins (Insulysin, Neprilysins, and THOP1) [223]. Pioneering studies on the 
role of metalloproteases in axon guidance were done in Marc Tessier-Lavigne’s 
laboratory showing that the inhibition of DCC ectodomain shedding potentiates axon 
outgrowth in response to Netrin stimulation [224]. 
 
Figure 1-12. Axon guidance at the spinal cord midline 
Scheme of commissural neuron guidance in the spinal cord illustrating guidance cues acting on the axons 
before (left) and after (right) crossing. Pre-crossing axons are attracted toward the midline by Netrin1, Shh 
and VEGF. At the floor plate Netrin attraction is silenced by Robo1/Slit, and plexinA1 expression on the 
axons is increased via NrCAM- and GDNF-mediated inhibition of its proteolytic cleavage by calpain. 
Sema3B and Slit drive axons away from the midline, while SCF provides trophic support. 
Commissural neuron guidance represents an elegant example of how receptor 
cleavage regulates receptor expression and allows axons to respond to different cues. 
Commissural neurons, located in the dorsal spinal cord, extend their axons towards the 
floor plate in response to an attractive gradient of Netrin. After reaching the floor plate 
the axons are repelled by the midline, and start growing along the longitudinal tract. This 
switch between attraction and repulsion is achieved through the regulation of the 
receptors present on the growth cone of commissural axons [225]. For example, PlexinA1 
expression is up-regulated at the growth cone after crossing the midline through the 
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inhibition of the calpain-dependent degradation of the receptor. PlexinA1 up-regulation 
sensitizes these axons to the repulsive Sema3B expressed at the midline [93, 226] (Figure 
1-12).  
In addition to regulating receptor expression levels, ectodomain shedding can also 
reduce the availability of ligand, further limiting the extent of receptor activation. For 
example, Met receptor cleavage releases the Met ectodomain, which acts as a decoy, 
binding to HGF and preventing its action on the full length receptor [227].  
Cleavage is also an important component of Eph/ephrin signaling: it represents a 
mechanism to promote cell-cell repulsion upon the initial binding and the released 
fragments can initiate an independent signaling cascade [122, 192, 228]. EphB2 cleavage 
can be triggered by two different mechanisms: one ligand-dependent and one induced by 
calcium influx. The ligand-dependent pathway triggers EphB2 ubiquitination, 
internalization and endosomal processing of the receptor. Upon ligand binding the 
receptor is cleaved, independently of metalloproteases and the released carboxiterminal 
fragments are degraded by the proteasome [228]. And probably, this inhibition of ligand-
dependent EphB2 cleavage is what prevents cell-cell detachment [122]. Calcium-induced 
cleavage happens at the plasma membrane and requires metalloproteases and γ-secretase. 
NMDA receptor activation enhances receptor cleavage, via the calcium influx pathway 
[228]. In addition to EphB2, another member of the Eph receptor family undergoes 
proteolytic processing: EphA4. EphA4 is cleaved in two consecutive steps by 
metalloproteases and γ-secretase. This leads to the release of a shed ectodomain (EphA4-
ECD), with an yet unidentified function, and of an intracellular fragment (EphA4-ICD), 
which preferentially activates Rac1. In transfected hippocampal neurons, EphA4-ICD 
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induces the formation of spines. Interestingly, EphA4 cleavage is not induced by ligand 
but by synaptic activity [192]. “What is the in vivo function of EphA4 shedding?”, “In 
which tissues EphA4 is cleaved?” and “Is EphA4 shedding a developmentally regulated 
process?” are still unexplored questions.  
1.3.3. Cooperation of guidance cues and receptor cross-talk 
Once all the major families of axon guidance and growth molecules have been 
discovered, the big challenge is to understand how they cooperate to progressively 
instruct the growth of neurons towards their synaptic targets. To date there are several 
reported examples of sets of guidance cues that act simultaneously or in subsequent steps 
on the same neuron population. 
The best studied example is the spinal cord midline where different families of 
guidance cues cooperate in consecutive steps. Netrin, Shh and Vascular endothelial 
growth factor (VEGF) cooperate to guide the axons toward the floor plate; Slit, 
Semaphorins and stem cell factor (SCF) cooperate to push axons away from the midline 
(Figure 1-12). The phenotypes observed in the knockout mice reflect the different 
requirements during guidance: the commissural axons in netrin, Shh and VEGF signaling 
mutants terminate before the floor plate; in Slit, Robo1, Sema3B and PlexinA1 mutants 
axons reach the floor plate but either they stall at the midline or they recross to the 
ipsilateral side; and in SCF knockouts axons stall after crossing the floor plate [199, 225, 
229-233]. At the molecular level the switch from attraction to repulsion is achieved by 
regulating receptor dynamics at the surface, either as previously described by cleavage of 
the receptors or by receptor cross-talk. Robo can, indeed, silence the attractive effect of 
Netrin, by binding to its receptor DCC [233]. 
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In the hindlimb, multiple signaling systems cooperate to ensure that motor axons 
follow the appropriate trajectories [194]. In contrast to the spinal cord midline, in the 
hindlimb these signaling pathways act in parallel. Ret and GDNF knockouts display 
misguidance of LMCL neurons, similarly to what is observed in EphA4 mutants [196]. 
The molecular mechanisms underlying Ret function in the LMCL guidance choice are not 
yet clarified. Although GDNF/Ret signaling has a well established growth-promoting 
function, emerging evidence suggests that GDNF can act as a chemoattractant [55]. 
Which aspect of GDNF/Ret signaling is necessary to support this dorsal/ventral choice 
has not been addressed. Intriguingly, EphA4/Ret double knockout mice have a stronger 
phenotype than the single mutants, suggesting that the two receptors cooperate in guiding 
LMCL axons in the dorsal mesenchyme of the hindlimb. However, the two receptors do 
not influence each other’s expression levels. Indeed in Ret-/- or GDNF-/-, although 
rerouted to the ventral mesenchyme, LMCL axons keep expressing higher levels of 
EphA4 than LMCM fibers. Similarly, in EphA
-/- embryos, Ret expression was maintained 
on the misguided LMCL axons [196]. If the two receptors cooperate at the molecular 
level is still unknown, although a few mechanisms can be speculated. The two receptors 
could influence each other’s signaling (cross-talk) or converge on common downstream 
effectors, such as ephexin or Src kinases, to amplify the signaling output. Ret could 
enhance EphA4-mediated repulsion, hence in the absence of Ret, EphA4+ LMCL axons 
would no longer be able to be repelled by the ventral region of the hindlimb. Similarly, 
EphA4 could positively modulate Ret signaling, thus in EphA4 knockouts Ret+ LMCL 
axons would no longer be responsive to GDNF present at the choice point. Alternatively, 
as has been described for SCF at the midline [234], GDNF can provide trophic support to 
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enable LMCL axons to leave the intermediate target upon being repelled by ephrinAs. 
Another alternative is that EphA4 and Ret act in parallel, exerting opposite effects on the 
growth cones.   
1.4. Purpose of thesis project 
As mentioned in the previous paragraphs, molecular mechanisms to fine tune and 
integrate different guidance cues are still not fully elucidated. In my thesis I focused on 
two different guidance systems: trigeminal and motor neurons, and three potential 
mechanisms to regulate receptor signaling: interaction with RPTPs, proteolytic 
processing and cooperation with other guidance cues. 
Growth promoting signals required for trigeminal neuron growth and branching are 
well known, however how the same receptors can regulate a great variety of trajectories 
and how axons expressing the same Trk receptor can grow at different speeds has not yet 
been clarified. I analyzed the trigeminal projections at two developmental stages and 
observed an enhanced complexity of the maxillary and ophthalmic arbors. To define the 
underlying molecular mechanism, I examined the potential interaction of PTPRO with 
Trk receptors and Ret. In parallel, I studied whether PTPRO’s role as a specific Eph 
receptor phosphatase was conserved between chick and mice.  
The roles of receptor cleavage during development have not been well characterized. 
In particular, nothing is known about the in vivo relevance of Eph receptor cleavage and 
its impact on Eph-dependent guidance decisions. To address this question I generated a 
knock-in mouse carrying a mutation to abolish EphA4 receptor cleavage. I analyzed three 
of the most prominent phenotypes observed in EphA4 knockout mice: motor neuron axon 
guidance at the sciatic plexus, dorsal funiculus and anterior commissure formation. 
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Finally, I focused on if and how two RTKs, EphA4 and Ret cooperate in guiding 
LMCL neurons. Although the genetic interaction of Ret/GDNF and EphA4/ephrinAs has 
already been described, the underlying molecular mechanism has been poorly elucidated. 
To shed light on the potential cross-talk between the two receptors, I studied their sub-
cellular localization in motor neuron growth cones. Moreover, in collaboration with Dr. 
Irina Dudanova, we addressed whether Ret signaling was dependent on EphA4 and vice 
versa. 
2. Results 
2.1. PTPRO’s role during development 
2.1.1. PTPRO’s developmental expression pattern 
To address the function of PTPRO in axon growth and guidance of sensory and motor 
neurons I analyzed its temporal expression pattern between E10.5 and post-natal day 0 
(P0). The specificity of the PTPRO antibody was tested on different tissues derived from 
PTPRO knockout embryos (Figure 2-1) (see also [235]).  
 
Figure 2-1. Specificity of the anti-PTPRO antibody  
Top panels show cross sections of the trigeminal ganglion (TG) from wild-type and PTPRO-/- E12.5 
embryos stained with anti-PTPRO and anti-Ret (as control) antibodies. Lower panels show cross sections 
of the spinal cord from wild-type and PTPRO-/- E12.5 embryos crossed with a transgenic line expressing 
GFP under the Hb9 promoter (Hb9-GFP) stained with anti-PTPRO antibody. Scale bar is 50µm. 
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In particular, I analyzed PTPRO expression pattern in lateral motor column (LMC), 
trigeminal (TG), dorsal root ganglia (DRG) and RGC neurons. I prepared cryosections 
from E12.5 embryos and performed co-immunostaining of PTPRO with Lim1 and Islet1, 
to label LMCL and LMCM neurons, respectively. At E12.5, PTPRO was not specifically 
localized to either of the two populations but seemed evenly distributed in both (Figure 2-
2). The expression in both classes of neurons was consistent with the idea that PTPRO 
interacts with both EphA and EphB receptors, which are enriched in the LMCL and 
LMCM populations, respectively. 
 
Figure 2-2. PTPRO expression pattern in LMC neurons 
Cross sections from E12.5 lumbar spinal cord were stained with anti-PTPRO, anti-Isl1 and anti-Lim1 
antibodies. LMCL and LMCM populations were defined by Lim1 and Islet1 expression, respectively. 
PTPRO co-localizes with both markers. Scale bar is 50µm.  
Regarding the sensory system, I analyzed two different types of peripheral sensory 
ganglia: trigeminal and lumbar DRG. I prepared cryosections from wild-type E10.5, 
E11.5, E12.5 embryos and stained them for PTPRO and the axonal marker Tuj1. At 
E10.5, PTPRO was barely detectable in trigeminal neurons, but by E11.5 was seen on 
trigeminal cell bodies and axons, both labeled by Tuj1 staining. PTPRO expression was 
maintained through all later embryonic stages of development and in newborns (Figures 
2-3 and 2-4). The expression pattern on trigeminal cell bodies suggested that PTPRO 
expression might be restricted to a subset of trigeminal neurons. Trigeminal neurons are 
divided into four populations, according to the expression of TrkA, TrkB, TrkC and Ret. 
TrkA labels nociceptive neurons, TrkB and Ret (at early stages) mechanoceptive. Later in 
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development, TrkA+ neurons further differentiate into peptidergic and non-peptidergic, 
and start expressing Ret [236].  
 
Figure 2-3. PTPRO expression pattern during TG development 
Trigeminal ganglion cross sections were stained with anti-PTPRO and anti-Tuj1 antibodies. PTPRO 
expression was analyzed at three developmental stages E10.5, E11.5 and E12.5. Scale bar is 250µm. 
To verify in which populations PTPRO was expressed, I prepared co-immunostainings 
with TrkA, TrkB, TrkC and Ret at three different developmental stages: E12.5 (time of 
axon elongation), E15.5 (time of axon arborization), and P0 [162]. At E12.5 PTPRO was 
expressed in roughly half of TrkB+ and Ret+, in a small population of TrkC+, but rarely in 
TrkA+ neurons (Figure 2-4). At E15.5, and similarly at P0, PTPRO expression decreased 
significantly in TrkB+ but remained high in Ret+ neurons, and did not increase in the 
other two populations (Figure 2-4). The expression pattern showed that PTPRO is 
localized in mechanoceptive neurons in the early phases of their development. Since at 
E16.5 PTPRO is reportedly expressed mainly in E16.5 TrkA+ and TrkC+ DRG neurons 
[237], I repeated the expression analysis in the DRG looking at three developmental 
stages. Consistent with the trigeminal data at E12.5, PTPRO was expressed in roughly 
half of the TrkB+, in a tenth of TrkC+, and rarely in TrkA+ neurons. In contrast to the TG, 
PTPRO was expressed only in a third of Ret+ DRG neurons.  
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Figure 2-4. PTPRO expression in a subset of TG neurons 
(A-D) Confocal images showing colocalization of PTPRO with TrkA (A), TrkB (B), TrkC (C) and Ret (D) 
in E12.5, E15.5 and P0 trigeminal ganglia. Scale bar is 100µm. Arrowheads point to neurons coexpressing 
PTPRO and either Trks or Ret. (E) Graph shows mean±SEM of the percentage of TrkA+, TrkB+, TrkC+ and 
Ret+ neurons expressing PTPRO at E12.5 and P0. For each data point N=3 embryos (9 images/embryo). For 
each group (TrkA, TrkB, TrkC and Ret) the percentages of neurons expressing PTPRO at different 
developmental stages were compared using one-way ANOVA followed by Bonferroni’s post-hoc 
comparison test (*p<0.05, **p<0.01). 
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Figure 2-5. PTPRO expression in a subset of DRG neurons 
(A-C) Confocal images showing colocalization of PTPRO with TrkA and TrkB (A), TrkC (B) and Ret (C) 
in E12.5, E15.5 and P0 lumbar DRGs. Scale bar is 25µm. Arrowheads point to neurons coexpressing 
PTPRO and either Trks or Ret. (D) Graph shows mean±SEM of the percentage of TrkA+, TrkB+, TrkC+ and 
Ret+ neurons expressing PTPRO at E12.5, E15.5 and P0. For each data point N=3 embryos (9 
images/embryo). 
At E15.5, no differences were observed between TG and DRG regarding PTPRO 
expression in TrkA+ and TrkC+ neurons. In contrast to what I described in the TG, in the 
DRG PTPRO expression in TrkB+ and Ret+ neurons remained high at this developmental 
stage. At P0, as has been observed for the TG, phosphatase expression decreased in Ret+ 
and TrkB+, and did not increase in TrkA+ neurons, but in contrast to the TG, the 
percentage of neurons coexpressing PTPRO and TrkC increased (Figure 2-5).  
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Figure 2-6. PTPRO expression at the spinal cord midline 
Cross sections of E12.5, E13.5, E14.5, E15.5 and P0 lumbar spinal cord were stained with anti-PTPRO 
antibody. PTPRO is expressed at the spinal cord midline. Arrows point to the roof plate, and arrowheads to 
the floor plate. 
The differences in PTPRO expression between TG and DRG could reflect a different 
requirement of the molecule in the development of these two populations of sensory 
neurons. While PTPRO was not expressed in the peripheral target region of TG and DRG 
neurons, i.e. whisker pad and hindlimb, it was expressed in the central target region of the 
DRG axons, the spinal cord. I detected PTPRO expression at the spinal cord midline and 
at the dorsal root entry zone (DREZ). PTPRO expression at the midline was quite 
interesting since it resembled the expression pattern of a midline marker, like ephrinB3 
(Figure 2-6). 
Finally, since PTPRO was required for Eph-dependent retinotectal projection in 
chick, I performed immunostaining on the retina of newborn mice. Consistent with the 
data from chick, PTPRO was expressed in the inner nuclear layer (INL) of the retina 
(Figure 2-7).  
 
Figure 2-7. PTPRO expression in the retina 
PTPRO immunostaining on sagittal sections of P0 retina. Scale bar is 200µm. ONL – outer nuclear layer, 
INL – inner nuclear layer. 
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2.1.2. E11.5 and E12.5 PTPRO-/- embryos have bigger and more complex TG arbors 
To investigate a possible requirement of PTPRO for the outgrowth of sensory axons 
in vivo, I examined PTPRO-/- embryos at two different stages of development. I 
performed neurofilament immunostaining on whole embryos to analyze the trajectories of 
sensory axons and the formation of peripheral arbors. At both developmental stages, there 
were no major changes in the mandibular branch, but I observed defects in the maxillary 
branch and in one of the arbors of the ophthalmic branch. This arbor starts to grow at 
E10.5, forms a complex branch above the eye at E12.5, and is fully developed by E13.5.  
 
Figure 2-8. E11.5 PTPRO-/- embryos have a more complex ophthalmic arbor 
(A) Representative pictures of TG nerve branches from whole-mount neurofilament stained E11.5 wild-
type and PTPRO-/- embryos. Red and blue dashed lines encircle the area of ophthalmic and maxillary 
arbors, respectively. The inset shows a higher magnification of the arbor of the ophthalmic branch that was 
analyzed. (B) Graph represents the mean±SEM area of 18 wild-type, 21 PTPRO+/- and 15 PTPRO-/- TG 
arbors. Statistical analysis was done using two-tailed Student’s t-test (*p<0.05, **p<0.01, ***p<0.001). 
Scale bar is 500µm. 
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Figure 2-9. E12.5 PTPRO-/- embryos show exuberant arborization of the ophthalmic branch of the 
TG nerve 
(A) Representative pictures of TG nerve branches from whole-mount neurofilament stained E12.5 wild-
type and PTPRO-/- embryos. Lower panels in A show tracings of the ophthalmic arbors. (B) Sholl analysis 
of the ophthalmic arbor at E12.5 was done on 32 wild-type and PTPRO+/-, and 24 PTPRO-/- TG ganglia. 
Statistical analysis was done as for Figure 2-8. 
In E11.5 wild-type embryos, the arbor had two main axon bundles, whereas in stage-
matched PTPRO-/- embryos the two bundles were longer and presented collateral 
branching (Figure 2-8). Similarly, the maxillary arbor covered a bigger area in PTPRO-/- 
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embryos (Figure 2-8). The difference in the ophthalmic branch was, however, greater 
than in the maxillary branch. Hence, the ratio measurement (ophthalmic/maxillary 
branch) also showed a significant difference and normalized the data to compensate for 
eventual small developmental differences (Figure 2-8).  No difference was observed 
between wild-type and heterozygous PTPRO+/- embryos (Figure 2-8). At E12.5 I 
analyzed the ophthalmic arbor by Sholl analysis, and found an increased complexity in 
PTPRO-/- embryos compared to wild-type controls (Figure 2-9). Taken together, these 
data support a role for PTPRO as an outgrowth or branching inhibitor.  
 
Figure 2-10. E12.5 PTPRO-/- embryos show defasciculation of the maxillary branch 
(A) Tuj1 immunostaining on sagittal sections of E12.5 wild-type and PTPRO-/- TG ganglia. The inset 
displays a higher magnification of the maxillary nerve. Red arrowheads point to defasciculated axons. 
Scale bar is 500µm. The dashed white lines depict the areas analyzed for terminal branching (B) Graph 
represents the percentage of sections with defasciculated axons (mean±SEM, N=16 embryos per genotype).  
(C) Graph represents the percentage of tissue area covered by axons in the terminal region of the maxillary 
arbor (mean±SEM, N=16 embryos per genotype). Statistical analysis was done as for Figure 2-8. 
 
B
0
10
20
30
40
50
60
*
%
of
d
ef
a
sc
ic
ul
a
te
d
se
ct
io
n
s
p
e
r
e
m
b
ry
o
+/+ -/-
A +/+ -/-
0
0.05
0.10
0.15
0.20
0.25
+/+ -/-
%
ax
on
s/
ar
ea
C
Results 
 
54 
 
I then prepared cryosections of E12.5 embryonic head and further analyzed the 
complexity of the maxillary branch to complement the quantification in the whole-mount 
configuration. Immunostaining for the axon marker Tuj1 showed more numerous areas of 
defasciculation in PTPRO-/- embryos than in wild-type littermates (Figure 2-10), possibly 
due to enhanced branching or defasciculation of these neurons. The areas of 
defasciculation were seen mainly in the proximal region of the nerve; more distal 
terminal arborizations were not affected (Figure 2-10). To assess the terminal 
arborization pattern, I determined the percentage of the maxillary arbor terminal area 
covered by axons, and did not see any difference between PTPRO-/- and wild-type 
embryos (Figure 2-10). 
2.1.3. Cultured E12.5 PTPRO-/- TG neurons display increased sensitivity to BDNF 
and GDNF, but not NGF 
The observed phenotypes suggested either impaired axon bundling or enhanced 
outgrowth of certain axons. To better understand PTPRO’s role in developing TG 
neurons I prepared primary TG neuron cultures and stimulated them with different 
neurotrophic factors. E12.5 neurons were incubated for 18 hours with 10ng/ml NGF, 
alone or in combination with 5ng/ml BDNF or 5ng/ml GDNF (Figure 2-11). Since 
PTPRO is mainly expressed in TrkB+ and Ret+ neurons, I expected an effect on the 
growth and branching only in presence of BDNF and GDNF. Indeed, stimulation with 
NGF alone did not elicit any difference in outgrowth or branching between wild-type and 
PTPRO-/- neurons. In contrast, in the presence of BDNF and GDNF, PTPRO-/- neurons 
had longer neurites than the wild-type controls (Figure 2-11). Although E12.5 neurons 
were mainly bipolar, BDNF stimulation triggered a significant increase in the mean 
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number of primary branch points (Figure 2-11). BDNF stimulation increased the number 
of branching points to the same extent in wild-type and PTPRO-/- neurons, whereas 
GDNF stimulation enhanced branching only in PTPRO-/- neurons (Figure 2-11). To 
further study their neurite arbors, I performed Sholl analysis on these neurons [238]. In 
all conditions, I observed an increased complexity of the arbors in PTPRO-/- cultures, but 
this effect was stronger for BDNF and GDNF as compared to NGF (Figure 2-11). 
To better uncouple PTPRO’s effects on axon growth from those on cell survival, and 
to exclude a possible synergistic effect of BDNF and GDNF with NGF, I performed a 
dose-response analysis for neurotrophins and GDNF in the presence of caspase inhibitors. 
Interestingly, in the absence of any neurotrophic stimulation PTPRO-/- axons were 
already longer than wild-type controls (Figure 2-12). Consistent with the previous 
experiment, stimulation with NGF, except at high doses (100ng/ml), did not show 
significant differences between wild-type and PTPRO-/- neurons (Figure 2-12). However, 
since at this concentration NGF is reported to exert TrkA-independent growth inhibiting 
effects, these data are still consistent with PTPRO not being coexpressed with TrkA 
[239]. Stimulation with 1ng/ml of BDNF or GDNF was sufficient to keep the PTPRO-/- 
neurons growing more than controls. Responses generally plateaued by 10ng/ml of 
neurotrophic factor (Figure 2-12). The shift in sensitivity was more evident when data 
were plotted as a logarithm of the concentration of neurotrophins on the x-axis versus the 
axon length on the y-axis, and could be fitted to a sigmoid dose-response curve by 
nonlinear regression. Since logarithm of 0 is infinity, I assigned to the condition with no 
neurotrophin stimulation the arbitrary value of -3.  
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Figure 2-11. E12.5 PTPRO-/- TG neurons are more sensitive to BDNF and GDNF 
(A) Representative pictures of E12.5 TG neurons, stimulated with growth factors as indicated. Scale bar, 
100µm. Quantification of the length of the axons (B) or the number of branch points (C) of neurons 
stimulated as indicated on the x-axis. (D-F) Sholl analysis of cultured primary TG neurons from E12.5 
wild-type and PTPRO-/- embryos, stimulated with NGF (D), BDNF (E) and GDNF (F). Graphs represent 
mean±SEM. Numbers of TG neurons analyzed from at least 3 independent cultures: for NGF stimulation 
200 neurons (wild-type) and 195 neurons (PTPRO-/-), for BDNF and GDNF stimulation 150 neurons per 
genotype. Statistical analysis was done as for Figure 2-8. 
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Figure 2-12. E12.5 PTPRO-/- TG neurons are more sensitive to BDNF and GDNF, but not NGF 
stimulation 
(A,D) Quantification of the length (A) and branching (D) of the TG axons from wild-type and PTPRO-/- 
E12.5 embryos stimulated with increasing concentration of NGF, BDNF or GDNF in the presence of 
caspase inhibitors. Graphs represent mean±SEM. Numbers of TG neurons analyzed from at least 3 
independent cultures: for no stimulation 542 (wild-type) and 550 (PTPRO-/-) neurons, for NGF stimulation 
200 neurons (wild-type) and 195 neurons (PTPRO-/-), for BDNF and GDNF stimulation 150 neurons per 
genotype. Statistical analysis was done as for Figure 2-8. (B-C) Nonlinear regression representation of the 
dose-response curves for BDNF (B,E) and GDNF (C,F). Dashed blue and red lines indicate EC50 of wild-
type and PTPRO-/- response, respectively. 
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The nonlinear regression allows the calculation of half of the maximal response (EC50), 
and although this is not an absolute value, since I assigned an arbitrary value to the 
lowest concentration, it still gives a relative indication of sensitivity to neurotrophins. For 
both BDNF and GDNF the EC50 values were significantly lower in the PTPRO-/- curves 
(Figure 2-12) compared to controls. 
Axon branching was not affected in PTPRO-/- neurons stimulated with NGF except at 
very high doses (100ng/ml) (Figure 2-12). BDNF stimulation had the biggest effect on 
branching for both wild-type and PTPRO-/- neurons. For both BDNF and GDNF I 
observed a strong difference for intermediate concentrations of neurotrophic factor 
(10ng/ml) and the response generally plateaued by 100ng/ml (Figure 2-12). Analyzing 
the data as a nonlinear regression showed a difference in EC50 for GDNF but not BDNF 
stimulation (Figure 2-12).  
Taken together, these results indicate that embryonic PTPRO-/- neurons are more 
responsive to BDNF and GDNF, consistent with the expression of PTPRO in TrkB+ and 
Ret+ neurons.  
2.1.4. Cultured P1 PTPRO-/- TG neurons do not display increased sensitivity to BDNF 
and GDNF 
To further investigate the role of PTPRO in TG neuron branching and growth, I 
prepared primary TG neuron cultures from P1 wild-type and PTPRO-/- pups. At this stage 
of development primary cultured TG neurons display several branch points and a very 
complex structure. As done for E12.5 cultures, neurons were kept in 10ng/ml NGF or 
10ng/ml NGF plus 5ng/ml BDNF or GDNF.  
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Figure 2-13. P1 PTPRO-/- TG neurons do not show increased sensitivity to neurotrophins and GDNF 
(A) Representative pictures of P1 TG neurons, stimulated with growth factors as indicated. Scale bar, 
100µm. Quantification of the length of the axons (B) or the number of branch points (C) of neurons 
stimulated as indicated on the x-axis. (D-F) Sholl analysis of cultured primary TG neurons from P1 wild-
type and PTPRO-/- embryos, stimulated with NGF (D), BDNF (E) and GDNF (F). Graphs represent 
mean±SEM. Numbers of TG neurons analyzed from at least 3 independent cultures: for NGF stimulation 
230 neurons (wild-type) and 234 neurons (PTPRO-/-), for BDNF 176 neurons (wild-type) and 190 neurons 
(PTPRO-/-) and for GDNF 232 neurons (wild-type) and 216 neurons (PTPRO-/-). Statistical analysis was 
done as for Figure 2-8. 
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In contrast to the results obtained with E12.5 neurons, PTPRO-/- neurons from newborn 
mice were not more branched or longer than controls. The only significant difference 
observed was the decreased number of branch points in PTPRO-/- after NGF treatment 
(Figure 2-13). Interestingly, BDNF and GDNF were able to further stimulate branching 
in wild-type but not PTPRO-/- neurons, suggesting that these two signaling pathways 
might be already activated in the absence of stimulation in knockout neurons. The lack of 
a differential response in the knockout neurons could be due to the decreased expression 
of PTPRO in TrkB+ and Ret+ neurons observed at E15.5 and P0.   
2.1.5. The exuberant growth and branching observed in PTPRO-/- embryos and 
neurons are not due to alterations in cell fate or survival. 
Since cranial sensory neurons display intrinsic differences in growth rates [166], the 
enhanced growth and arborization of a sensory nerve branch may also result from a 
relative increase in the numbers of fast versus slow growing neurons. The observed 
phenotype could be secondary to changes in cell fate or absence of a selective population. 
To test this hypothesis, I counted the number of TrkA+, TrkB+, TrkC+, Ret+ and NeuN+ 
neurons at E12.5. At this developmental stage, TG neurons were NGF-dependent and 
expressed mainly TrkA, and the other three populations accounted for less than half of 
the overall contingent (Figure 2-14) [240]. I did not detect any difference in the number 
of neurons (Figure 2-14), suggesting that the absence of PTPRO does not affect the cell 
fate of TG neurons. Consistent with this observation, I did not observe changes in any of 
the populations in E12.5 PTPRO-/- DRGs (Figure 2-15). 
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Figure 2-14. PTPRO-/- embryos do not have defects in TG neuron differentiation 
(A) Immunostainings for TrkA, TrkB, TrkC, Ret and NeuN on TG ganglia cryosections from E12.5 wild-
type and PTPRO-/- embryos. Scale bar is 50µm. (B) Graph represents the average number (mean±SEM, 
N=3, 9 images/embryo) of TrkA+, TrkB+, TrkC+, Ret+ and NeuN+ neurons per section. Statistical analysis 
was done as for Figure 2-8.  
 
Figure 2-15. PTPRO-/- embryos do not have defects in DRG neuron differentiation 
(A) Immunostainings for TrkA, TrkB and TrkC on lumbar DRG cryosections from E12.5 wild-type and    
PTPRO-/- embryos. Scale bar is 50µm. (B) Graph represents the average number (mean±SEM, N=3, 9 
images/embryo) of TrkA+, TrkB+ and TrkC+ neurons per section. Statistical analysis was done as for Figure 
2-8. 
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At P0, TrkA+ neurons were still the largest subpopulation, although reduced in 
number compared to E12.5; TrkB+ neurons were unchanged in number compared to 
E12.5; TrkC+ neurons were slightly reduced, and the Ret+ population had increased 
(Figure 2-16) [241]. I counted the number of TrkA+, TrkB+, TrkC+, Ret+ and NeuN+ 
neurons at P0 (Figure 2-16), and did not observe a reduction in the number of TrkB+ and 
Ret+, but there was a significant loss of TrkA+ and TrkC+ neurons (Figure 2-16). The loss 
of TrkA+ neurons in the TG is also consistent with the data shown for the DRGs at P0 by 
the Bixby laboratory [218]. Since PTPRO shows very little colocalization with TrkA, the 
loss of TrkA+ neurons could be due to a non-cell autonomous role of PTPRO.  
 
Figure 2-16. Loss of TrkA+ and TrkC+ neurons in newborn PTPRO-/- mice 
(A) Immunostainings for TrkA, TrkB, TrkC, Ret and NeuN on TG cryosections from newborn wild-type 
and PTPRO-/- embryos. Scale bar is 50µm. (B) Graphs represent the average number (mean±SEM, N=3-4, 
9-20 images/pup) of TrkA+, TrkB+, TrkC+, Ret+ and NeuN+ neurons per section. Statistical analysis was 
done as for Figure 2-8. 
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PTPRO is localized in 10% of TrkC+ neurons, suggesting that it could cell autonomously 
cause the loss. Interestingly, staining for the general neuronal marker “NeuN” did not 
reveal changes in the total numbers of neurons, suggesting a role of PTPRO in regulating 
TG neuronal differentiation more than survival (Figure 2-16). 
Together these results suggest that changes in cell fate and survival do not contribute 
significantly to the exuberant growth and branching of E12.5 embryonic TG axons in 
vivo and in vitro.  
2.1.6. PTPRO regulates TrkB and Ret signaling 
Next I tested whether PTPRO directly regulates TrkB and Ret signaling, and whether 
it inhibits growth by suppressing TrkB and Ret kinase activity. I tried to examine 
colocalization of PTPRO with RTKs in cultured neurons, but was unable to detect 
PTPRO with sufficient subcellular resolution using the available antibodies. As an 
alternative, I investigated colocalization and activation of these proteins in heterologous 
cell culture, over-expressing the mouse isoform of PTPRO with a Flag-tag (mPTPRO). 
Over-expression of TrkB in Hela cells led to ligand-independent activation [214], as 
shown by anti-phosphotyrosine immunostaining (Figure 2-17). When TrkB and mPTPRO 
were coexpressed, the intensity of phosphotyrosine staining was markedly reduced 
(Figure 2-17). I repeated the experiment in HEK293 cells to complement the 
immunostaining data with biochemical evidence. Stimulation of TrkB-transfected cells 
with 50ng/ml BDNF for 5 or 20 minutes increased the levels of receptor phosphorylation 
and led to the activation of downstream effectors, e.g. phosphoERK. When TrkB and 
mPTPRO were coexpressed in HEK293 cells, BDNF-induced TrkB autophosphorylation 
and ERK1/2 phosphorylation were strongly suppressed (Figure 2-17). 
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Figure 2-17. Regulation of TrkB signaling by PTPRO in transfected cells 
(A) Hela cells transfected with TrkB, with or without PTPRO, stimulated with BDNF and immunostained 
for PTPRO, TrkB, and phosphotyrosine (pTyr). Cells outlines are labeled with Cell Mask Blue. Insets are 
higher magnification images of the areas marked with a box. Scale bar is 20µm. (B) Graph represents the 
intensity of phosphotyrosine (pTyr) staining normalized to the intensity of TrkB staining (mean±SEM). 
Number of cells analyzed: 26 cells for TrkB and 29 cells for TrkB and PTPRO from 3 independent 
experiments. (C) Western blots of HEK293 cells transfected with TrkB with or without PTPRO-flag and 
stimulated as indicated. Total cell lysates (TCL) were probed against phosphoERK (pERK), ERK1/2 and 
Flag (PTPRO). Immunoprecipitates of TrkB (IP αTrkB) were probed against pTyr and TrkB. (D,E) Graphs 
represent TrkB autophosphorylation levels (D) and ERK phosphorylation (E). Three independent 
experiments were performed and the intensities of the phospho bands were quantified using ImageJ and 
normalized to the total levels of the proteins. Statistical analysis was done as for Figure 2-8. 
Since the two Ret isoforms - Ret9 and Ret51 - elicit similar response to GDNF 
stimulation in sympathetic neurons [242], for the following in vitro experiments I used 
only the Ret51 isoform. I transfected Hela cells with Ret51 and stimulated them for 5 
minutes with 50ng/ml GDNF and soluble GFRα1. Stimulation increased the intensity of 
phosphotyrosine staining and this increase was suppressed when Ret was coexpressed 
with PTPRO (Figure 2-18).  As for TrkB, I assessed by Western Blot Ret signaling in 
presence and absence of PTPRO. In transfected HEK293 cells, basal Ret 
autophosphorylation, which was visualized by immunoblotting with anti-phosphotyrosine 
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(pTyr) and anti-phosphotyrosine1062 (pY1062) antibodies, was high and was not 
increased by GDNF stimulation. 
 
Figure 2-18. Regulation of Ret51 signaling by PTPRO in transfected cells 
(A) Hela cells transfected with Ret51, with or without PTPRO, and stimulated as indicated.  Fixed cells 
were stained with anti-Flag (PTPRO), anti-Ret and pTyr antibodies and marked with Cell Mask Blue. Scale 
bar is 20µm. (B) Graph represents pTyr staining intensity normalized to the intensity of Ret staining 
(mean±SEM). Numbers of cells analyzed: 48 cells before and 26 cells after stimulation for Ret alone, and 
36 cells before and 26 cells after stimulation for Ret and PTPRO, from at least 3 independent experiments. 
(C) Western blots of HEK293 cells transfected with Ret, with or without PTPRO, and stimulated as 
indicated.  TCL were probed against Ret phosphotyrosine 1062 (Ret pY1062), Ret, pERK, ERK1/2, and 
Flag. (D-F) Graphs represent Ret autophosphorylation levels (D,E) or ERK phosphorylation (F).Three 
independent experiments were performed and the intensities of the phospho bands were quantified using 
ImageJ and normalized to the total levels of the proteins. Statistical analysis was done as for Figure 2-8. 
When PTPRO and Ret were co-transfected, Ret phosphorylation was strongly suppressed 
(Figure 2-18). However, PTPRO-induced dephosphorylation was more evident using the 
pY1062 than the pTyr antibody, suggesting that PTPRO might target only some of the 
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tyrosine residues present on the receptor (Figure 2-18). Although stimulation with GDNF 
and soluble GFRα1 did not increase the levels of Ret phosphorylation, it led to a 
significant increase in the levels of phosphoERK. PTPRO coexpression was sufficient to 
abolish this GDNF-induced ERK phosphorylation (Figure 2-18). 
Finally, I analyzed whether the phosphatase directly interacted with the two RTKs. I 
was not able to co-immunoprecipitate either of the two RTKs and PTPRO, but in 
transfected Hela cells I observed nice colocalization. To examine the degree of 
colocalization I tested the colocalization staining for the total pools of receptor and 
phosphatase (cells were permeabilized), or I restricted the analysis to only the cell 
surface. To restrict the colocalization analysis to the cell surface, I did not permeabilize 
the cells and I used an antibody raised against the extracellular domain of PTPRO. When 
PTPRO and TrkB were coexpressed in Hela cells and cells were permeabilized and 
stained, I observed 40% of the puncta to be colocalized. Stimulation with BDNF did not 
increase the percentage of TrkB/PTPRO colocalizing puncta (Figures 2-17 and 2-19). 
Surface staining for PTPRO and TrkB showed a higher degree of colocalization of the 
two proteins compared to total staining, and this percentage was not affected by BDNF 
stimulation (Figure 2-19). Ret colocalization with PTPRO, upon total staining, was 
stronger compared to TrkB (60% of Ret+ puncta co-localized with PTPRO) and the 
degree of colocalization in transfected Hela cells was enhanced by stimulation with 
GDNF and soluble GFRα1 (Figures 2-18 and 2-19). This increase, however, was only 
detectable when cells were permeabilized but not when only the surface staining was 
considered, suggesting that upon stimulation mPTPRO and Ret may co-localize in 
intracellular compartments, e.g. endosomes (Figure 2-19). 
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Figure 2-19. PTPRO does not regulate TrkB and Ret 51 surface expression 
(A,D) Hela cells transfected with TrkB (A) or Ret51 (D) with or without PTPRO, and stimulated as 
indicated. Cells were stained to detect surface expression of PTPRO (PTPRO surface) and TrkB or Ret 
(TrkB or Ret surface) and total expression of TrkB or Ret (TrkB or Ret total). Scale bar is 20µm. (B,E) 
Graphs represent the degree of colocalization of TrkB (B) or Ret (E) and PTPRO (mean±SEM) before and 
after stimulation, with (total) or without (surface) cell permeabilization. % of colocalization was 
normalized to PTPRO staining. 14-23 cells analyzed from at least 3 independent experiments. (C,F) Graph 
represents the ratio of surface and total intensities of TrkB (C) and Ret (F) staining (mean±SEM). 14-23 
cells analyzed from at least 3 independent experiments. Statistical analysis was done as for Figure 2-8. 
I then checked whether PTPRO coexpression influenced surface levels of Ret and 
TrkB in presence and absence of their ligands. I stained the fixed cells for TrkB and Ret 
before and after permeabilization in order to detect the surface and the total expression of 
the receptors. In absence of stimulation the surface levels of TrkB were unaffected by 
PTPRO coexpression. Upon stimulation with BDNF for 5 minutes, TrkB expression on 
the surface slightly increased and no differences were observed if PTPRO was 
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coexpressed (Figure 2-19). Without GDNF, Ret expression on the surface was unaltered 
by coexpression of PTPRO. Upon stimulation with GDNF, Ret was internalized. Also in 
this case, I did not observe significant differences in Ret distribution when PTPRO was 
coexpressed (Figure 2-19). 
Together, these results revealed that PTPRO regulates TrkB and Ret kinase activity 
and signaling, supporting the role of PTPRO as a negative regulator of BDNF- and 
GDNF-induced axon growth and branching. 
2.1.7. PTPRO does not regulate Eph receptors in the developing TG ganglion  
Since PTPRO was shown to be a regulator of Eph signaling [219] and several 
members of the Eph family are expressed in the TG [178] I decided to investigate 
whether Eph signaling was affected and contributed to the in vivo phenotype. Firsty, I 
assessed whether TG explants were responsive to ephrin stimulation, so I prepared 
explants from different stages of development and stimulated them with Fc (as a negative 
control) or ephrinA5-Fc (human ephrinA5-fused to Fc portion of IgG) for 30 minutes. To 
visualize the growth cones, I performed a staining using an anti-phallodoin antibody. As 
expected, I observed an increase in the growth cone collapse rate after stimulation with 
ephrinA5-Fc (Figure 2-20). At E12.5, axons showed less variability in their response to 
Fc and ephrinA5 (smaller standard deviation and higher p value) and the effect was not 
maximal, leaving a bigger window for assessing differences upon PTPRO removal. I then 
performed the same experiment using wild-type and PTPRO-/- TG explants, and found 
that knockout explants were equally sensitive as wild-type to ephrin stimulation (Figure 
2-20). Stimulation with a higher dose of pre-clusterd ephrinA5 did not elicit an increase 
in growth cone collapse, neither in wild-type nor in knockout explants (Figure 2-20). 
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Therefore, these results suggest that during TG development, genetic removal of PTPRO 
does not affect Eph signaling.  
To explore whether in PTPRO-/- mice Eph signaling was at all affected, I analyzed 
two different axon guidance systems: LMC motor axon guidance at the sciatic plexus and 
retinotectal mapping, where Eph receptors have been proven to play a pivotal role. I 
complemented the in vivo approach with in vitro experiments, to assess sensitivity to 
ephrins. 
 
Figure 2-20. PTPRO-/- TG explants do not show increased sensitivity to ephrinAs 
(A) Representative pictures of E11.5 TG growth cones stimulated with 0.5 µg/ml pre-clustered Fc (negative 
control) or pre-clustered ephrinA5. Explants were stained with Phalloidin-568. Scale bar is 50µm. (B) 
Graph represents mean±SEM of the percentage of collapsed growth cones at three developmental stages. 
Analysis was done on four to six explants per condition from at least 2 independent cultures. (C) 
Representative pictures of E12.5 TG neuron explant cultures stimulated with 0.5µg/ml pre-clustered Fc 
(negative control) or pre-clustered ephrinA5. Arrows point to non-collapsed growth cones and arrowheads 
show collapsed growth cones. Scale bar is 100µm. (D,E) Graphs represent mean±SEM of the percentage of 
collapsed growth cones at E12.5. Three to six explants per condition were analyzed from 3 embryos per 
genotype. Statistical analysis was done as for Figure 2-8. 
2.1.8. PTPRO is dispensable as Eph-regulator in LMC axon guidance 
Over-expression of Eph receptors in chick or genetic deletion of Ephs in mice have 
resulted, amongst other phenotypes, in misguided projections at the sciatic plexus. EphA4 
guides LMCL axons into the dorsal mesenchyme of the hindlimb, whereas EphBs guide 
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LMCM axons into the ventral mesenchyme. LMCL and LMCM axons form the peroneal 
and tibial nerve, respectively. Since PTPRO is expressed in both populations of LMC 
neurons and it has been shown to act on both types of Eph receptors, I analyzed both 
LMCL and LMCM projections. I performed neurofilament staining of the whole embryo at 
E11.5 and E12.5 (Figure 2-21). 
 
Figure 2-21. Neurofilament staining on whole-mount PTPRO-/- embryos does not show any guidance 
defects 
(A) Representative pictures of neurofilament stained E11.5 whole-mount embryos. (B) Graph represents 
the ratios between the length of the peroneal and the tibial nerves of 19 wild-type, 12 PTPRO+/-, and 16 
PTPRO-/- hindlimbs (mean±SEM). (C) Representative pictures of neurofilament stained E12.5 whole-
mount embryos of the indicated genotypes. GDNF-/- were used a positive controls for LMCL misguidance 
[196]. (D) Graph represents the ratios between the diameter of the peroneal and the tibial nerves of 16 wild-
type, 12 PTPRO+/-, 15 PTPRO-/- and 3 GDNF-/- hindlimbs (mean±SEM). Arrowheads point to the peroneal 
nerve; arrows point to the tibial nerve. Scale bar is 250µm. Statistical analysis was done as for Figure 2-8. 
 
At E11.5 the peroneal and the tibial nerve had the same length in wild-type and PTPRO 
knockout embryos, and at E12.5 the ratio of their diameters was not changed. As 
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expected, at E12.5 GDNF-/- embryos (used as positive controls for the technique) 
displayed an increase in the diameter of the tibial nerve and a decrease in the diameter of 
the peroneal nerve (Figure 2-21). Since whole-mount staining is not a very sensitive 
technique and does not allow distinction between sensory and motor neurons, Dr. Irina 
Dudanova performed retrograde tracings from the ventral and dorsal hindlimb. For the 
dorsal tracing she injected Rhodamine Dextran (RD) in the dorsal shank of the hindlimb, 
which should be innervated only by LMCL (Lim
+ neurons), and counted the number of 
Isl1+ neurons labeled with the dye (data not shown). The number of cells labeled was 
similar in wild-type and PTPRO-/- E12.5 embryos (data not shown). Additionally, she 
injected RD in the ventral shank, which should be innervated only by LMCM (Isl1
+ 
neurons), and counted the number of neurons labeled with RD and Lim1 (data not 
shown). As before, she did not observe any misprojections, suggesting that Eph-mediated 
motor neuron axon guidance is not affected in vivo in PTPRO-/- embryos. 
To exclude a potential in vivo compensation by other guidance systems, I assessed the 
response of MN explant culture to ephrin stimulation. I cultured explants of lumbar motor 
columns from Hb9-GPF+ transgenic embryos [243] for 18 hours and stimulated them for 
30 minutes with 0.1µg/ml or 0.5µg/ml clustered Fc, ephrinA2/A5 (mixed 1:1) or 
ephrinB2 (Figure 2-22), to assess response of EphA and EphB receptors, respectively. I 
used ephrinA2 and ephrinA5 in a 1:1 mix, since this resembled the in vivo expression 
[188]. Consistent with the results of growth cone collapse with TG explants, I did not 
observe an increased sensitivity towards ephrin stimulation in PTPRO-/- motor neurons 
(Figure 2-22).  
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Figure 2-22. PTPRO-/- motor neurons are not more sensitive toward ephrin stimulation 
(A) Representative pictures of motor neuron explant cultures stimulated with Fc (as a control) or ephrins. 
Arrows and arrowheads point to non-collapsed and collapsed growth cones, respectively. In green is the 
Hb9-GFP and in red the Phalloidin-568 staining. Insets show a higher magnification of non-collapsed and 
collapsed growth cones. Scale bar is 200µm. (D) Graph represents the percentage of collapsed growth 
cones. Three to six explants per condition were analyzed from 4 embryos per genotype. Compared to the 
respective controls, all the ephrinA2/A5 and ephrinB2 stimulated explants show a statistically significant 
increase in the percentage of growth cone collapse (0.1µg/ml ephrinA2/A5-Fc on wild-type cultures, 
p=0.038; 0.5µg/ml on wild-type, p=0.009; 0.1µg/ml on PTPRO-/-, p=0.007; 0.5µg/ml on PTPRO-/-, 
p=0.002; 0.1µg/ml ephrinB2-Fc on wild-type cultures, p=0.015; 0.5µg/ml on wild-type, p=0.001; 0.1µg/ml 
on PTPRO-/-, p=0.009; 0.5µg/ml on PTPRO-/-, p=0.001). Statistical analysis was done as for Figure 2-8. 
Taken together these data argue against a role of PTPRO in regulating Eph receptor 
signaling in LMC axon guidance. 
2.1.9. PTPRO is not required for retinotectal mapping in mouse 
Since ephrins in the hindlimb are presented as a bimodal choice, it is possible that 
there is no requirement for a fine-tuning of Eph phosphorylation. Conversely, the fine 
tuning of phosphorylation levels is more likely to be required in the retinotectal system, 
where Ephs and ephrins are expressed in gradients. In line with this hypothesis, the initial 
study on PTPRO-mediated Eph regulation showed a critical role for the phosphatase in 
the retinotectal mapping [219]. On these bases, we collaborated with Dr. Philipp 
Suetterlin and Prof. Uwe Drescher to perform retinocollicular tracings in PTPRO-/- mice 
at P8. They did not observe misguidance defects or ectopic branching in PTPRO-/- mice 
(Figure 2-23), suggesting that PTPRO is dispensable for development of the mouse 
retinocollicular map.  
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Figure 2-23. PTPRO-/- mice do not show misguidance or aberrant branching in the retinocollicular 
map (in collaboration with Dr. Philipp Suetterlin and Prof. Uwe Drescher) 
Representative pictures for the analysis of the retinocollicular projection in wild-type and PTPRO-/- mice at 
P8. Injection of DiI into a small area of nasal retina (drawings on left side) result in labelling of 
topographically appropriate termination zones in the caudal part of the superior colliculus. Numbers of 
animals analyzed for the termination zone were: 7 wild-type, 12 PTPRO+/- and 5 PTPRO-/-. Numbers of 
animals analyzed for ectopic branching were: 3 wild-type, 4 PTPRO+/- and 4 PTPRO-/-. 
2.1.10. The chick but not the mouse isoform of PTPRO can dephosphorylate EphA4 
The lack of Eph-related phenotypes in PTPRO-/- mice could be due to functional 
redundancy of PTPRO with another Eph phosphatase or to an evolutionary divergence of 
the mouse (mPTPRO) and chick (cPTPRO) isoforms of PTPRO. To distinguish between 
these two possibilities, I over-expressed in HEK293 cells EphA4 together with either 
mPTPRO or cPTPRO. The day after transfection cells were stimulated with 1µg/ml pre-
clustered Fc (as a control) or ephrinA4 for 30 minutes. As expected, ephrinA4 
stimulation increased EphA4 phosphorylation levels. When EphA4 was coexpressed with 
cPTPRO, the receptor was significantly less phosphorylated upon stimulation (Figure 2-
24). When EphA4 was coexpressed with mPTPRO, receptor phosphorylation was 
significantly higher than in presence of cPTPRO and not significantly different from the 
receptor expressed alone (Figure 2-24). These results indicate that mPTPRO does not 
regulate Eph signaling and suggest that mPTPRO and cPTPRO have different substrate 
specificities. 
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Figure 2-24. The chick but not the mouse isoform of PTPRO can dephosphorylate EphA4 
(A) Western blots of HEK293 cells co-transfected with EphA4 and mouse (mPTPRO) or chick (cPTPRO) 
isoforms of PTPRO-Flag and stimulated as indicated. Total cell lysates (TCL) were probed against 
phospho- and total EphA4 and Flag (PTPRO). Asterisks indicate PTPRO bands; mPTPRO runs at 140 kDa 
and cPTPRO at 160 kDa. (B) Graph represents the levels of EphA4 autophosphorylation (mean±SEM) 
after control Fc and ephrinA4-Fc stimulation. The experiment was done in triplicate and the intensities of 
the phospho bands were quantified using ImageJ and normalized to the total level of the proteins. Statistical 
analysis was done as for Figure 2-8. 
2.2. Role of EphA4 cleavage during development 
2.2.1. EphA4 is cleaved in Hela and HEK293 cells, independently of ligand stimulation 
EphA4 has previously been shown to undergo two consecutive proteolytic cleavages, 
first by a still unknown metalloprotease in its extracellular region, and then by γ-secretase 
in its transmembrane domain [192]. To assess whether EphA4 cleavage could be 
modulated by kinase activity or ligand binding, I over-expressed EphA4 with an 
extracellular Flag-tag (EphA4-Flag) in two cell lines, Hela and HEK293 cells. I then 
collected the supernatant and prepared total cell lysates (TCL) 24 hours after transfection. 
To detect the shed ectodomain (EphA4-ECD) I probed the membrane with an antibody 
against the Flag-tag. Although in HEK293 cells EphA4 and EphA4-ECD were expressed 
at higher levels than in Hela cells (Figure 2-25), both cell lines represented a valid and 
reliable model to assess receptor shedding.  
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Figure 2-25. EphA4 is cleaved in Hela and HEK293 cells 
Western blots of Hela and HEK293 cells transfected with EphA4 carrying a Flag tag in its extracellular 
domain (EphA4-Flag). Total cell lysates (TCL) and supernatants were probed against Flag. 
 
Having characterized the cell lines, I compared two differently tagged EphA4 
constructs. In addition to the Flag-tagged construct, where the Flag was positioned at the 
beginning of the extracellular domain (N-term), I used a construct where mCherry was 
inserted in the juxtamembrane region of the receptor (EphA4-mCherry). HEK293 cells 
transfected with EphA4-mCherry, showed again the release of the EphA4-ECD in the 
supernatant (Figure 2-26).  
 
Figure 2-26. EphA4 cleavage is proportional to EphA4 expression levels 
Western blots of HEK293 cells transfected with 0.1, 0.2, 0.5, 1, 5µg of EphA4 carrying an mCherry tag in 
its intracellular domain (EphA4-mCherry). Total cell lysates (TCL) were immunoprecipitated and probed 
with an antibody against GFP. Supernatant was probed with EphA4-SEK.  
I then decided to test several antibodies against different intracellular and 
extracellular domains of EphA4 to detect the intracellular fragment (EphA4-ICD) and the 
EphA4-ECD, to recognize the endogenous protein and its fragments in ex vivo 
experiments. To detect the EphA4-ECD I used an antibody produced by BD Bioscience 
(referred to EphA4-SEK in the following experiments) (Figure 2-26). For EphA4-ICD 
detection, I obtained the best results with the antibody produced by Zymed (referred to 
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EphA4-Zymed in following experiments) (Figures 2-27) and one produced by Santa-Cruz 
(referred to EphA4-S20 in the following paragraphs). 
I transfected HEK293 cells with increasing amounts of EphA4-mCherry, and 24 
hours after transfection I collected the supernatant and prepared total lysates. EphA4 
shedding positively correlated with EphA4 expression levels, suggesting that cleavage 
could be an intrinsic cell mechanism to control the receptor expression on the surface 
(Figure 2-26).  
I then examined whether the stimulation with soluble ligand had an effect on EphA4 
cleavage by over-expressing EphA4-Flag in HEK293 cells and stimulating either with 
1µg/ml of pre-clustered Fc (as control) or ephrinA4. Stimulation with ephrinA4 induced 
EphA4 phosphorylation. The EphA4-ICD was also phosphorylated upon stimulation, but 
its expression was not increased (Figure 2-27). These results were consistent with the 
reported results showing that EphA4 cleavage in hippocampal cultured neurons is ligand-
independent [192]. 
 
Figure 2-27. EphA4 cleavage is independent of ligand stimulation 
(A-B) Western blots of HEK293 cells transfected with EphA4-Flag stimulated with 1µg/ml pre-clustered 
Fc or ephrinA4. TCLs were probed against phospho- (A) and total (B) EphA4 (EphA4-Zymed antibody). 
The two bands visible correspond to EphA4 full length and the EphA4-ICD (ICD). (C) Western blots of 
HEK293 cells transfected with EphA4-Flag stimulated with 1µg/ml pre-clustered Fc or ephrinA2/A5 (1:1 
mix). TCLs and supernatant were probed with EphA4-SEK antibody. 
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2.2.2. EphA4 shedding during embryonic development is temporally and spatially 
regulated 
To complement the cell culture data, I prepared E16.5 cortical neuron dissociated 
cultures from wild-type and EphA4 knockout mice. I kept neurons in culture for 14 hours, 
then collected the supernatant and harvested the cells. Since EphA4 is a glycosylated 
protein, I immunoprecipitated the proteins present in the supernatant by lectin pull-down.  
 
Figure 2-28. EphA4 is cleaved in E16.5 cortical neurons and cleavage regulates receptor levels in 
culture 
(A-B) Western blots of E16.5 cortical neurons from wild-type and EphA4-/- embryos. Samples were probed 
with EphA4SEK and FLRT3 (as control) antibodies (A), and with EphA4-Zymed and tubulin antibodies 
(B). (C) Western blots of wild-type E16.5 cortical neurons kept in culture for one (1DIV) or seven days 
(7DIV). TCLs were probed with EphA4-Zymed and tubulin antibodies. Supernatants were probed with 
EphA4-SEK antibody. 
Using Western Blot I showed that the EphA4-ECD was detected only in the wild-type 
supernatant, whereas the EphA4-ICD was present only in the wild-type TCL (Figure 2-
28). As a control, FLRT3-ECD (a known cleaved protein [244]) was detected in the 
supernatant of both wild-type and EphA4-/- cortical neuron cultures. Interestingly, after 7 
days in culture, cortical neurons showed decreased expression of full length EphA4, and 
EphA4-ECD was accumulated in the supernatant. No differences were observed in the 
levels of EphA4-ICD, suggesting the presence of an intracellular regulatory mechanism 
in maintaining its constant expression, e.g. proteasome degradation (Figure 2-28). These 
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data confirmed the ex vivo cleavage of EphA4, and reinforced the idea that EphA4 
shedding could be a way of regulating EphA4 expression.   
Although I showed cleavage in transfected cells and neuronal cultures, it was still 
unclear if cleavage was happening in vivo or was a culture artifact. Thus, I prepared 
spinal cord and hindlimb lysates from E12.5 wild-type and EphA4-/- embryos and probed 
the membranes with the EphA4-SEK antibody. The antibody recognized two bands in 
both tissues, one corresponding to the full length protein and one to the EphA4-ECD 
(Figure 2-29). Interestingly, EphA4-ECD was in a 1:1 ratio with the full length EphA4 in 
the hindlimb, and in a 1:2 ratio in the spinal cord, suggesting that the extent of cleavage 
might be tissue-specific. 
 
Figure 2-29. EphA4 is cleaved in vivo 
Western blots of E12.5 spinal cord and hindlimb lysates from wild-type and EphA4-/- embryos. Samples 
were probed with EphA4SEK and tubulin antibodies. 
To further characterize the space and time regulation of EphA4 cleavage during 
development I prepared lysates from three different tissues - spinal cord, hindlimb and 
forebrain – at several developmental stages. EphA4-ICD and EphA4-ECD showed a 
similar regulation (quantified as percentage of full-length protein) in all the tissues and at 
every developmental stage (Figures 2-30 and 2-31). 
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Figure 2-30. EphA4 cleavage is spatially and temporally regulated 
(A-C) Western blots of wild-type and EphA4-/- spinal cord (A), hindlimb (B) and forebrain (C) lysates 
prepared from several developmental stages probed with EphA4-S20 and tubulin antibodies.  
 
Figure 2-31. EphA4 cleavage has a peak between E12.5 and E15.5 
(A-C) Western blots of wild-type spinal cord (A), hindlimb (B) and forebrain (C) lysates prepared from 
several developmental stages probed with EphA4-SEK and tubulin antibodies. (D) Graph showing 
quantification of the cleavage, calculated as the intensity of the EphA4-ECD band divided by the intensity 
of the full length EphA4 band, at different developmental stages in different tissues (mean±SEM). 
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In the spinal cord, although it was possible to observe a peak between E13.5 and E15.5, 
at all stages EphA4-ECD represented a minimal percentage of the total EphA4 expression 
(Figures 2-30 and 2-31). In the hindlimb, EphA4 cleavage peaked at E12.5 and decreased 
by E17.5 (Figures 2-30 and 2-31). In the forebrain EphA4-ICD was highly expressed 
across all the developmental stages, although decreasing in post-natal stages (Figures 2-
30 and 2-31).   Taken together these data suggest that EphA4 shedding is a temporally 
and spatially limited process. Interestingly, the temporal regulation of EphA4 cleavage 
and the extent of cleavage differ in the three tissues analyzed, implying a tissue-specific 
regulation, probably due to the presence of specific proteases. 
2.2.3. Identification of the EphA4 cleavage site 
To identify the cleavage site in the receptor, I transfected Hela cells with different 
EphA4 mutants, carrying deletions of the whole extracellular domain (EphA4ΔN), or of 
the two fibronectin domains (EphA4ΔFN3) or of the ligand binding domain 
(EphA4ΔLBD), and an EphA4 mutant, in which the intracellular domain was replaced by 
GFP (EphA4-GFP). All these mutants had an N-terminal Flag tag. As additional controls, 
I used two other receptors belonging to the Eph family, EphB2 and EphA3, both carrying 
a Flag-tag in their extracellular domain. EphB2 was already reported to be shed [122, 
228], but nothing was known about EphA3. This experiment gave three important lines 
of evidences. First, it strengthened the concept that shedding is independent of the kinase 
activity, since the EphA4-GFP, although lacking completely the kinase domain, was 
cleaved to the same extent as wild-type EphA4 (Figure 2-32). Second, it showed that not 
all the Eph receptors undergo cleavage, since EphA3 was not shed (Figure 2-32). Finally, 
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it suggested that the cleavage site was not in one of the previously known domains of 
EphA4, since all the EphA4 mutants, except the EphA4ΔN, were shed (Figure 2-32). 
 
Figure 2-32. Eph receptor cleavage 
Western blots of total cell lysates (TCL) and supernatant of Hela cells transfected with EphA4 wt (EphA4-
Flag), EphA3, EphB2 and different constructs carrying deletion in the extracellular or intracellular region 
of EphA4. Blots were probed with an antibody against Flag. The weak band seen at 75kDa is an unspecific 
band. 
The only portion of the protein not affected by the deletions was a stretch of 15 amino 
acids in the extracellular juxtamembrane region. Deleting these amino acids (EphA4Δ15, 
carrying an N-terminal Flag tag) led to a strong decrease of EphA4 cleavage, although 
still did not completely abolish shedding (Figure 2-33). EphA4Δ15 cleavage released a 
smaller EphA4-ECD, implying that the deletion either abolished a glycosylation site or 
unmasked a different cleavage site. 
 
Figure 2-33. EphA4Δ15 is still cleaved with low efficiency 
Western blots of total cell lysates (TCL) and supernatant of Hela cells transfected with EphA4 wt (EphA4-
Flag) and EphA4Δ15. Blots were probed with an antibody against Flag. 
Since deleting the extracellular juxtamembrane region was not sufficient to fully 
abolish receptor shedding, I decided to use a different approach and do site-directed 
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mutagenesis to alter this stretch of amino acids. Since EphA3 was not cleaved (see Figure 
2-32) I performed site-directed mutagenesis to convert the 15 amino acids in the 
extracellular juxtamembrane region of EphA4 to the corresponding 13 amino acids of 
EphA3. The reduction of shedding was proportional to how much the mutated sequence 
resembled EphA3. The complete exchange of these amino acids (EphA4CR, where CR 
stands for Cleavage Resistant) completely abolished EphA4 shedding. EphA4-ECD and 
EphA4-ICD were no longer detected in the supernatant and TCL, respectively (Figure 2-
34).  
 
Figure 2-34. EphA4CR is cleavage resistant 
Western blots of total cell lysates (TCL) and supernatant of Hela cells transfected with EphA4 wt (EphA4-
Flag) and several EphA4 mutants obtained by site-direct mutagenesis. 
2.2.4. In vitro characterization of the EphA4CR mutant 
Before generating a knock-in mouse carrying the CR mutation, I characterized 
EphA4CR in selected in vitro assays. Flag staining of Hela cells transfected with EphA4CR 
confirmed that the protein was expressed normally at the cell surface (Figure 2-35). 
Moreover, activation of the receptor upon stimulation with increasing amounts of 
ephrinA5 was not changed (Figure 2-35).  
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Figure 2-35. EphA4CR is expressed on the cell surface and it is phosphorylated upon ephrinA5 
stimulation 
(A) Hela cells transfected with EphA4wt-Flag and EphA4CR-Flag were stained with Flag antibody to detect 
surface expression. Scale bar is 50µm. (B) Western blots of total cell lysates (TCL) of Hela cells 
transfected with EphA4-Flag and EphA4CR and stimulated as indicated. EphA4 phosphorylation was 
assessed using an anti-phosphoEphA antibody. Full-length protein and EphA4-ICD were detected using the 
EphA4-Zymed antibody. Anti-Flag staining showed the EphA4-ECD in the supernatant. 
As already mentioned, Eph receptors undergo bi-directional endocytosis, so I decided to 
assess whether impairing cleavage would affect the trans-endocytosis rate by co-culturing 
EphA4-transfected Hela cells with SKN-TG2 cells. SKN-TG2 cells are stably expressing 
histone2B-mCherry, and endogenously express ephrinAs and ephrinBs. As a negative 
control I used Hela cells expressing EphA4ΔLBD since it does not bind to ephrins. I 
seeded the SKN-TG2 cells on top of the Hela-transfected cells and after 1 hour and 30 
minutes I fixed cells. I performed immunostaining before and after permeabilization to 
detect the surface and total expression of EphA4. In the case of wild-type EphA4 it was 
possible to detect the receptor inside the SKN-TG2 cells, suggesting that the molecule 
was trans-endocytosed into the ephrin-expressing cells. EphA4ΔLBD was not present in 
the SKN-TG2 cells, showing that impairing ligand-receptor binding blocks trans-
endocytosis (Figure 2-36). EphA4CR was trans-endocytosed into the ephrin expressing 
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SKN-TG2 (Figure 2-36) more than the wild-type receptor, suggesting that endocytosis 
could counteract the absence of cleavage. 
 
Figure 2-36. EphA4CR shows increased trans-endocytosis into ephrin expressing cells 
(A-C) Hela cells transfected with EphA4 wild-type (A), EphA4CR (B) and EphA4ΔLBD (C) co-cultures 
with SKN-TG2 cells. Cells were stained with anti-Flag antibody before and after permeabilization to detect 
surface and total expression of EphA4. Cell outlines were labeled by Cell Mask Blue (CMB) staining. 
Insets show higher magnification of the cells. (D) Graph represents the number of vesicles internalized per 
SKN cells (mean±SEM). 5 SKN cells in the surrounding of each transfected Hela cell were analyzed. 
N=344 cells for EphA4 wild-type and 365 cells for EphA4CR from 4 independent experiments. Scale bar is 
10µm. Statistical analysis was done as for Figure 2-8. 
2.2.5. Generation of the EphA4CR knock-in mouse 
To address how the impairment of receptor cleavage would affect EphA4 signaling 
during development, I generated a knock-in mouse carrying the mutation. I inserted the 
mutated EphA4 cDNA in frame in the exon 3 of the EphA4 gene. The targeting vector 
carried a gene for resistance to neomycin, so embryonic stem (ES) cells were selected by 
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antibiotic resistance and then screened by Southern Blot for the mutation. For screening 
by Southern Blot I digested genomic DNA with BamHI and used a probe that annealed in 
the 5’ region of the EphA4 locus and to confirm the positive clones, I used a probe for the 
3’ region of the locus (see Figure 2-37 for the targeting strategy). If the clones carried the 
mutation an additional BamHI site was created, generating an additional band on the 
Southern Blot with the 3’ probe (running at ~5kb). Out of 338 clones screened 5 clones 
were positive for the insertion (Figure 2-37). Three clones were used for blastocyst 
injections and all gave rise to chimaeric mice. Chimaeric mice were then crossed with 
PGK-Cre+ mice to remove the neo cassette, and bred for three generations. 
 
Figure 2-37. Generation of the EphA4CR knock-in mouse. 
(A) Scheme representing the knock-in strategy. B indicates BamHI restriction sites. II and III indicate 
EphA4 gene exons. Blue dashed lines show the long and short arm of recombination. (B) Southern Blot of 
wild-type and heterozygous EphA4CR/wt ES cells. Samples were probed with a radioactively labeled 3’ 
probe. 
Before starting phenotypic analysis, I checked that the mutation was sufficient to 
abolish cleavage in vivo. I prepared lysates from different tissues of E12.5 embryos and 
performed a Western Blot to detect EphA4 cleavage and expression. In EphA4CR/CR 
embryos the EphA4-ICD and the EphA4-ECD were no longer detected in any of the 
tissues (Figure 2-38). 
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Figure 2-38. EphA4CR mutation is sufficient to abolish receptor cleavage in vivo. 
Western blots of E12.5 wild-type and samples from two different EphA4CR/CR embryos, forebrain, spinal 
cord and hindlimb probed with EphA4-Zymed, EphA4-SEK and tubulin antibodies.  
2.2.6. EphA4 expression in EphA4CR/CR embryos 
Data from cortical primary culture and transfected cells hinted that the cleavage might 
regulate EphA4 expression. Thus, I investigated whether genetically blocking EphA4 
cleavage in vivo would affect the expression of the full length protein. Western Blot 
performed at E12.5 and E13.5 showed an increase in the amount of full length EphA4 in 
EphA4CR/CR hindlimb, spinal cord and forebrain lysates as compared to controls (Figure 
2-39). At E12.5 the increase was more dramatic in the forebrain and in the hindlimb 
where EphA4 was cleaved to a greater extent. In the heterozygous EphA4wt/CR spinal 
cords, the mutation increased the full length expression as much as in EphA4CR/CR 
embryos. At E13.5 the expression of EphA4 was higher still, although the difference 
between wild-type and mutant was less evident, suggesting the presence of additional 
mechanisms regulating full length protein expression. 
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Figure 2-39. EphA4CR/CR has increased levels of EphA4 full-length protein. 
(A-C) Western blots of E12.5 wild-type, EphA4wt/CR and EphA4CR/CR forebrain (A), spinal cord (B) and 
hindlimb (C) probed with EphA4-Zymed and tubulin antibodies. (D-F) Western blots of E13.5 wild-type, 
EphA4wt/CR and EphA4CR/CR forebrain (D), spinal cord (E) and hindlimb (F) probed with EphA4-Zymed and 
tubulin antibodies. (G,H) Graphs representing full-length EphA4 expression, normalized to tubulin, at 
E12.5 (G) and E13.5 (H) in wild-type, EphA4wt/CR and EphA4CR/CR tissues.  
To complement the Western Blot analysis and to identify whether the increase in full 
length protein expression was ubiquitous or limited to specific cell populations, I 
prepared cryosections of E12.5 embryos and performed immunostaining using an EphA4 
antibody. In the hindlimb there are two sources of EphA4 expression: the hindlimb 
mesenchyme and the motor axons. EphA4 is expressed at higher levels on the peroneal 
nerve, which innervates the dorsal mesenchyme, and at lower levels on the tibial nerve, 
which provides innervation to the ventral mesenchyme [187, 188, 196]. In EphA4CR/CR 
embryos EphA4 expression did not increase on either of the two nerves and the ratio of 
peroneal and tibial expression remained unaffected (Figure 2-40). In the hindlimb EphA4 
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is widely expressed in the mesenchyme, although at higher levels in the dorsal region. In 
EphA4CR/CR embryos I observed an increase in EphA4 expression in both the dorsal and 
the ventral part of the hindlimb mesenchyme (Figure 2-40), although the ratio between 
the two was not changed. These data suggest that abolishing cleavage is sufficient to up-
regulate EphA4 expression in the mesenchyme but not on the growing axons. Moreover, 
I showed that inhibiting cleavage does not change the relative expression of the protein, 
indeed, the dorsal/ventral ratio is conserved.  
 
Figure 2-40. In EphA4CR/CR embryos full-length EphA4 is up-regulated in the hindlimb mesenchyme 
but not on motor axons. 
(A) Immunostaining of E12.5 wild-type and EphA4CR/CR hindlimb with EphA4-S20 and neurofilament (NF) 
antibodies. Arrowheads point to the peroneal nerve, and arrows to the tibial. Scale bar is 100µm. (B) Graph 
representing mean±SEM of EphA4 staining intensity on the peroneal and tibial nerves, normalized to 
neurofilament (N=3 embryos per genotype). (C) Graph representing mean±SEM of EphA4 staining 
intensity on the dorsal and ventral mesenchyme (N=3 embryos per genotype). Statistical analysis was done 
as for Figure 2-8. 
At E12.5 EphA4 is expressed in several neuronal populations within the spinal cord, 
although most strongly in motor neurons. I prepared cryosections of E12.5 embryos and 
stained them with EphA4 and neurofilament antibodies. I identified the motor neurons by 
their position in the spinal cord and measured EphA4 expression, normalizing to the 
intensity of neurofilament staining. In the EphA4CR/CR spinal cord, EphA4 was not up-
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regulated on motor neuron cell bodies as compared to wild-type littermates (Figure 2-41). 
When I compared the levels of EphA4 between the dorsal and ventral regions of the 
spinal cord, I made the surprising observation that in EphA4CR/CR embryos the protein is 
expressed at higher levels in the dorsal part. Taken together these data suggest that in the 
spinal cord the up-regulation of EphA4 expression is restricted to the dorsal spinal cord. 
 
Figure 2-41. In EphA4CR/CR embryos full-length EphA4 is up-regulated in the dorsal spinal cord but 
not on motor neurons.  
(A) Immunostaining of E12.5 wild-type and EphA4CR/CR spinal cord with EphA4-S20 antibody. (B) Graph 
representing mean±SEM of EphA4 staining intensity on motor neurons normalized to neurofilament 
staining (N=3 embryos per genotype). (B’) Staining of EphA4 on motor neurons was analyzed in the area 
encircled by the orange dashed line. (C) Graph representing mean±SEM ratio of EphA4 staining intensity 
on the dorsal and ventral spinal cord (N=3 embryos per genotype). (C’) Red and blue lines indicate the total 
and half length of the spinal cord, respectively. Two boxes (height equals one quarter of the total length of 
the spinal cord) were draw beginning at the middle of the spinal cord. The green box represents the area 
considered dorsal, and the yellow the ventral one. Statistical analysis was done as for Figure 2-8. 
2.2.7. EphA4 shedding is required for LMCL neuron axon guidance 
Since EphA4 has been shown to be a key player in motor neuron axon guidance at the 
sciatic plexus [194], and the protein was up-regulated in the hindlimb mesenchyme, I 
next investigated the role of receptor shedding in LMC axon guidance.  
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Figure 2-42. Hindlimb retrograde tracings show misguidance of LMCL neurons in EphA4
CR/CR 
embryos 
(A) Confocal pictures of ventral retrograde tracings in E12.5 embryos. Rhodamine dextran (RD) was 
injected in the ventral shank of the hindlimb and sections were stained with Islet1 and Lim1 to label LMCM 
and LMCL (populations are delineated by dashed lines), respectively. (B) Graph represents the percentage 
of misprojections (neurons positive for RD and Lim1 staining) in relation to all RD-labeled cells in ventral 
retrograde tracings of 5 wild-type embryos and 8 EphA4CR/CR embryos. Each dot in the graphs represents 
one embryo. The black line represents the mean. (C) Confocal pictures of dorsal retrograde tracings in 
E12.5 embryos. Rhodamine dextran (RD) was injected in the dorsal shank of the hindlimb and sections 
were stained as above. (D) Graph represents the percentage of misprojections (neurons positive for RD and 
Islet1) in relation to all RD-labeled cells in dorsal retrograde tracings. The black line represents the mean. 7 
wild-type embryos, 4 EphA4wt/CR and 7 EphA4CR/CR were analyzed. Each dot in the graphs represents one 
embryo. Scale bar is 50 µm. Statistical analysis was done using the non-parametric Mann-Whitney test 
(*p<0.05). 
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The two populations of LMC neurons, LMCL and LMCM, can be separately examined 
using ventral and dorsal retrograde tracings, respectively. As has already described for 
the PTPRO project, I injected Rhodamine Dextran (RD) in the dorsal and ventral shanks 
of E12.5 EphA4CR/CR embryos, and labeled the two neuronal populations by staining for 
Islet1 and Lim1. Dorsal retrograde tracings did not show any misprojections, since all the 
labeled cells colocalized with Lim1 and there was no difference with wild-type embryos. 
However, ventral tracings showed 14% of mis-projecting axons in EphA4CR/CR embryos 
(Figure 2-42). Unexpectedly, this mis-projection phenotype resembled qualitatively the 
EphA4-/- phenotype.  
Taken together these data suggest that abolishing cleavage in vivo impairs LMCL 
axon guidance, re-routing them to the ventral mesenchyme. Further experiments will be 
required to uncover the mechanism underlying this phenotypic change in the EphA4CR/CR 
embryos.  
2.2.8. EphA4 shedding is dispensable for dorsal funiculus and anterior commissure 
formation 
Since the phenotype observed in the hindlimb is similar to that of EphA4-/- embryos, I 
decided to analyze other developmental processes dependent on EphA4 signaling: the 
morphology of the dorsal funiculus (DF) and the formation of the anterior commissure 
(AC). The DF is the structure in the dorsal spinal cord containing ascending and 
descending projections, including sensory afferents and CST axons. Formation begins at 
E14.5 and is completed by birth. In EphA4-/- and EphA4KD (kinase dead knock-in) mice 
the DF is shallower [150, 151]. In EphA4CR/CR embryos full-length EphA4 is highly 
expressed in the dorsal spinal cord as compared to controls. I dissected spinal cords from 
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wild-type and EphA4CR/CR adult mice and prepared vibratome sections from the lumbar 
region. To compare wild-type and EphA4CR/CR I measured the length of the dorsal 
funiculus and normalized it to the distance between the dorsal tip of the spinal cord and 
the central canal. Although in the embryonic dorsal spinal cord EphA4 expression was 
increased and EphA4 cleavage abolished, I did not observe any alteration in the dorsal 
funiculus anatomy (Figure 2-43). 
 
Figure 2-43 Dorsal funiculus morphology and anterior commissure formation are not affected in 
EphA4CR/CR mice 
(A) Cross-sections of adult spinal cord from wild-type and EphA4CR/CR mice. Red line marks the dorsal 
funiculus length, and green, the distance between the dorsal tip of the spinal cord and the central canal. (B) 
Graph represents the mean±SEM ratio of the length of the dorsal funiculus (DF) and distance to central 
canal  (N=3 mice per genotype). (C) Cross-sections of adult brain from wild-type and EphA4CR/CR. Arrows 
point to the anterior tract of the anterior commissure (N=3 mice per genotype). 
I next analyzed the formation of the anterior commissure. It has been shown that 
EphA4-mediated ephrin reverse signaling is required for the correct formation of the aAC 
tract. In EphA4-/- mice the aAC tract is absent, while it is not affected in EphA4KD [152]. I 
dissected brains from wild-type and EphA4CR/CR adult mice and prepared vibratome 
sections. Although in embryonic forebrain lysates EphA4 expression was increased and 
EphA4 shedding abolished, the aAC tract was correctly formed. I compared 3 wild-type 
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and 3 EphA4CR/CR brains and did not observe any morphological differences (Figure 2-
43). 
Taken together these data show that EphA4 is dispensable for the formation of the 
dorsal funiculus and of the aAC tract. Interestingly, the data on the anterior commissure 
suggest that EphA4 is capable of acting as a ligand, even as a membrane-bound protein.   
2.3. Receptor cross-talk during development 
2.3.1. EphA4 and Ret do not interact in LMC neurons 
As mentioned in the introduction, another way of regulating signaling and combining 
different stimuli in a great variety of outputs, is the cooperation of different receptors. In 
the hindlimb, as reported by Kramer et al. [196], Ret and EphA4 cooperate in guiding 
LMCL axons in the dorsal mesenchyme. In collaboration with Dr. Irina Dudanova, I 
assessed whether these two receptors converge on the same pathway or act 
independently.  
 
Figure 2-44 Characterization of dissociated LMC cultures 
(A,B) The difference in EphA4 expression between LMCM and LMCL neurons is maintained in overnight 
cultures. Representative images of LMCM and LMCL neurons immunostained for Islet1 and EphA4, 2 
hours (A) and 17 hours (B) after seeding. Islet1- (LMCL) neurons show stronger EphA4 staining than 
Islet1+ neurons. Scale bars are 12µm. (C) Quantification of fluorescence intensity of EphA4 staining. Data 
are presented as mean values (±SEM), the numbers of cells analyzed are: 13 neurons from 1 culture for 
Islet1- 2 hours, 22 neurons from 1 culture Islet1+ 2 hours, 19 neurons from 2 cultures Islet1- 17 hours, 20 
neurons from 2 cultures for Islet1+ 17 hours. Statistical analysis was done as for Figure 2-8. 
To identify a potential direct interaction between the two RTKs, I performed 
immunostaining on dissociated cultures of motor neurons and co-immunoprecipitation 
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experiments from spinal cord and hindlimb lysates. First, I characterized the E12.5 
primary motor neuron culture system to make sure that LMCL and LMCM are equally 
represented. I cultured Hb9-GFP+ motor neurons for 2 or 17 hours and then did an 
immunostaining for EphA4 and Islet1 (marker of LMCM). At both time points, as 
expected, EphA4 expression was higher on Islet1- neurons (Figure 2-44), and the number 
of Islet1+ and Islet1- neurons was roughly equal. Moreover, I prepared primary motor 
neuron dissociated cultures from E12.5 Ret-/- and EphA4-/- embryos, and tested the 
specificity of the Ret and EphA4 antibodies (Figure 2-45).  
Having characterized the culture system and the antibodies, I did co-staining for Ret 
and EphA4, before and after stimulation with their respective ligands, and I did not 
observe a significant degree of colocalization between the two receptors in any of the 
conditions analyzed (Figure 2-46). Consistently, I was not able to co-immunoprecipitate 
EphA4 and Ret from the hindlimb or spinal cord lysates. As a positive control for the 
immunoprecipitation I used an antibody against FRS2, a known interactor of Ret [56] 
(Figure 2-46).  
 
Figure 2-45 Specificity of Ret and EphA4 antibodies 
(A,B) Dissociated cultures of LMC motor neurons from Ret-/- (A), EphA4-/ -(B) and corresponding wild-
type littermate embryos were immunostained for the respective proteins. Axons were outlined based on 
Hb9-GFP staining. Scale bars are 25 µm. 
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Figure 2-46 Ret and EphA4 do not directly interact in motor axons 
(A) Immunodetection of endogenous Ret (green) and EphA4 (red) in dissociated LMC cultures from Hb9-
GFP+ transgenic embryos stimulated with the indicated proteins. (B) Quantification of colocalization of Ret 
and EphA4 on motor neuron growth cones in the indicated stimulation conditions. The growth cone was 
manually selected based on the Hb9-GFP signal and the correlation between Ret and EphA4 staining was 
calculated as Pearson’s correlation coefficient. Data are presented as mean values (±SEM), the numbers of 
cells analyzed are: 5-14 neurons from at least 2 cultures. Scale bars represent 10μm. (C) Lysates of E12.5 
spinal cords were subjected to immunoprecipitation (IP) with the Ret antibody and examined by anti-Ret, 
anti-EphA4 and anti-FRS2 western blots as indicated. EphA4 does not coimmunoprecipitate with Ret. As a 
positive control, we observed coimmunoprecipitation of Ret and FRS2, a known interaction partner of Ret. 
TCL denotes total cell lysate. (D) Lysates of E12.5 spinal cords were immunoprecipitated with the EphA4 
antibody and examined by anti-Ret and anti-EphA4 western blots. No Ret protein is detected in the 
precipitates. 
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These results suggest that the two receptors are unlikely to directly interact on motor 
neuron axons or growth cones, raising the possibility that they signal independently in an 
additive fashion. 
2.3.2. EphA4 signaling is not impaired in Ret-/- mice 
Although the two receptors do not interact directly, it is still possible that they 
influence each other’s signaling. Therefore, I analyzed EphA4 phosphorylation and 
cleavage in spinal cord and hindlimb lysates in the presence and absence of Ret. I 
prepared spinal cord lysates from wild-type and Ret-/- embryos, immunoprecipitated them 
with an EphA4 antibody and then probed the membrane with a phosphotyrosine antibody 
(4G10). As a control for the specificity of the immunoprecipitate, I also prepared lysates 
from EphA4-/- embryos. EphA4 was not differentially phosphorylated in Ret-/- lysates as 
compared to controls (Figure 2-47).  
 
Figure 2-47 EphA4 phosphorylation and shedding are not altered in E12.5 Ret-/- embryos 
(A) E12.5 spinal cord lysates from wild-type and Ret-/- embryos were immunoprecipitated with an antibody 
against EphA4, and probed with phosphotyrosine (pTyr) and EphA4 antibodies. Total cell lysates (TCL) 
were probed with EphA4-Sek and Ret antibodies. (B) E12.5 spinal cord lysates from wild-type and   
EphA4-/- embryos were immunoprecipitated with an antibody against EphA4 and probed with 
phosphotyrosine (pTyr) and EphA4 antibodies. (C) Graph representing the mean±SEM ratio of pTyr and 
EphA4 staining. N=5 embryos per genotype. (D) Graph representing the mean±SEM ratio of shed 
ectodomain (ECD) of EphA4 and full length EphA4 in hindlimb and spinal cord lysates from wild-type and 
Ret-/- embryos. N=5 embryos per genotype for the spinal cord, 5 wild-type and 4 Ret-/- embryos for the 
hindlimb. 
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GDNF/NCAM signaling has been implicated in the proteolytic processing of 
PlexinA1 by calpain at the spinal cord midline [93]; and, GDNF/Ret signaling is involved 
in LMCL guidance. Therefore, I addressed the potential involvement of Ret-dependent 
GDNF signaling in EphA4 shedding. I prepared lysates from E12.5 Ret-/- spinal cords and 
hindlimbs and analyzed EphA4 cleavage using Western Blot. The ratio of EphA-ECD 
and EphA4 full-length was not affected in Ret-/- spinal cord and hindlimb, excluding a 
modulatory role for Ret in EphA4 cleavage, similarly to what was reported for PlexinA1 
cleavage at the midline [93] (Figure 2-47).  
Consistent with these data, Dr. Irina Dudanova showed that EphA4-mediated growth 
cone collapse was not affected in Ret-/- motor explants (Figure 2-48). Similar to as 
previously described for the PTPRO project (see Figure 2-22), she stimulated motor 
explants with pre-clustered Fc, as a control, or ephrinA2/A5 (1:1 mix) and then 
quantified the percentage of collapsed growth cones. Taken together these data 
demonstrate that genetic ablation of Ret does not impair EphA4 forward signaling. 
 
Figure 2-48 EphA4-induced growth cone collapse is not affected in Ret-/- embryos (Dr. Irina 
Dudanova) 
EphrinAs-induced growth cone collapse is not Ret dependent. Explants from Ret knockout embryos and 
control littermates were treated with 500ng/ml pre-clustered ephrinA2-Fc and ephrinA5-Fc or pre-clustered 
Fc. The graph represents mean values (±SEM) from two cultures (2–3 explants were counted per 
condition). 
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2.3.3. GDNF and ephrinAs cooperate in Motor Axon Turning 
While it was already known how EphA4 guided motor axons, how Ret instructed 
axons upon binding to GDNF was still unclear. The expression pattern of GDNF, slightly 
dorsally to the dorsal/ventral choice point, suggested that it might act as a chemo-
attractant cue. To test this hypothesis Dr. Irina Dudanova analyzed growth cone turning 
in response to a gradient of GDNF using the Dunn’s chamber [245]. The Dunn’s chamber 
consists of two concentric circular wells connected by a narrow bridge. If a guidance 
factor is added to the outer well it will slowly diffuse to the inner well, creating a 
gradient. To show the reliability of the assay, motor axons were exposed to a gradient of 
pre-clustered ephrinA5, and, as expected, they were repelled by high doses of the 
molecule. Interestingly, when motor neurons were challenged with a gradient of GDNF, 
they showed positive turning towards higher concentration of the neurotrophic factor. 
More interestingly, when they were challenged with opposing gradients of GDNF and 
ephrinA5 (such as to resemble the in vivo expression pattern of the two ligands in the 
hindlimb) the turning response was stronger than the response to either of the cues alone. 
However, if both ligands were applied in the same well, the attraction towards GDNF 
was neutralized by the repulsion away from ephrin, resulting in the absence of a net 
turning response (Figure 2-49). To further confirm that EphA4/ephrinAs and Ret/GDNF 
acted in an additive manner and that the receptors did not cross-talk, Dr. Dudanova 
repeated the turning assay in response to GDNF using wild-type and EphA4-/- neurons, 
showing that EphA4 was dispensable for GDNF-induced turning (Figure 2-49).  
Discussion 
 
99 
 
 
Figure 2-49 Cooperation between GDNF and ephrinA5 in motor axon turning ((Dr. Irina Dudanova) 
(A) Quantification of LMC axon turning in the indicated gradients. Data are presented as mean values 
(±SEM). The numbers of axons analyzed are: ephrinA5-Fc, 65 axons from six cultures; GDNF, 145 axons 
from three cultures; GDNF and ephrinA5 in counter gradients, 66 axons from five cultures; GDNF and 
ephrinA5 in overlapping gradients, 43 axons from two cultures; Fc, 73 axons from five cultures. (B) The 
absence of EphA4 does not change the turning response to GDNF. Data are presented as mean values 
(±SEM). The numbers of axons analyzed are: EphA4+/+, 44 axons from two cultures; EphA4-/-, 44 axons 
from two cultures. The difference between wild-type and knockout cultures is not significant (p = 0.80, t 
test). Statistical analysis was done as for Figure 2-8. 
Taken together these data suggest that in vivo LMCL axons are guided by a push-and-
pull mechanism, where GDNF pulls them towards the dorsal mesenchyme and ephrinAs 
push them away from the ventral side. 
3. Discussion 
The great variety of trajectories followed by neurons in vivo is due to the presence of 
modulatory cues that enlarge the spectrum of responses generated by a limited number of 
guidance molecules. In my thesis I focused on three different mechanisms of signal 
modulation: de-phosphorylation, cleavage and receptor cross-talk.  
I demonstrated that PTPRO, previously shown as an Eph-specific phosphatase in 
chick, in mice does not act as an Eph-specific phosphatase, but rather regulates Ret and 
TrkB phosphorylation to modulate trigeminal neuron growth and branching. 
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Interestingly, PTPRO sets a functional threshold in response to BDNF and GDNF, and 
the genetic removal of the phosphatase sensitizes trigeminal neurons to a lower 
concentration of neurotrophic factors.  
I generated a new mouse model to study the role of EphA4 cleavage during 
development and provided initial evidence for its requirement in LMCL axon guidance. 
Using this mouse model I also showed that abolishing cleavage is sufficient to up-
regulate the expression of the full-length protein, hinting that cleavage is a regulatory 
mechanism, fine tuning receptor expression during development.  
Finally, I provided evidence that EphA4 and Ret signal independently and additively 
in LMCL growth cones and thereby engage in a push-pull mechanism for LMCL axon 
guidance. The two receptors do not co-localize on the growth cones of LMC neurons. 
Genetic removal of Ret does not affect EphA4 signaling, and vice versa. Stimulation of 
LMC axons with GDNF and ephrinAs in opposing gradients strengthens the turning 
response up the GDNF gradient.  
3.1. Roles of RPTPs during development 
Over the last years, the roles of RPTPs in regulating axon guidance in Drosophila, C. 
elegans and vertebrates have been clearly shown; however, the underlying molecular 
mechanisms have been poorly characterized. In particular, there is still sparse knowledge 
on how the specificity and enzymatic activity of RPTPs are regulated. Moreover, since 
RPTPs can act either as ligand or as receptor, independently of their phosphatase activity, 
there is an additional level of complexity in deciphering their molecular interactions.  
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3.1.1. Regulation and specificity of the phosphatase activity 
To date it has not yet been clarified how the phosphatase activity of RPTPs is 
regulated, and how their substrate specificity is achieved. The current view is based on 
four hypothetical regulatory mechanisms: 1) dimerization, 2) binding to extracellular 
ligands, 3) cis-interactions with other transmembrane proteins, and 4) a combination of 
the above models (Figure 3-1). I will discuss these mechanisms in the following 
paragraphs. 
PTPRO knockout mice display exuberant growth and branching of trigeminal but not 
motor nerves in vivo, although Ret, one of its potential substrates, is expressed in both 
neuronal populations. Moreover, E12.5 PTPRO-/- cultured trigeminal neurons are more 
sensitive to BDNF and GDNF stimulation, but at P1, a similar behavior is not observed. 
These two observations raise the question of how PTPRO phosphatase activity and 
specificity is regulated in space and time. 
 
Figure 3-1. Models for the regulation of RPTP phosphatase activity 
(A) Model of the active state of RPTP. The phosphate domain is catalytically active (green). (B) Model of 
the inactive state of RPTP. The phosphate domain is catalytically inactive (red) upon dimerization. (C) 
Model of potential cross-talk with other receptors or with other RPTP to silence the catalytic activity. (D) 
Model of ligand induced activation of the phosphatase domain. (E) Model of ligand induced inactivation of 
the phosphatase domain. 
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On one hand, this could be achieved by tightly controlled expression of the phosphatase, 
on the other hand it could be regulated by dimerization. In vitro, PTPRO can act on TrkC 
[220], TrkB and Ret, but in vivo PTPRO expression is restricted mainly to TrkB+ and 
Ret+ neurons, suggesting that in vivo the selective expression of the phosphatase might 
restrict the number of potential substrates. In newborn mice the percentage of TrkB+ and 
Ret+ neurons expressing PTPRO decreases, partially explaining the lack of increased 
sensitivity towards BDNF and GDNF in P1 PTPRO-/- trigeminal neuron cultures 
compared to controls. Thus, PTPRO substrate specificity is partially achieved by 
restricted expression in space and time. 
PTPRO phosphatase activity has been shown to be regulated by dimerization [220]. 
When PTPRO is dimerized it is catalytically inactive. How dimerization is normally 
induced is still unknown. The most accredited hypothesis is that dimerization is induced 
by an extracellular ligand. To date very few proteins have been identified as potential 
ligands for RPTPs. The interaction between PTPσ and proteoglycans is an example of 
how trans-interaction with an extracellular ligand leads to changes in phosphatase 
activity. If PTPσ binds to chondroitin sulfate proteoglycans, it inhibits DRG neuron 
outgrowth, however, if it binds to heparan sulfate proteoglycans, it triggers neurite 
extension [246]. Wnt3 has been shown to bind to PTPRO, however it has not yet been 
addressed whether this interaction has any effect on phosphatase activity [247]. Based on 
what has been reported for other RPTPs, it would be interesting to study a potential 
interaction of PTPRO with proteoglycans, and how this interaction might affect its 
enzymatic activity.  
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Another challenging question is to understand how RPTPs regulate developmental 
processes independently of their phosphatase activity. There is growing evidence that 
RPTPs can act as receptors, can be phosphorylated and can activate signaling cascades 
leading to cytoskeletal re-arrangements [248]. LAR has been reported to bind heparan 
sulfate proteoglycans mediating attractive guidance of sensory axons to the skin 
independently of its phosphatase activity [249]. In my thesis I showed that PTPRO can 
directly regulate TrkB and Ret phosphorylation in vitro, but this did not demonstrate a 
requirement of its phosphatase activity in vivo. The generation of a knock-in mouse 
expressing a trapping mutant isoform of PTPRO (in which the phosphatase activity is 
inhibited by a DA mutation [219]) would unequivocally prove this point.  
Interestingly, I found a clear difference in substrate specificity between the mouse 
and chick isoforms of PTPRO. The chick, but not the mouse, isoform is able to 
dephosphorylate Eph receptors. Site-directed mutagenesis or domain swapping between 
the two isoforms could explain how this divergence in substrates has evolved. Direct 
comparison of the chick and mouse cDNA sequences points to a difference in the first 10 
amino acids in the N-terminal region, raising the possibility that the two isoforms might 
have different extracellular regulation. From an evolutionary perspective, it will be 
intriguing to understand if and why the mouse isoform has restricted its substrate 
specificity. 
3.1.2. Non cell-autonomous role of PTPRO 
PTPRO-/- mice were reported to have a reduced number of a subset of nociceptive 
(CGRP+) DRG neurons at birth and as adults [218]. Moreover, the central projections of 
the surviving nociceptive DRG neurons are abnormal and PTPRO-/- mice perform 
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abnormally on behavioral tests to assess response to thermal stimuli [218]. My data on 
PTPRO expression in the spinal cord at different developmental stages show that PTPRO 
is rarely coexpressed with TrkA in DRG neurons, but is highly expressed at the spinal 
cord midline (CGRP+ fibers crossing the midline are absent in PTPRO-/- mice [218]). In 
the TG, consistently with what has been reported by Gonzales-Britos et al. [218], there is 
a partial loss of TrkA+ neurons. As has been described for the DRG, in the TG PTPRO is 
rarely expressed in TrkA+ neurons at all the developmental stages analyzed. Thus, the 
defects observed in nociceptive neuron guidance and survival, are most likely caused by a 
non-cell autonomous function of PTPRO on TrkA+ neurons. Although the ex vivo 
experiments do not completely support a non cell-autonomous role of PTPRO in TrkA+ 
neurons, they do not rule it out. E12.5 PTPRO-/- trigeminal neurons, although not more 
sensitive to low doses of NGF, have longer and more branched neurites at high doses of 
NGF. As discussed previously, these effects are likely to be independent of TrkA 
signaling, and could be due to NGF effects on different sub-populations of TG neurons. 
Although PTPRO-/- P1 trigeminal neuron cultures are more branched in response to NGF, 
this might be a secondary effect due to the loss TrkA+ neurons observed in newborn 
PTPRO-/- TG. A conditional knockout approach, specifically ablating PTPRO from 
TrkA+ neurons would unambiguously distinguish between cell-autonomous and non-cell 
autonomous roles of the phosphatase.  
With respect to TrkC+ neurons, understanding PTPRO’s role is more challenging. 
PTPRO expression in TrkC+ neurons increases during development and the loss of 
neurons observed is consistent with the number of neurons expressing the phosphatase. 
How the phosphatase leads to a post-natal loss of TrkC+ neurons and to misguidance of 
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DRG proprioceptive projections, as reported by the Bixby’s group [218], is still unclear. 
Proprioceptive fibers develop in the spinal cord from E13.5 onward [236], and PTPRO at 
this stage is only expressed in 10% of TrkC+ neurons. At birth PTPRO is expressed in 
35% of neurons, and the majority of parvalbumin+ fibers (a subpopulation of TrkC+ 
axons) do not reach their synaptic target: motor neuron cell bodies. Characterizing 
PTPRO expression in the different subsets of TrkC+ neurons would better clarify its role 
in proprioceptive fiber growth and guidance. Moreover, as described in the case of 
nociceptive fibers, PTPRO is also expressed on the synaptic target of proprioceptive 
axons (Figure 2-2). Conditional ablation of PTPRO in sensory axons versus their target 
fields should resolve whether PTPRO acts cell-autonomously regulating receptor kinase 
activity or non-cell autonomously as a ligand. 
PTPRO acting as a target-derived ligand represents an intriguing possibility. This idea 
is supported by a study from 2001, showing that the PTPRO ectodomain acts as a 
chemorepulsive cue for chick RGC axons [250]. However, to date there is no evidence 
for such a function in vivo. Challenging DRG axons with the PTPRO ectodomain, either 
in axon turning or stripe assays, would shed light on PTPRO’s chemorepellent properties 
towards nociceptive and proprioceptive fibers. 
3.1.3. PTPRO as a potential therapeutic target  
The activation of RTKs is a spatially and temporally well controlled process to avoid 
aberrant cellular behavior and diseases. The de-regulation of half of the RTK families has 
been associated with human tumors [251]. To ensure the fidelity of signaling, cells have 
evolved several regulatory mechanisms including ligand sequestration, receptor 
dephosphorylation, activation of inhibitory proteins or inhibitory feedback loops, receptor 
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endocytosis and degradation. Although several regulatory proteins have been identified in 
vitro, thus far their role in vivo has not been completely clarified.  
To date, there is growing evidence supporting a role for PTPRO as a tumor 
suppressor, since its de-regulation has been associated with several human tumors [252-
255]. Here, I presented evidence that PTPRO is expressed in the nervous system and that 
in PTPRO-/- mice de-regulation of TrkB and Ret signaling causes excessive outgrowth 
and branching of trigeminal neurons in vitro and in vivo. In the future, it would be 
interesting to analyze the effects of PTPRO in the physiology and disease of other 
populations of neurons, where TrkB and Ret play a key role in development or 
maintenance. PTPRO is expressed in the substantia nigra of adult mice (Allen Brain Atlas 
staining), where Ret has been shown to prevent neurodegeneration in genetic or toxin-
induced Parkinson models [79, 256, 257]. It would be intriguing to analyze if genetic 
ablation or pharmaceutical inhibition of PTPRO potentiates Ret signaling and prevent 
dopaminergic neuron degeneration. Since PTPRO is expressed in the adult hippocampus 
[235] it would be interesting to analyze PTPRO and TrkB interaction in synaptic 
plasticity. TrkB-/- mice have impaired LTP, and a point mutation abolishing the PLCγ 
docking site on TrkB specifically affects hippocampal plasticity [19, 53]. Since in 
PTPRO knockout mice TrkB signaling is upregulated, it is possible that these mice have 
an enhanced LTP. 
3.2. How does receptor cleavage regulate axon guidance decisions? 
Work over the last decade has unraveled an important role for proteolytic processing 
of RTKs in neuronal development. Interestingly, cleavage can play versatile, and 
sometimes opposite functions. Cleavage can either inhibit or activate receptor signaling. 
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At the spinal cord midline the protease calpain is required to silence PlexinA1, by 
reducing its expression levels [93, 226]. By contrast, in Drosophila the protease 
kuzbanian is required to positively enhance Slit/Robo signaling [258, 259]. Cleavage can 
differentially regulate not only receptor activation, but also cell-cell contact. In the case 
of Eph/ephrin signaling cleavage has been proposed as a way to disrupt the initial 
adhesion and turn it into cell-cell repulsion [110, 123]. By contrast, work in Drosophila 
has shown that metalloproteases promote axon fasciculation, by enhancing adhesive 
interactions [260]. In summary, to date, it seems that receptor cleavage can mediate 
opposing functions in different neuronal populations and at different developmental 
stages. Considering the comprehensive literature on receptor cleavage in cultured cells it 
was surprising to learn that there are no reports addressing the question on how cleavage 
regulates the function of a single receptor in vivo. Genetic removal of metalloproteases or 
presenilin genes is likely to affect more than one receptor, and the resulting phenotypes 
can never be associated with the inhibition of the processing of a single protein. For 
example, a study from Sam Pfaff’s group showed the requirement of presenilin1 in motor 
axon guidance [261]. In mammals, there are two highly homologous presenilin genes, 
presenilin-1 (PS1) and presenilin-2 (PS2) [262]. Two of the better known substrates are 
Notch and amyloid precursor protein (APP), but there are also several axon guidance 
molecules, including DCC and EphA4. If γ-secretase activity is impaired, DCC 
intracellular fragment (DCC-ICD) rapidly accumulates and enhances neurite outgrowth 
in cultured cells [263, 264]. Interestingly, in a mouse mutant called Columbus, identified 
by a ENU mutagenesis screen, motor axons do not leave the spinal cord through the 
ventral roots but converge towards the floor plate [261]. The mutation in Columbus mice 
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affects presenilin activity and therefore DCC processing. Normally, motor neurons are 
not attracted by Netrin1 since Robo interacts with DCC, silencing the receptor and 
preventing attraction towards the floor plate. In Columbus or Presenilin1-/- mice, DCC-
ICD accumulates in motor neurons and prevents Robo interaction with DCC, making 
motor axons inappropriately attracted to Netrin1, which is expressed at the floor plate 
[261]. Although this study characterized in much detail the role of a protease in axon 
guidance, it does not take into account the effects of presenilin1 removal on all the other 
potential substrates. A test of the proposed model would be the generation of a DCC 
cleavage-resistant knock-in mouse. Difficulties in generating such a knock-in mouse arise 
from the fact that even once the cleavage sites have been identified, deleting or mutating 
them is often not sufficient to inhibit receptor shedding. The EphA4CR represents the first 
example of a knock-in mouse carrying a mutation in a guidance receptor that completely 
prevents its cleavage. By Western Blot and immunostaining, I demonstrated that 
inhibiting EphA4 shedding is sufficient to up-regulate EphA4 full-length expression in 
vivo in several tissues. Moreover, abolishing EphA4 cleavage is also sufficient to re-route 
LMCL axons into the ventral mesenchyme of the hindlimb.  
I showed that the extent of EphA4 cleavage differs among tissues and during 
development, but how this is achieved and why cleavage is required only for some 
EphA4-mediated cellular processes remain unanswered questions. Identifying the 
molecules involved in EphA4 cleavage, e.g. metalloproteases, would reveal new players 
in the regulation of LMC axon guidance. Once this analysis will be completely and the 
underlying mechanism discovered (see below), the results from this knock-in mouse will 
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provide a significant contribution to our understanding of receptor shedding in 
development. 
3.2.1. Potential molecular mechanisms leading to LMCL misguidance in EphA4CR/CR 
embryos 
EphA4 is expressed on the growing LMC axons and in the hindlimb mesenchyme. 
Although I showed the requirement of EphA4 cleavage at the sciatic plexus choice point, 
further experiments are required to unravel the molecular mechanisms. There are three 
possible scenarios: 1) EphA4 forward signaling is impaired, 2) EphA4 up-regulation in 
the hindlimb mesenchyme initiates aberrant ephrinA reverse signaling 3) EphA4 up-
regulation in the hindlimb masks ephrinAs in cis (Figure 3-2). 
Cleavage could be required on the axons to achieve cell-cell repulsion. LMCL axons 
express high levels of EphA4, and upon entering the ventral mesenchyme are repelled by 
ephrinA2 and ephrinA5 [187, 188, 196]. Inhibiting EphA4 cleavage might abolish the 
ability of LMCL axons to leave the ventral mesenchyme, because they could be unable to 
switch from the initial adhesion to repulsion (Figure 3-2). The easiest explanation is that 
in EphA4CR/CR mice, axons remain “glued” to the ephrinA-expressing mesenchyme. 
However, to compensate for the absence of cleavage, other repulsive mechanisms, such 
as bi-directional endocytosis, could be activated in vivo. In support of this theory, Hela 
cells transfected with EphA4CR displayed a higher rate of reverse-endocytosis when 
compared to controls. Another possibility is that EphA4 signaling is affected by the lack 
of cleavage. EphA4CR cannot generate the EphA4-ICD and EphA4-ECD fragments, and 
it has been shown that the EphA4-ICD specifically enhances Rac1 activation [192]. 
Rac1-activation triggers Eph-dependent growth cone collapse [102, 265, 266]. Therefore, 
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it is possible that in the absence of the EphA4-ICD, Rac1 activation is reduced, and cell-
cell repulsion could be impaired.  
 
Figure 3-2. Hypothetical molecular mechanisms leading to LMCL misguidance in EphA4
CR/CR mice 
(A,A’) EphA4 cleavage is necessary to trigger repulsion. If EphA4 expressed on LMCL axons is not 
cleaved, these axons are no longer repelled by ephrinA-expressing ventral mesenchyme. (B,B’) EphA4 
shed ectodomain acts as a chemoattractant. If EphA4 expressed on the dorsal mesenchyme is not shed, it is 
unable to bind to ephrinAs, expressed on LMCL axons, and initiate reverse signaling. (C-D’) EphA4 
cleavage reduces EphA4 expression in the ventral mesenchyme (C). In EphA4CR/CR embryos EphA4 
expression is up-regulated in the ventral mesenchyme, and attracts ephrinAs-expressing LMCL axons (C’). 
EphA4 cleavage reduces EphA4 expression in the ventral mesenchyme and prevents cis-interactions with 
ephrinAs (D). In EphA4CR/CR embryos, EphA4 full-length protein over-expression in the ventral 
mesenchyme masks ephrinAs. The increased cis-interactions reduce the availability of mesenchymal 
ephrinAs for trans- interactions with EphA4-expressing LMCL axons, thus impairing repulsion (D’). 
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The generation of a transgenic mouse expressing the EphA4-ICD in an inducible 
manner could clarify this mechanistic issue. This hypothetical lack of EphA4-mediated 
repulsion raises the question of whether axons would stall in the ephrinA-expressing 
mesenchyme or continue accumulating errors at secondary choice points. Staining of 
whole-mount Hb9-GFP+, EphA4CR/CR embryos to selectively visualize motor axons at 
different developmental stages would provide more insights.  
The second scenario is that cleavage is required for ephrinA reverse signaling. On one 
hand it is possible that EphA4 has to be shed to act as a chemo-attractant for ephrinA-
expressing LMCL axons. Inhibiting the cleavage could prevent the chemo-attraction in 
the dorsal mesenchyme and, thus re-route LMCL axons in the ventral shank. On the other 
hand, the increase in EphA4 full-length protein in the EphA4CR/CR ventral mesenchyme 
might erroneously attract LMCL axons (Figure 3-2). In vivo it is very difficult to 
discriminate between these two scenarios, however, genetic evidence hints at the second 
hypothesis. Genetic ablation of EphA4 in the hindlimb is not sufficient to cause a 
phenotype, whereas EphA4 over-expression in the chick ventral hindlimb is sufficient to 
re-route 15% of LMCL neurons [191]. Moreover, in EphA4
CR/CR mice the aAC tract 
develops normally, suggesting that the ability of the receptor to mediate reverse signaling 
is not affected. Over-expressing EphA4CR in the ventral mesenchyme would 
unequivocally clarify whether ectodomain shedding is a requirement for the protein to act 
as a chemoattractant.  
Finally, the observed phenotype could be due to the cis-interaction of EphA4 and 
ephrinAs in the ventral mesenchyme. Up-regulation of EphA4 expression in the 
EphA4CR/CR hindlimb could favor binding to coexpressed ephrinAs, thus limiting ligand 
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availability for trans-interactions. This reduced propensity for interacting with EphA4 in 
trans would enable EphA4-expressing axons to grow into the ventral mesenchyme. If this 
is the case, it would be possible to observe a significant difference in the amount of free 
ephrinAs detected by EphA4-Fc overlay, as done in the paper from Dudanova et al. 
[191]. Cross-sections of the hindlimb could be incubated with pre-clustered EphA4 
protein that should bind to free ephrinAs (not bound in cis), and then stained using a 
fluorescent antibody raised against the Fc region.   
In conclusion, further in vitro and in vivo experiments are required to shed light on 
the molecular mechanisms underlying LMCL misguidance. However, the above described 
scenarios are not mutually exclusive; indeed, it is possible that the phenotype is due to the 
combination of two or more of them. 
3.2.2. What triggers EphA4 cleavage? 
 Interestingly, EphA4 seems to have a different proteolytic regulation compared to 
EphB2. While EphB2 shedding is dependent on both ligand stimulation and calcium 
influx, EphA4 seems to be dependent on expression levels and neuronal activity [122, 
192, 228].  Motor neuron guidance and spinal circuit formation are dependent on 
electrical activity, at all stages of development [267]. How activity shapes the circuits and 
the connections is not yet known, however it has been shown that reduction in the 
frequency in ovo causes misguidance of LMC axons in the hindlimb [268]. One of the 
suggested mechanisms is that reducing the neuronal firing frequency leads to down-
regulation of EphA4 and EphB1 expression on LMC axons. However, an increase in the 
frequency, although sufficient to impair the guidance of some motor pools, has no effect 
on the level of EphA4 [268]. To date the molecular mechanisms by which activity 
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instructs Eph expression are unknown. Activity-dependent expression of Eph receptor is 
independent of Islet1 and Lim1, but may be dependent on proteins like c-Jun and 
MEK/ERK [268-271]. In addition to regulating Eph receptor expression, neuronal 
activity could also modulate downstream signaling, possibly by controlling cyclic 
nucleotide dynamics, i.e. cAMP. In vitro, growth cone collapse of RGC axons stimulated 
with ephrinA5 is inhibited when activity is acutely blocked, and rescued by the induction 
of cAMP oscillations [272].  
In summary, two models have been proposed by which activity regulates Eph/ephrin 
signal transduction: regulation of receptor expression and modulation of the signaling 
cascade. Interestingly, EphA4 cleavage could be the molecular mechanism to achieve 
both types of regulation. Abolishing cleavage is sufficient to increase EphA4 expression 
and in hippocampal neurons, the EphA4-ICD can initiate an independent signaling 
cascade [192]. However, further experiments are required to show that cleavage is the 
mechanism by which electrical activity instructs EphA4 signaling. A key experiment 
would be to assess whether in EphA4CR/CR embryos a reduction in the frequency is still 
able to down-regulate the expression levels of the receptor. 
3.2.3. EphA4 cleavage in neurodegenerative diseases 
EphA4 is cleaved consecutively by metalloproteases and γ-secretase. The latter is the 
enzyme that cleaves APP to generate Aβ-fragments. In Alzheimer’s mouse models and 
patients, the generation of Aβ-oligomers leads to cognitive impairment [273, 274]. 
EphA4 cleavage by γ-secretase is dependent on synaptic activity and generates the 
EphA4-ICD, which does not translocate to the nucleus but stays in the cytosol to promote 
Rac1 activation [192]. Over-expressing the EphA4-ICD in hippocampal neurons 
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potentiates the Rac1 pathway and induces the formation of dendritic spines [192]. 
Interestingly, when EphA4 is co-transfected in presenilin knockout cells, with presenilin1 
carrying Alzheimer's disease-related familial mutations, the generation of the EphA4-
ICD is severely impaired [192]. This would suggest that the synaptic failure observed in 
the Alzheimer’s mouse model could be due to the reduced generation of the EphA4-ICD, 
which would lead to a decrease in the formation of dendritic spines. Interestingly, two 
downstream effectors of Rac1, PAK1 and cofilin, seem also to be altered in Alzheimer's 
disease patients and mouse models. PAK1 is less active and cofilin forms pathological 
aggregates, consistent with the idea that impairing EphA4 cleavage may negatively 
regulate the Rac1 pathway [275]. Crossing EphA4CR/CR mice with an Alzheimer mouse 
model would unravel whether inhibiting the generation of the EphA4-ICD worsens the 
disease. 
Moreover, as described previously EphA4 and ephrinA3 are required for modulation 
of hippocampal LTP, a critical component of the cellular mechanisms underlying certain 
aspects of learning and memory [276]. ephrinA3, expressed in astrocytes, upon binding 
to EphA4, expressed in post-synaptic CA1 neurons, regulates the levels of glial glutamate 
transporters. Impairing ephrinA3 reverse signaling leads to the up-regulation of glial 
glutamate transporters and to defects in LTP. ephrinA3–/– mice perform abnormally in 
behavioral tasks requiring the hippocampus, implying that abundance of glial glutamate 
transport and regulation of synaptic plasticity could be essential for certain forms of 
hippocampal learning [276]. Several neurological and neurodegenerative diseases, such 
as epilepsy and amyotrophic lateral sclerosis (ALS), are correlated with defects in the 
glial glutamate transporters [277, 278]. Since EphA4 has been shown to be cleaved in 
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hippocampal neurons, in response to change in electrical activity, it would be interesting 
to analyze LTP and glial glutamate transporter levels in EphA4CR/CR mice. If reverse 
signaling is impaired in these mice, then this mutation would be sufficient to phenocopy 
EphA4 and ephrinA3 knockouts. If abolishing cleavage leads to an up-regulation of 
EphA4 and enhancement of reverse signaling, the phenotype would be similar to that 
which has been observed in mice over-expressing ephrinA3 in glia [158]. 
3.3. Guidance cue integration 
Axons, while navigating towards their final target, are challenged by multiple cues 
that can act either independently or synergistically. Two cues are defined as additive, if 
the net effect of their cooperation is the sum of the effects they generate when acting 
singularly. If two cues trigger a final effect bigger or smaller than the effects they 
generate separately, they are defined as non-additive. Non-additive effects are generally 
due to receptor or ligand cross-talk.  
3.3.1. Additive and non-additive effects of guidance cues  
The spinal cord midline represents a nice model system to analyze how multiple cues 
are integrated by growth cones of commissural axons. Upon crossing the midline 
multiple repulsive cues act simultaneously to drive the axons away from the midline, and 
removing any of these proteins results in the same stalling or ipsilateral recrossing 
phenotype [226, 230]. Conversely, Netrin/DCC and Slit/Robo signaling cross-talk and 
cooperate in a non-additive manner. Upon crossing the midline, the activation of the 
Slit/Robo signaling pathway, on one hand promotes repulsion away from the midline, and 
on the other hand silences netrin-mediated attraction to the midline [233]. 
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In my thesis, I presented data in a different model system, the hindlimb where Ret 
and EphA4 act in an additive manner. Moreover, this represents a remarkable example, 
since in this case, the two cues have opposing effects on the growth cone. Ret promotes 
attraction towards the GDNF source, whereas EphA4 mediates repulsion from the 
ephrinA-expressing mesenchyme. In addition, our work combined with what has been 
reported by Kramer et al. [196] provided evidence for an additive effect of these two cues 
in vivo and in vitro. In vivo the Ret and EphA4 double knockout has a more severe 
phenotype than the single knockout, and in vitro stimulation with an opposing gradient of 
ephrinA5 and GDNF has a net effect comparable to the sum of the effects of the two 
molecules applied individually.  
Interestingly, GDNF cooperates additively with ephrinAs, when ephrinAs act as 
ligands.  But GDNF acts synergistically (non-additively) when ephrinAs act as receptors 
[279]. To attract LMCL axons in the dorsal mesenchyme, both GDNF and EphAs signal 
via Ret. However, GDNF binds to a receptor complex, formed by Ret and GFRα1, and 
EphAs to a complex, formed by Ret and ephrinAs [279]. When applied in combination 
with EphAs, GDNF strengthens their growth-promoting activity [279]. LMC axons are 
not responsive to lower doses (subthreshold doses) of GNDF and EphAs applied 
individually, but show a robust turning response to the two ligands when applied together 
[279]. Thus, Ret acts as a coincidence detector, which, when activated by both EphAs 
and GDNF, ensures a stronger response of LMCL axons [279]. 
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4. Materials and Methods 
4.1. Chemicals and drugs 
Chemicals were purchased from Millipore, Merck, Roth and Sigma. Enzymes and 
relative buffers were purchased from New England Biolabs (NEB) or Roche. Kits for 
plasmid and PCR purification and gel-extraction were purchased from Qiagen. All water 
solutions were filtered using the Milli-Q-Water System (Millipore).  
4.2. Reagents 
4.2.1. Plasmids 
Insert Species Backbone Use Reference 
EphA4-wt Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression 
Sónia Paixão 
EphA4ΔN Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression 
Sónia Paixão 
EphA4ΔC-GFP 
Flag 
Mouse 
p3XFlag-
CMV 
Mammalian 
expression 
Sónia Paixão 
EphA4ΔLBD 
Flag 
Mouse 
p3XFlag-
CMV 
Mammalian 
expression 
Sónia Paixão 
EphA4ΔFN3 
Flag 
Mouse 
p3XFlag-
CMV 
Mammalian 
expression 
Sónia Paixão 
EphA4Δ10 Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression  
EphA4Δ2 Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression  
EphA4Δ4 Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression  
EphA4Δ6 Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression  
EphA4Δ8 Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression  
EphA4CR Flag Mouse 
p3XFlag-
CMV 
Mammalian 
expression  
EphA4 mCherry Mouse pcDNA3.1 
Mammalian 
expression 
Irina Dudanova 
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EphA3 Flag Mouse 
pCMV3-
3xFlag 
Mammalian 
expression 
Uwe Drescher 
Ret51wt Human pcDNA3.1 
Mammalian 
expression 
Carlos Ibañez 
TrkB Mouse pMEXneo 
Mammalian 
expression 
Rüdiger Klein 
PTPRO-Flag Mouse pFlag-CMV5
Mammalian 
expression 
Eek-hoon Jho 
PTPRO-Flag Chick 
p3XFlag-
CMV14 
Mammalian 
expression 
John Bixby 
GFP   pcDNA3.1 
Mammalian 
expression 
  
mCherry   pcDNA3.1 
Mammalian 
expression 
  
EphA4CR Mouse TOPO-IIA Subcloning   
EphA4CR Mouse pKSII+ Targeting vector   
EphB2 Mouse pcDNA3.1 
Mammalian 
expression 
Jenny Köhler 
EphA4 3’ probe   TOPO-IIA 
Southern Blot 
probe 3’ 
Christine Hassler 
EphA4 5’ probe   TOPO-IIA 
Southern Blot 
probe 3’ 
Christine Hassler 
 
4.2.2. Oligonucleotides 
Oligonucleotides were purchased from MWG as HPSF purified. 
4.2.3. Cloning primers 
Name Sequence 
A4FlagΔ2-Fw 5'-CGCATCATTGGCGATCTCGAGAACTCCACT-3' 
A4FlagΔ2-Rev 5'-GCCAATGATGCGGGAAGGCACTGTATTAGT-3' 
A4FlagΔ4-Fw 5'-CCTTCCCGCATCATTGGCGAGAACTCCACT-3' 
A4FlagΔ6-Fw 5'-GGAAGTCACTACTAGTCCAGTGCCTTCCCG-3' 
A4FlagΔ6-Rev 5'-AGTAGTGACTTCCAGGGGCTCGCTGAAGTC-3' 
Materials and Methods 
 
119 
 
A4FlagΔ8-Fw 5'-GTCACTACTAGCCCAGACTCTTCCCGCATC-3'  
A4CR-Fw 5'-CTACTAGCCCAGACTCTTTCAGCATCTCTGGC-3' 
A4CR-Rev 5'-AGAGTCTGGGCTAGTAGTGACTTCCAGGGG-3' 
A4mCherryΔ2-Fw 5'-GTCGACGTCCTGCTGGTCTCCGTCTCTG-3' 
A4mCherryΔ2-Rev 5'-GGCACTGTATTAGTCGACAGTAGTGACTTCC-3' 
 
4.2.4. Genotyping primers 
Name Sequence 
PTPROwt-Fw 5′ AAA CCT TAA ACT CCT GAT CCT CCT GCC TCC 3' 
PTPROko-Fw 5′ GCC TTC TAT CGC CTT CTT GAC GAG TTC TTC 3' 
PTPRO-Rev 5′ CAC TGA ATC AAA ATG TCC CAC CCA TGT TTC 3' 
Retgeno5 5`CCA ACA GTA GCC TCT GTG TAA CCC C 3` 
Retgeno7 5`GCA GTC TCT CCA TGG ACA TGG TAG 3` 
Retgeno6 5`CGA GTA GAG AAT GGA CTG CCA TCT CCC 3` 
Ret3E 5`ATG AGC CTA TGG GGG GGT GGG CAC 3` 
A4WT-Fw 5' CAAGCCGGCTGGGATCTAAGTGCCTGTTAGC 3' 
A4WT-Rev 5`ACCGTTGCAAATCTAGCCAGT 3` 
A4KO-Fw 5' GACTCTAGAGGATCCACTAGTGTCGA 3' 
A4KO-Rev 5'-TTTTCTGCCCTCTTTAAGCAAGGATCAAGC 3' 
A4KIGG-Fw 5' GCCCAGACTCTTTCAGCATCTCTGGCGAG 3' 
A4KIGG-Rev 5' GCCAGCTTTCAGAGTCTTGATGGCCACAC 3' 
A4wtKI-Fw 5' GACTCTAGAGGATCCACTAGTGTCGA 3' 
A4wtKI-Rev 5' TTTTCTGCCCTCTTTAAGCAAGGATCAAGC 3' 
GFP-F 5`GCA CGA CTT CTT CAA GTC CGC CAT 3` 
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GFP-R 5`GCG GAT CTT GAA GTT CAC CTT GAT 3` 
GDNF wt – Fw 5’TCT GCC TCC GCC ATC TTG GTC CTT ATC 3’ 
GDNF ko – Fw 5’CAG ATA AAC AAG CGG CAG CGC TTC C 3’ 
GDNF - Rev 5’CGC ATC GTA ACC GTG CAT CTG CCA GTT TGA 3’ 
 
4.2.5. Primary antibodies 
Antibody Species Company Dilution Application 
EphA4S20 Rabbit Sigma 1:100 WB, IF 
EphA4SEK Mouse Sigma 1:1000 WB 
EphA4-1383 Mouse Homemade 1:1000 IP 
EphA4-Zymed Mouse Zymed 1:1000 WB, IP 
Ret Goat Fitzgerald 1:1000 WB, IP 
Ret Goat R&D 1:100 IF 
TrkA Rabbit Millipore 1:500 WB, IF 
TrkB Goat R&D 1:500 WB, IP, IF 
TrkC Goat R&D 1:500 IF 
NeuN Mouse Millipore 1:500 IF 
Islet1 Mouse DHSB, clone 1:50 IF 
Lim-1 Rabbit 
Homemade, gift from 
A. Huber 
1:1000 IF 
PTPRO Rat 
Homemade, gift from 
T. Matosaki 
1:200 IF 
Flag Rabbit Sigma 1:1000 WB, IF 
Tubulin Mouse Sigma 1:20000 WB 
Tuj1 Mouse Covalence 1:500 IF 
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NF-160 Mouse Sigma 
1:300 or 
1:500 
Whole-mount 
staining, IF 
FRS2 Rabbit Santa Cruz 1:1000 WB 
phosphotyrosine Mouse Upstate 
1:500, 
1:1000 
IF, WB 
Phalloidin-594  Molecular Probes 1:200 IF 
 
4.2.6. Secondary antibodies 
Antibody Species Company Dilution Application 
Rabbit-cy2 Donkey Jackson Immunoresearch 1:200 IF 
Rabbit-cy3 Donkey Jackson Immunoresearch 1:200 IF 
Rabbit-cy5 Donkey Jackson Immunoresearch 1:200 IF 
Mouse-cy2 Donkey Jackson Immunoresearch 1:200 IF 
Mouse-cy3 Donkey Jackson Immunoresearch 1:200 IF 
Mouse-cy5 Donkey Jackson Immunoresearch 1:200 IF 
Goat-cy2 Donkey Jackson Immunoresearch 1:200 IF 
Goat-cy3 Donkey Jackson Immunoresearch 1:200 IF 
Goat-cy5 Donkey Jackson Immunoresearch 1:200 IF 
Mouse-HRP Sheep GE Healthcare 1:5000 WB 
Rabbit-HRP Donkey GE Healthcare 1:5000 WB 
Goat-HRP Donkey DAKO 1:5000 WB 
 
4.2.7. Cell lines 
Hela: Human epithelial adenocarcinoma cell line. 
HEK293: Human embryonic kidney cell line. 
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SKN-TG2: Human neuroblastoma cell line expressing Histone2B-tagged with RFP. 
Generated by Dr. Thomas Gaitanos. 
4.2.8. Media 
4.2.8.1. Luria-Bertani (LB) medium 
Bacto-Tryptone 10g 
Bacto-Yeast extract 5g 
NaCl 5g 
Distilled water up to 1L.  
Solution was prepared, pH was adjustedtot 7.5, autoclaved and stored at RT. 
4.2.8.2. LB plates 
15 g of Bacto Agar was dissolved in 1 L of LB media and autoclaved. After cooling 
down, antibiotics were added (Ampicillin 100mg/ml or Kanamycin monosulfate 
50mg/ml), solution was poured in 10 cm dishes, and stored at 4°C. 
4.2.8.3. Cell culture media 
Hela and HEK293: DMEM, 10% FBS (1% FBS for starving medium), 1% Glutamine, 
1% Penicillin-Streptomycin 
SK-N-TG2: OptiMEM with Glutamax, 10% FBS, 1% Penicillin-Streptomycin, 1% 
zeocin 
ES cells: DMEM+HEPES, 1% Pyruvate, 1% Penicillin-Streptomycin, 1% Non-essential 
amino acids, 1% nucleosides, 0.2% β-mercaptoethanol, 15% fetal bovine serum, 1000 
units LIF. 
 
4.2.9. Primary culture reagents 
BSA 4% (w/v) in L15: 
20 g of BSA was dissolved in 500 ml of L15 medium. Solution was then dialysed against 
PBS, using Spectra/Por membranes (MWCO: 25 000, Spectrum) overnight at RT. After 
washing with water membranes were dialysed against L15 medium. After 3 days, the 
solution was filtered (22 µm) and stored at -20°C.  
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Dnase I 1 mg/ml in L15, stored at -20°C. 
Glucose 72 mg/ml in L15; filtered and stored at -20°C. 
Poly-D,L-ornithine 3 mg/ml in water; stored at -20°C.  
Glutamate 25 mM in L15; stored at -20°C. 
2-mercaptoethanol 25 mM in L15; stored at -20°C. 
Poly-D-Lysine 1 mg/ml in Borate Buffer (Boric Acid 1.24g, 1.9g Sodium Borate in 
400ml of H20 pH=8.5); sterilized by filtration. Prepared fresh each time. 
Papain 20 mg/ml in PBS, stored at -20°C. 
Trypsin inhibitor 10 mg/ml in dissociation media, filtrate and pre-warm at 37°C. 
4.2.10. Primary culture media 
Complete Neurobasal medium; prepared freshly (50 ml) 
NeuroBasalTM (Invitrogen) 47.5 ml 
Glutamine 125 μl 
Glutamate 50 μl 
β-Mercaptoethanol 50 μl 
Horse serum 500 μl 
B27 supplement 500 μl 
 
MN culture medium 500 ml (modified from Garces et al. 2000, J. Neurosci. 20: 4992) 
Neurobasal medium 450 ml 
B-27 supplement to 1x from 50x stock 
L-Glutamate 0.5 mM 
L-Glutamine 25 mM 
Penicillin-Streptomycin to 1x from 100x stock 
 
Dissociation medium 
HBSS 500 ml 
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HEPES (pH 7.5) 3.5 ml 
1 M MgCl 5 ml 
Penicillin-Streptomycin to 1x from 100x stock 
4.2.11. Buffers and Solutions 
50x TAE 
2 M Tris acetate 
50 mM EDTA 
 
Gel loading buffer 
Glycerol 25 ml 
50x TAE 1 ml 
Orange G 0.1 g 
H2O 24 ml 
 
Lysis buffer (Cell lysate for protein extraction) 
50 mM Tris pH 7.5  
150 mM NaCl  
50 mM EDTA 
1% Triton  
Distilled water.  
Stored at 4°C. Before use, 1 tablet of Protease Inhibitor (Roche) was added to 50 ml of 
Buffer and 1 tablet of PhosphoSTOP (Roche) to 10 ml of Buffer. 
 
SDS PAGE separating gel 7.5% (10 ml) 
H2O 4.85 ml 
1.5M Tris pH 8.8, 0.4% SDS 2.6 ml 
30% (w/v) Acrylamide : 0.8% (w/v) Bis-Acrylamide 2.5 ml 
10% APS 50 μl 
TEMED 5 μl 
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SDS PAGE stacking gel 4% (5 ml) 
H2O 3.05 ml 
1.5M Tris pH 6.8, 0.4% SDS 1.3 ml 
30% (w/v) Acrylamide : 0.8% (w/v) Bis-Acrylamide 0.65 ml 
10% APS 50 μl 
TEMED 5 μl 
 
6x Sample buffer for reducing conditions 
12% SDS  
300 mM Tris-HCl, pH 6.8  
600 mM DTT  
0.6% BPB  
60% Glycerol 
Distilled water.  
Stored at -20°C. 
 
5x Electrophoresis buffer 
Tris base 154.5 g 
Glycine 721 g 
SDS 50 g 
Distilled water was added to 10 L. Stored at RT. 
 
Protein transfer buffer 
Tris base 3.03 g 
Glycine 14.4 g 
Methanol 200 ml 
Approximately 650 ml of distilled water were added. Mixed to dissolve and made up to 
a final volume of 1 L. Stored at 4°C. 
 
Sodium phosphate buffer, pH 7.2 
1M Na2HPO4 60.5 g 
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1M NaH2PO4 31.6 g 
2% SDS 
Distilled water was added to 1 L. Stored at RT. 
 
PBS-Tween (PBS-T) 
1x PBS 
0.1% Tween®20 
Stored at RT. 
 
BABB 100% 
1 part Benzyl alcohol 
2 parts Benzyl benzoate 
Protected from light and stored at RT. 
 
BABB 50% 
50% BABB 
50% MetOH 
Protected from light and stored at RT. 
 
Blocking solution 
0.2% Gelatine 
0.5% Tritonx100 
50% NCS 
in PBS. 
 
PGT and TGT buffer 
0.2% Gelatine 
0.5% Tritonx100 
in PBS or TBS, respectively. 
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Dextrantetramethylrhodamine 3000MW, lysine fixable 20 mg/ml in PBS (Molecular 
Probes) 
 
Lysis buffer (Cell lysate for DNA extraction) 
10mM Tris pH 8.0 
10mM NaCl 
10mM EDTA 
0.1% SDS 
0.2-0.4mg/ml Proteinase K 
0.1mg/ml RNaseA 
Distilled water 
 
TNE 
100mM Tris pH 8 
5mM EDTA 
200mM NaCl 
Distilled water. 
 
Church Buffer 
1% (w/v) BSA 
1 mM EDTA 
0.5 M Phosphate Buffer 
7% (w/v) SDS 
 
Denaturing Buffer 
0.4 M NaOH 
1M NaCl 
 
Neutralizing Buffer 
0.5 M Tris pH7.5 
1M NaCl 
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Phosphate Buffer 
134g Na2HPO4-7H20 
4 ml of 85% H3PO4 
H20 to 1 L 
 
Washing Buffer I 
5% SDS 
40 mM Phosphate Buffer 
1mM EDTA 
0.5% BSA 
 
Washing Buffer II 
1% SDS 
40 mM Phosphate Buffer 
1mM EDTA 
 
4.2.12. Mouse lines 
Ret knockout mice were generated by Edgar Kramer [196] and maintained in a 
C57Bl6/J genetic background. 
 
EphA4 knockout mice were generated in Andrew W. Boyd laboratory [150], and 
maintained in a mixed 129 x C57Bl6/J genetic background. 
 
EphA4CR knock-in mice were generated by me, and maintained in a C57Bl6/J genetic 
background. 
 
PGK-Cre transgenic mice were generated by Yvan Lallemand [280]. The mice were 
used to remove the neo-cassette in the EphA4CR knock-in mice. 
 
PTPRO knockout mice were generated by Wiggins [281], received by the John Bixby 
laboratory and maintained in a mixed 129/P3J x C57Bl6/J genetic background.  
 
Hb9-GFP transgenic mice were generated by Hynek Wichterle [243] and received from 
the Jackson Laboratory. 
 
GDNF knockout mice were generated by Mark Moore [67], an maintained in a C57Bl6/J 
genetic background 
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4.3. Methods 
4.3.1. Molecular Biology 
4.3.1.1. Preparation of plasmid DNA  
Cultures of a single colony of transformed bacteria were grown overnight at 37°C in 
LB containing 100μg/ml ampicillin or kanamycin. Using the Qiagen Plasmid kits DNA 
was purified from small-scale (Miniprep) or large-scale (MaxiPrep) bacterial cultures. 
DNA concentration was measured using the Nanodrop. 
4.3.1.2. Transformation of competent E. coli by electroporation 
1-2 µl of plasmid DNA was added to 50μl of electrocompetent bacteria (DH5α from 
Invitrogen), and the mix was transferred to pre-chilled 0.2 cm cuvettes. Cuvettes were 
placed in the electroporation chamber and a pulse of 25 μF (2.5 k, 200 Ω) was given.  
After the pulse, cells were resuspended in 200μl of LB medium and placed at 37°C to 
recover for 45 minutes. Bacteria were then plated on LB plates with the required 
antibiotics for selection. Plates were incubated overnight at 37°C. 
4.3.1.3. Site-direct mutagenesis 
Mutations were introduced in the EphA4 over-expression construct using specific 
primers (mentioned in the cloning primers table, section 4.2.2.1) and high-fidelity PFU-
Phusion polymerase (NEB). After the PCR reaction, the restriction enzyme DpnI was 
added to the reaction to digest methylated DNA (template) for 1 hour at 37°C. DNA was 
then purified using the PCR purification kit and transformed in DH5α bacteria. Positive 
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mutants were screened by digestion (since site-direct mutagenesis created new restriction 
sites) or sequencing. 
4.3.1.4. TOPO cloning 
Specific primers were used to amplify EphA4 cDNA with PFU Turbo DNA 
polymerase (Invitrogen) and cloned into the pCRIITOPO vector. 4μl of linearized DNA 
(PCR product), 1μl of 1:4 diluted salt solution and 1μl of TOPO vector were mixed and 
incubated at RT for 15 min. DH5α cells were the transformed with this mix. Bacterial 
clones were screened by digestion to determine the orientation of the inserted DNA. 
4.3.1.5. Tail DNA preparation and genotyping using PCR 
To genotype mice or embryos, DNA was extracted from tail, forelimb or yolk sac 
biopsies. Tissues were incubated with 100μl of 50mM NaOH for 45 minutes at 95°C and 
afterward the solution was neutralized with the addition of 10μl 1.5mM Tris-HCl (pH 
8.8) and stored at 4°C.  
For the PCR reaction:  
2μl of DNA 
2.5mM dNTPs, 
50mM primers 
1X PCR Buffer (NEB) 
0.5μl of Taq polymerase (NEB) 
Distilled water to 50μl 
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Program Denaturing Denaturing Annealing Extension 
N. 
cycles 
Cre 94°C for 2’ 94°C for 1’ 67°C for 1’ 
72°C 
for 2’ 
40 
EphA4 WT 95°C for 2’ 95°C for 30’’ 60°C for 1’20’’
72°C 
for 1’15’’ 
30 
EphA4 KO 95°C for 3’ 94°C for 1’ 65°C for 1’ 
72°C 
for 1’ 
38 
EphA4KI-GG 95°C for 1’ 95°C for 1’ 60°C for 1’ 
72°C 
for 1’ 
38 
EphA4GG 95°C for 1’ 95°C for 1’ 60°C for 1’ 
72°C 
for 1’ 
38 
Ret WT 94°C for 1’ 94°C for 20’’
62°C 
for 20’’ 
72°C 
for 40’’ 
35 
Ret KO 94°C for 1’ 94°C for 20’’  
72°C 
for 1’ 
35 
HB9-GFP 94°C for 1’ 94°C for 1’ 68°C for 1’ 
72°C 
for 1’ 
36 
PTPRO 94°C for 2’ 94°C for 30’’
56°C 
for 45’’ 
72°C 
for 45’’ 
36 
GDNF 94°C for 3’ 94°C for 15’’
56°C 
for 30’’ 
72°C 
for 30’’ 
40 
   
4.3.1.6. Agarose gel electrophoresis  
PCR or enzymatic digestion products were loaded on 1% or 2% agarose gels. Agarose 
was dissolved in 1X TAE and boiled. Once cooled, ethidium bromide (1:20000 Roth) 
was added, the solution was poured into a gel chamber, and combs were added. Combs 
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were removed after the gel was solidified. Gel was then placed into an electrophoresis 
chamber filled with 1X TAE. Samples were loaded into the wells and separated for 10-30 
minutes at ~200V. DNA was then visualized under UV light using a gel documentation 
system (BioRad). 
4.3.2. Cell culture 
4.3.2.1. Propagation, thawing and freezing of mammalian cells 
Hela, HEK293 or SKN cells were grown at 37°C with 5% CO2 in appropriate growth 
medium. Confluent cells were washed with warm 1X PBS before splitting, and then 
incubated at 37°C with 1ml of Trypsine/EDTA (Invitrogen) for ~2 minutes. Fresh 
medium was added and cells were harvested and centrifuged at 1200 rpm for 3 minutes at 
RT. Supernatant was then discarded and cells were gently resuspended and seeded. Cells 
were frozen in 10%DMSO and 90% FBS. They were first kept at -80°C overnight and 
then transferred to the liquid nitrogen tank. Cells were thawed in warm medium, 
centrifuged at 1200 rpm for 3 minutes at RT to remove DMSO, resupended and seeded. 
4.3.2.2. Transfection of cell lines using Lipofectamine 
Cells were transiently transfected using Lipofectamine2000 (Invitrogen) according to 
the manufacturer protocol. Briefly, Lipofectamine was mixed with DMEM in an 
eppendorf tube and incubated for 5 minutes at RT. DNA was then added to this mix (3 µl 
Lipofectamine per 1 µg DNA) and the reaction was incubated for 15 minutes at RT. The 
mix was then added to the cells, and medium was changed after 5-6 hours. For Hela and 
SKN cells, growth medium was changed to OPTIMEM Glutamax, just before 
transfection.  
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4.3.2.3. Primary culture of dissociated mouse trigeminal neurons 
4-well plates were coated with poly-ornithine (diluted 1:1000 from stock) overnight 
at RT. Plates were then washed 3 times with water, air dried for 2 hours at RT, and 
incubated with 20μg/ml laminin for at least 3 hours at 37°C and 5% CO2. Pregnant 
females were sacrificed by cervical dislocation, and uteri were removed from the 
abdomen. Embryos were taken out of the uteri and placed in ice-cold L15 medium 
(Invitrogen). Two coronal cuts were made through the head using tungsten needles, in 
order to dissect the region delineated by the area just above the eye and the area between 
the maxillary and mandibular processes. The trigeminal ganglia were then exposed by 
cutting in front of the hindbrain curvature and behind the eyes. Adherent mesenchymal 
tissues surrounding the ganglia were removed with tungsten needles and ganglia 
collected in L15 medium with a 1 ml pipette tip in a falcon tube. L15 medium was 
replaced with 1ml of HBSS (Invitrogen), and 50 µl of trypsin were added, and ganglia 
were incubated for 5 minutes at 37°C. Medium was the removed and ganglia washed 
twice with 10ml of F12 (Invitrogen) supplemented with 10% of horse serum. Neurons 
were then centrifuged at 2000rpm for 2 minutes and resuspended in F12 medium 
supplemented with 10ng/ml NGF (R&D) or as indicated in the result section. Using a 
Pasteur pipette neurons were dissociated by triturating them for at least 20 times. 
Dissociated trigeminal neurons were then seeded onto 4-well plates and put in the 
incubator at 37°C and 5% CO2. Neurons were grown for 18 hours in F12 medium 
supplemented with 10ng/ml NGF, and where indicated, 5ng/ml BDNF (R&D) or 5ng/ml 
GDNF (R&D) were added to the culture medium. Neurons were fluorescently labelled 
with calcein-AM (Invitrogen) and imaged using an Axiovert 200M microscope (Zeiss) 
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with a 10X objective. Neurite length and number of branches were quantified as 
described in [238]. For culture in the presence of caspase inhibitors, neurons were grown 
on coverslips. Coverslips were smoothed with nitric acid for 24-36 hours at RT, and then 
extensively washed for 2-3 days in water, dried and autoclaved. Coverslips were then 
coated as above described for 4-well plates. E12.5 dissociated trigeminal neurons where 
then seeded on the coverslips and grown for 18 hours in F12 supplemented with 10µM 
Q-VD-Oph (Calbiochem) and NGF, BDNF or GDNF as indicated. Neurons were stained 
with Cell Tracker Green (Invitrogen), fixed 5 minutes with 4% PFA on ice, and 
coverslips were mounted using Dako fluorescent medium. Images were acquired using a 
Zeiss epifluorescent microscope. Explant cultures of trigeminal neurons from E12.5 
embryos were grown on poly-D-lysin/laminin coated coverslips for 15 hours in F12 
medium supplemented with 10ng/ml NGF at 37°C and 5% CO2. 
4.3.2.4. Explant of trigeminal neurons 
Lysine pre-coated coverslips (BD Bioscience) were incubated with 50µg/ml laminin 
for at least 3 hours at 37°C and 5% CO2. Trigeminal ganglia were dissected as mentioned 
above and cut in 4 pieces. 2-3 trigeminal explants were placed onto the coverslips and 
grown in F12 medium supplemented with 10ng/ml NGF for 18 hours at 37°C and 5% 
CO2.  
4.3.2.5. Primary culture of dissociated mouse motor neurons 
Coverslips were then coated with poly-ornithine (diluted 1:1000 in water from stock) 
for 30 minutes at RT, air dried for another 30 minutes and incubated with 5μg/ml laminin 
at 37°C and 5% CO2 for at least 3 hours before seeding the neurons. Hb9-GFP
+ E12.5 
embryos were dissected in ice cold 1X HBSS. Embryos were decapitated and the spinal 
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cord was opened along the dorsal side along its length. The spinal cord was then 
separated from the embryo. Open book preparation of the spinal cord was then pinned on 
an agarose plate and using a fluorescent microscope (to detect Hb9-GFP expression) 
motor neuron were identified. The lower half of the lumbar LMC was dissected using 
fine scissors and a scalpel. The lower half was then cut into small pieces. Using a 1 ml 
pipette tip the spinal cord fragments were transferred into 1 ml of HAM-F10 (Invitrogen), 
later replaced with 1 ml of fresh HAM-F10 plus 10 μl of trypsin (2.5% w/v). The mix 
was incubated at 37°C with frequent shaking. After 10 minutes, the supernatant was 
discarded and fragments were triturated in a mix of 0.8ml L15 complete medium without 
bicarbonate (medium M) + 100μl BSA (4% w/v in L15) + 100μl DNase (1 mg/ml in 
L15).  After leaving the mix to settle for 2 minutes, the supernatant was collected in 
another tube, and the residual fragments were triturated again in a mix of 0.9 ml of L15 
complete medium without bicarbonate + 100μl of BSA (4% w/v) + 20μl of DNase (1 
mg/ml in L15 medium). After 2 minutes, the supernatant was again collected and 
transferred to the same tube as before. A 2ml BSA (4% w/v) cushion was dispensed to 
the bottom of the tube containing the pooled supernatants using a long Pasteur pipette. 
The dissociated cells were centrifuged for 5 minutes at 1500 rpm and resuspended 4 
times with a 1 ml pipette tip in 1 ml of Neurobasal complete. Approximately one half of a 
spinal cord was seeded per coverslip. Growth factors [BDNF (1ng/ml), CNTF (10ng/ml) 
and GDNF (1ng/ml)] were added to NB medium just before seeding. 
4.3.2.6. Explant culture of mouse motor neurons 
Lysin pre-coated coverslips were coated under sterile conditions with 50μg/ml 
laminin for at least 3 hours at 37°C or alternatively overnight at 4°C. Open book 
Materials and Methods 
 
136 
 
preparation of the spinal cord was done as previously described, however in this case the 
spinal cord fragments were smaller (around 10 per lower half of lumbar LMC). 3 to 6 
explants were seeded onto coated cover slips and incubated at 37°C and 5% CO2. 
4.3.2.7. Primary culture of dissociated cortical neurons 
Coverslips were coated overnight with poly-lysine at 37°C. The day after, they were 
washed and incubated with laminin for at least 3 hours at 37°C. Forebrain neurons were 
dissected from E16 embryos. Embryos were collected in HBSS, decapitated, and brains 
were dissected from the opened skull. Samples were placed in dissociation medium, 
forebrains were isolated and meninges removed. Samples were incubated at 37°C with 
1mg/ml pre-activated (incubated 20 minutes at 37°C) Papain (Sigma) in HBSS for 10-15 
minutes, washed 3 times at RT with 10mg/ml Trypsin inhibitor solution (Roche) and then 
resuspended in Neurobasal medium (Invitrogen). Neurons were dissociated with a round 
glass Pasteur pipette, counted and plated onto coated coverslips. Cultures were incubated 
at 37°C and 5% CO2 for 1 to 7 days, according to the experimental design. 
4.3.3. Biochemistry 
4.3.3.1. Cell lysis and immunoprecipitation of proteins 
Transfected cells were washed in PBS and then incubated with Lysis Buffer for 20 
minutes on ice. Lysates were then transferred in eppendorf tubes and centrifuged at 4°C 
for 15 minutes at 13000rpm. Spinal cords or other tissues were lysed in 100 µl of Lysis 
Buffer. Protein concentration was measured using the DC Protein Assay (BioRad). Equal 
amount of protein from different samples were incubated in a final volume of 1ml with 2 
μl of the specific antibody overnight on the rotating wheel at 4°C. 40μl Protein-A coupled 
sepharose beads were added to each tube and incubated on the rotating wheel for two 
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hours at 4°C. For immunoprecipitation of proteins with a Flag-tag, lysates were added to 
M2-Flag beads (Sigma), already conjugated with the antibody. Supernatant was discarded 
and beads were then washed 3 times with Lysis Buffer. Beads were then resuspended in 
25µl of 2X SDS sample buffer and boiled at 95°C for 10 minutes before loading on a 
7.5% SDS-PAGE gel.  
4.3.3.2. Immunoblotting 
Proteins were separated by SDS-PAGE on a 7.5% gel, running at 124V for 1 hour 
and 30 minutes. Proteins were then transferred onto a nitrocellulose membrane 
(Whatman) by semi-dry blotting (10V for 2 hours). Nitrocellulose membranes were then 
blocked in 5% BSA in PBS (for phospho-antibodies) or in 5% Milk in PBS for at least 30 
minutes at RT. Primary antibodies were applied in 1% BSA in TBS or in TBS-T (for 
phospho-antibodies) or in PBS overnight at 4°C while rocking on a shaker. The 
membranes were washed with PBS-T for 5 minutes at least 3 times before incubation 
with the secondary antibodies for 1 hour at RT. After at least 3 washes of 5 minutes with 
PBS-T, the membranes were incubated with 1 ml of ECL solution (Amersham) and 
exposed to X-ray films (Amersham). If subsequent detection of another protein was 
necessary the next antibody (raised in a different species) was applied in 0.03% Na-
Azide. 
4.3.4. Immunofluorescence 
Hela cells or neurons grown on glass coverslips (Marienfeld) were stimulated 
according to experimental design, and rinsed with ice-cold PBS. Hela cells were fixed 
with 4% PFA/8% sucrose 20 minutes on ice, while neurons with 4% PFA for 2 minutes 
at RT. After rinsing with PBS, they were incubated with 50mM Ammoniumchloride for 
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10 minutes at RT, rinsed again and permeabilised with PBS-0.1% TritonX-100 for 5 
minutes on ice. Cells were washed 3 times for 5 minutes in PBS and then incubated with 
blocking solution (2% BSA, 4% Donkey serum in PBS) for 30 minutes at RT. Samples 
were incubated with the specific primary antibodies diluted in blocking solution for 2 
hours at RT, washed 3x with PBS and incubated for 1 hour at RT with secondary 
antibodies conjugated to fluorophores, also diluted in blocking solution. Coverslips were 
washed 3 times for 5 minutes at RT with PBS and incubated with a 1:10000 dilution of 
Cell Mask Blue in PBS for 10 minutes at RT. Coverslips were then washed in PBS and 
mounted using DAKO fluorescent medium or with “Antifade Prolong” mounting 
medium (Molecular Probes).  
4.3.5. Mouse work 
Cultures from Hb9-GFP+ embryos were done using CD1 females. Mice were 
genotyped using DNA from tail biopsies and ear-tagged. The morning after setting up the 
breeding, vaginal plugs were checked and counted as day 0.5 of pregnancy.  
4.3.6. Histology 
4.3.6.1. Cryostat sections 
The lower half (hindlimbs+tail) of PFA fixed embryos was embedded in OCT 
medium (Tissue Tek) and left in dry ice for few minutes to harden. 25 µm to 40 µm 
sections were cut using a Leica Cryotome and collected on coated glass slides (Menzel-
Gläser). Sections were left to dry for at least 2 hours at RT and later stored at -20°C. 
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4.3.6.2. Whole mount Neurofilament staining 
E11.5 and E12.5 embryos were fixed overnight in Dent`s solution (1 part DMSO; 4 
parts methanol). Then, they were bleached in one part 30% H2O2 – two parts Dent’s 
Solution for several hours at RT. Three washing steps (1 hour each at RT) in PBS 
containing 0.2% Gelatin and 1% Triton X-100 (SIGMA) were followed by incubation 
with the anti-neurofilament antibody (NF-160 from Sigma 1:300 in 4 parts newborn calf 
serum, 1 part DMSO) overnight at RT. Five washing steps in TBS containing 1% Triton 
X-100 and 0.2% gelatin for 1 hour each were followed by incubation with anti-mouse 
HRP-conjugated antibody (1:300 in 4 parts newborn calf serum, 1 part DMSO) overnight 
at RT. Finally, embryos were washed and incubated with diaminobenzidine working 
solution followed by dehydration in methanol and clearing in BABB. Images were 
acquired using the DC150 camera from Leica and analyzed using ImageJ or NeuronJ. 
The ophthalmic nerve phenotype at E11.5 was quantified as the ratio between the area of 
the ophthalmic nerve arbor and the area of the maxillary nerve arbor. The ophthalmic 
nerve arbor complexity at E12.5 was analyzed using the Sholl analysis plug-in of 
NeuronJ. The hindlimb phenotype at E11.5 was quantified as the ratio between the length 
of the tibial nerve and the length of the peroneal nerve. The bifurcation of the sciatic 
nerve was considered as the origin and the distal termination of each nerve was 
considered as the end point. The hindlimb phenotype at E12.5 was quantified as the ratio 
between the diameter of the tibial nerve and the diameter of the peroneal nerve. 
4.3.6.3. Staining of tissue sections 
E10.5, E11.5, E12.5, E15.5 embryos and newborn pups were fixed in 4% PFA for 2 
hours or overnight at 4°C, and then incubated overnight in 30% sucrose at 4°C. 30 µm 
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cryostat sections were blocked in 4% Goat Serum, 4% Donkey Serum, 2% BSA, 0.3% 
triton in PBS. Primary antibodies were applied overnight in 4% Goat Serum, 4% Donkey 
Serum, 2% BSA, 0.1% triton at 4°C. After 3 washes of 15 minutes in PBS, sections were 
incubated with secondary antibodies (1:200) for 1 hour at RT. After 3 washes of 15 
minutes in PBS, cryosections were mounted using Dako fluorescent medium. Images 
were acquired using the Axioplan epifluorescent microscope (Zeiss). For analysis of 
colocalization and to count neurons, images were acquired using the confocal microscope 
(Spinning Zeiss Axio Observer Z1 with a Yokagawa Spinning Disk Confocal Unit and a 
Cool SNAP HQ2 CCD Camera).  
4.3.6.4. Labeling of explant cultures and dissociated motor neurons 
Trigeminal explants were stimulated for 30 minutes with 0.5µg/ml pre-clustered 
ephrinA5 or with 0.5µg/ml pre-clustered human IgG Fc-fragments as a control. Motor 
neuron explants were stimulated for 30 minutes with 0.1µg/ml and 0.5µg/ml pre-
clustered ephrinA2/A5 (mixed 1:1), or with 0.1µg/ml and 0.5µg/ml pre-clustered 
ephrinB2, or with 0.1µg/ml and 0.5µg/ml pre-clustered human IgG Fc-fragments as a 
control. Explants were fixed twice for 30 minutes in 2% PFA-15% sucrose, blocked and 
permeabilised in 0.5% Triton X-100, 1% BSA in PBS and then stained using anti-
Phalloidin568. Coverslips were mounted using Dako fluorescent medium and images 
acquired with an Axioplan epifluorescence microscope (Zeiss). 
4.3.6.5. Motor neuron retrograde tracings 
E12.5 embryos were eviscerated and the lower halves were kept in DMEM/F-12 
medium (Invitrogen) aerated with 5% CO2/95% O2. The lower halves were pinned on an 
agarose plate and injected in the ventral or dorsal shank of the hindlimb with a solution of 
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6% lysine-fixable tetramethylrhodamine-dextran (MW 3000, Invitrogen) in PBS with 
0.4% Triton X-100. After injection, they were left bubbling in 5% CO2/95% O2 for 5-6 
hours at RT. They were then fixed for 1 hour at 4°C with 4% PFA, and incubated 
overnight in 30% sucrose at 4°C. The day after, they were washed in PBS and embedded 
in OCT medium. 
4.3.7. Generating EphA4CR/CR knock-in mouse 
4.3.7.1. Cloning 
A knock-in targeting construct for ephA4 was generated by Klas Kullander by fusing 
the wild-type EphA4 cDNA in frame to exon III within the 5.5 kb long arm of the vector. 
At the 3’ site the construct contained a poly(A) tail, a PGK-driven neo cassette flanked by 
loxP sites and a 1.2 kb short arm. EphA4CR cDNA was cloned into this targeting vector. 
This construct encodes EphA4 with 15 amino acids in the extracellular juxtamembrane 
domain replaced by the correspondent 13 amino acids of the EphA3 sequence. 
4.3.7.2. ES cells culture and DNA electroporation 
ES cells were maintained in an undifferentiated status in ES cell medium and cultured 
them on a monolayer of feeder cells [mouse embryonic fibroblast (MEF)] on gelatinized 
plates. ES cells were seeded in a 10cm dish and when confluent, cells were electroporated 
with 35 µg of linearized target vector (linearized using NheI overnight at 37°C) by the 
application of a 0.24kV/375µF pulse. After electroporation cells were removed from the 
cuvette, diluted in 50ml of ES cell medium supplemented with 150µg/ml neomycin 
(G418) and seeded in five 10cm dishes, pre-coated with MEFs. After a week, cells were 
washed with PBS and single colonies were picked, trypsinised and seeded in a 96 well 
plate containing feeder cells. 
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4.3.7.3. DNA extraction 
96 well plate: ES cells clones were grown in three 96 well plates until confluent. ¾ of 
the trypsinised cells were frozen down and ¼ were expanded to extract DNA. Briefly, 
media was removed completely and 100 µl of Lysis Buffer were added to each well. The 
plate was sealed, placed in a “wet chamber” and incubated for 1 day at 55°C. DNA was 
then precipitated by adding 12 µl of 8M LiCl and 110µl isopropanol to each well, and 
incubated for 2 days at 4°C. Samples were then centrifuged for 40 minutes at 4000rpm at 
4°C. The supernatant was discarded and DNA was washed with 70% ethanol. DNA was 
then air-dried, and resuspended in 110 µl TE (10 mM Tris, 1 mM EDTA, pH=8).  
6 well plate: When cells reached high confluency, they were detached by adding 0.5 
ml PBS-5 mM EDTA for 10 minutes at 37°C. Cells were harvested and centrifuged for 
10 minutes at 10000rpm at RT. Supernatant was discarded, 300 µl of TNE were added 
before vortexing. Then 300 µl of TNE supplemented with 0.4% SDS and 400 µg/ml 
Proteinase K were added and solution incubated overnight at 55°C. The day after, 600 µl 
of isopropanol were added and samples were centrifuged at 13200 rpm for 15 minutes. 
Supernatant was discarded and DNA pellet washed with 70% ethanol. DNA was air-dried 
and resuspended in 500 µl TE overnight at 55°C. 
4.3.7.4. Southern Blot 
To screen for positive clones 80ng of DNA were digested overnight with BamHI 
(1µl) at 37°C. Digestion was checked on a 1% Agarose gel and if not completed, 1µl of 
enzyme was added and reaction was carried on for one more hour at 37°C. Samples were 
then loaded on a 0.8% Agarose gel and run at 80-100V for 3 hours. The gel was washed 
twice for 20 minutes in Denaturing Buffer, while the membrane was washed in H2O and 
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Denaturing Buffer for 20 minutes. DNA was transferred by capillarity onto the 
membrane overnight at RT. The day after, the membrane was washed twice for 20 
minutes in Neutralizing Buffer, and then pre-hybridized with Church Buffer for 2 hours 
at 65°C. Meanwhile, the probe was labeled using an Amersham labeling kit. 50 ng of 
probe were denatured at 95°C for 5 minutes and then put on ice. Probe was then mixed 
with 5µl of 32P, water was added to the final volume (50 µl) and the reaction was 
incubated at 37°C for 30 minutes. The labeled probe was then purified by passing it 
through a gel separation column (Amersham). It was then added to the membrane in 20 
ml of Church Buffer, and hybridization was carried overnight at 65°C. The day after, the 
membrane was washed 4 times for 20 minutes in Wash Buffer I, and 4 times for 20 
minutes in Wash Buffer II at 65°C. The membrane was then wrapped in Saran Wrap 
paper and exposed for 1-5 days using a PhosphoImager. 
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